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Abstract
Nonadherence to medications for chronic illnesses is a public health problem that
requires education related to its illnesses and medications in order to reduce morbidity,
mortality, and health care costs, and to improve quality of life. Scholars have identified
that morbidity and mortality are much higher among African Americans due to poor
medication adherence when compared to Euro-Americans. This study focused on African
Americans to increase their medication adherence with chronic illnesses. The purpose of
this study was to analyze the effectiveness of using different educational methods to
enhance medication adherence. The social cognitive theory and the theory of planned
behavior were used as a foundation to develop this quantitative study. Three validated
tools were used to assess the effectiveness of educational methods to see if there would
be any increase in knowledge, self-efficacy, and change in health beliefs. A sample size
of 144 African Americans in Chicago with chronic illnesses was randomized to an
experimental group that received education on medication adherence for a period of 8
weeks through lecture, video presentation, roleplaying, and group discussion. A control
group received regular education for the same 8 weeks. ANOVA, ANCOVA, and
MANOVA statistical methods were used to analyze the findings that reported no
statistical significance in the knowledge difference scores F(1,261) = 0.17, p = 0.678,
self-efficacy difference scores F(1,259) = 0.96, p = 0.328, and health beliefs difference
scores F(4,258) = 0.46, p = 0.765. This study contributes to social change by identifying
a public health problem which can be improved by adding and testing other variables
such as fatigue and cognitive and sensory deficits associated with chronic illnesses,
which could yield a more valuable in-depth understanding.
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Chapter 1: Introduction of the Study
In the 21st century, people are living longer, which has led to an increase in the
prevalence of chronic illnesses such as hypertension, high cholesterol, chronic kidney
diseases, diabetes, congestive heart failure, asthma, arthritis, and other chronic conditions
(Williams, Manias, & Walker 2008; Wolff, Starfield, & Anderson 2002). Many of the
hospitalizations for these chronic illnesses could have been halted or averted if people
had received appropriate health care including effective health promotional work to
prevent further decline of these chronic illnesses to improve their quality of life
(Williams et al., 2008; Wolff et al., 2002). Wolff et al. (2002) explained that almost
every person above the age of 60-65 is diagnosed with two or more chronic conditions,
and some even live with four or more chronic illnesses resulting in an increase of 95% of
Medicare expenditures. Multiple chronic illnesses affect the burden of total health status,
which could have an increased negative impact on an individual’s total health beyond the
sum of the effects of each health condition. Verbrugge, Lepkowski, and Imanka, (1989);
de Groot, Beckerman, Lankhorst, and Bouter (2003), Williams (2004), and Tong and
Stevenson (2007) explained the seriousness of negative conditions on the influence of
chronic illnesses. Wolff et al. placed more importance on medication adherence with
chronic illnesses to explain how Medicare expenses continue to increase with chronic
illnesses. Wolff et al. tried to explain that people with chronic illnesses, who receive
Medicare help for their healthcare and do not take their medications as prescribed to
control their chronic illnesses, are more likely to develop serious adverse consequences in
their health resulting in frequently visiting urgent care as well as hospitalization, which
leads to further increases in Medicare expenditures.
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Chronic illnesses cluster with other chronic illnesses (Wolff et al., 2002) and a
person with one chronic Illness is most likely to have other chronic illnesses (Wolff et al.,
2002). For this reason, health promotion on medication adherence plays a key role in
controlling and preventing chronic illnesses (Cutler & Everett, 2010). Several scholars
have explained that poor medication adherence is an epidemic in the United States
(Vlasnik, Aliotta, & DeLor, 2005) and half of all patients with chronic illnesses do not
take their medications as prescribed for various reasons (Cutler & Everett, 2010; Haynes,
McDonald, & Garg, 2002; Osterberg & Blaschke, 2005; Vlasnik et al., 2005).
There are a number of factors that affect medication adherence, including lifestyle
(Cutler & Everett, 2010), psychological issues such as low self-efficacy (Bandura, 2004,
1977), health literacy (Vlasnik et al., 2005), support systems (Cutler & Everett, 2010),
and side effects of medications (Haynes et al., 2002). In addition, racial and ethnic
disparities have a role in medication adherence and in preventing and controlling chronic
illnesses (Downie et al., 2011). African Americans have high death rates because of
many chronic illnesses (Downie et al., 2011) such as hypertension, high cholesterol,
diabetes, stroke, cardiovascular diseases (Downie et al., 2011), asthma, and chronic
obstructive pulmonary disease (Mosen et al., 2010). Priest, Cantrell, Fincham, Cook, &
Burch (2011) have explained that numerous researchers have suggested that disparities of
care for chronic illnesses, including medication treatment and adherence, exist between
European Americans and African Americans within the Medicaid population.
Medicaid is financed by the U. S. government to provide health insurance
coverage to the poor, underserved, and vulnerable population in order to get access to
healthcare including acute, chronic, and preventive healthcare. In spite of the efforts that
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the US government has taken, disparities of care continue to exist among the Medicaid
population with treatment, medication adherence, and follow-up care, of which both
African Americans and European Americans are equally affected (Priest et al., 2011).
A patient’s beliefs about medications influences medication adherence (Gatti,
Jacobson, Gazmararian, Schmotzer, & Kripalani, 2009). Gatti et al. (2009) explained that
inner city African Americans have negative beliefs about medications and this negative
belief often results in the conscious decision by individuals to be non-adherent. Patients
in this population may forget to take medications because they perceive that those
medications are unimportant (Gatti et al., 2009). In addition, some unintentional nonadherence is possible among African Americans who, when lacking health information,
do not understand medication instructions and complex regimen, resulting in poor
medication adherence (Gatti et al., 2009).
A health promotion program on medication adherence for African Americans
with chronic illnesses may have long-term benefits in preventing and controlling chronic
illnesses and improving their quality of life. When different educational methods are
used with health promotion, African Americans may gain knowledge, increase their selfefficacy, and change their beliefs. This study was appropriate and significant for African
Americans because in this randomized control trial, I provided further guidance in
improving educational methods that will be culturally appropriate. This study was
particularly relevant and appropriate for African Americans because of the nature of
chronic illnesses and its burden on their lives.
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Background of the Study
Some people do not take their medications as prescribed, which may affect how
they are perceived by their healthcare providers (Krieger, Collier, Song, & Martin, 1999;
Kripalani, Yao, & Haynes, 2007; Osterberg & Blaschke, 2005). An estimated 20 to 50%
of patients do not take their medications as prescribed (Kripalani et al., 2007; Krieger et
al., 1999; Osterberg & Blaschke, 2005), and they are labeled as nonadherent or
noncompliant to medication therapy (Kripalani et al., 2007; Krieger et al., 1999;
Osterberg & Blaschke, 2005). Osterberg and Blaschke (1999, 2005) claimed that when
healthcare providers label patients as non-compliant, they could be stigmatized as
noncompliant and this could jeopardize their future relationship with their healthcare
providers. When people are stigmatized as noncompliant, the therapeutic communication
between the patient and the provider becomes strained, resulting in increased nonadherent behavior, which ultimately jeopardizes the patient’s health (Osterberg &
Blaschke, 2005). The relationship between the patient and the healthcare provider is vital
in enhancing medication adherence (Osterberg & Blaschke, 2005).
Multiple chronic illnesses leads to hypertension (Kripalani et al., 2007; Ogedegbe,
et al., 2007), hyperlipidemia (Kripalani et al., 2007; McDonald, Garg, & Haynes, 2002),
diabetes (Adams et al., 2008), and asthma (Wells et al., 2008), and medication nonadherence leads to worse medical treatment outcomes (Kripalani et al. 2007; McDonald
et al. 2002), frequent hospitalization (Kripalani et al. 2007), increased emergency
department visits and hospitalization (Kripalani et al. 2007; Wells, et al. 2008), and
increased healthcare costs (Kripalani et al. 2007; Ogedegbe et al. 2007). These scholars
have provided evidence on why Medicare expenses continue to increase.
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Medication adherence, combined with lifestyle modifications, reduces mortality
in congestive heart failure (Granger et al. 2005), but adherence to these interventions is
below optimal levels (Granger et al. 2005). Poor adherence limits the effectiveness of
proven therapies, resulting in lost opportunities to reduce mortality and recurrent
hospitalization rates (Granger et al. 2005). Indeed, poor adherence accounts for up to two
thirds of preventable admissions in heart failure and coronary artery disease and is
associated with mortality in patients with other chronic illnesses (Granger et al. 2005).
Many scholars have placed an emphasis on medication adherence with chronic illnesses
and its significance in preventing and reducing morbidity and mortality due to chronic
illnesses (Granger et al., 2005).
Scholars have argued that defining the concept of medication adherence is
confusing because of the complexity that is involved with prescribed medications
(McDonald et al., 2002). The regimen of prescribed medications satisfies empirical,
theoretical, and physiological underpinnings of the healthcare providers, but does not
meet certain requirements that would increase medication adherence such as the patient’s
real needs: patient centeredness and failure to recognize a patient’s concerns such as
nature, nurture, culture, economic background, and other impediments that the patient
experiences (McDonald et al., 2002). Some prescribed regimens are difficult for patients
to adhere to because of the difficulties involved with daily life situations and it becomes
cumbersome, resulting in nonadherence (McDonald et al., 2002). The current methods of
improving medication adherence for chronic illnesses are more complex, labor intensive,
and lack predictability of the outcome (McDonald et al., 2002). There are many
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difficulties involved with prescribed medications for chronic illnesses and promoting
medication adherence becomes a challenge.
Barriers to Medication Adherence
The problem of nonadherence to medications in relationship to chronic medical
conditions has been well recognized by many scholars (van Dulmen et al., 2007), and is
multifactorial and complex (Krousel-Wood, Muntner, Islam, Morisky, & Webber, 2009).
The efforts taken to explain and improve adherence appear to be ineffective (van Dulmen
et al., 2007); most of the interventions are not satisfactory because the theories on the
concept of adherence are not clear enough to explain as to why this behavior is persistent
and difficult to deal with (van Dulmen et al., 2007). The non-adherence behavior rates
have remained unchanged in the past decades.
Adherence to long-term medication therapy remains a problem with chronic
illnesses and it is below optimal level (Simpson, 2006; van Dulmen et al., 2007). There
is a difference in medication adherence between acute and chronic conditions.
Medication adherence is much higher during the acute stage of an illness when compared
to patients with chronic conditions, especially with hypertension, hypercholesteremia,
and asthma and the rates of adherence decreased after 6 months (Simpson, 2006; van
Dulmen et al., 2007). This persistent non-adherence is because healthcare providers fail
to recognize the problem and prescribe the needed treatment in a timely manner.
Furthermore, the instructions on medications lack clarity with dosage and frequency and
as how to take them. Finally, providers fail to involve patients in decision making,
especially with long-term therapy (Simpson, 2006; van Dulmen et al., 2007).
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Patient characteristics play a role in non-adherence (Krousel-Wood et al., 2009;
Simpson, 2006; van Dulmen et al., 2007). These characteristics include advanced age
(Simpson, 2006), patient’s beliefs about medications (Gatti et al., 2009), inadequate
health literacy (Gatti et al., 2009), cognitive impairment and depression (Gatti et al.,
2009; Simpson, 2006), and the fear of potential adverse reactions from medications (Gatti
et al., 2009; Simpson, 2006). Other barriers include polypharmacy, taking too many
medications at one time for four or more chronic conditions, (Simpson, 2006), frequent
dosing (Gatti et al., 2009; Simpson, 2006), and high cost, patients cannot afford to pay for
medications that they need, (Gatti et al., 2009; Simpson, 2006; van Dulmen et al., 2007).
Problems related to the healthcare system also act as a barrier for medication
adherence. These include patients’ lack of access to healthcare (Simpson, 2006; van
Dulmen et al., 2007; Zolnierek & DiMatteo, 2009), a lack of trust between healthcare
provider and patient (Simpson, 2006; Zolnierek & DiMatteo, 2009), a providers’ negative
attitudes towards patients (Simpson, 2006), a patient’s inadequate knowledge on diseases
(Simpson, 2006; Zolnierek & DiMatteo, 2009), and a provider’s lack of value for
prescribed evidence-based guidelines (Simpson, 2006). The World Health Organization
(WHO) identified the barriers that cause poor medication adherence as the following:
current healthcare system, provider-patient relationship, type of illnesses, prescribed
treatment, patient characteristics, and socioeconomic factors (as cited in Zolnierek &
DiMatteo, 2009). There are many challenges to controlling chronic illnesses and
enhancing medication adherence.
To improve medication adherence, successful interventions are needed (Simpson,
2006) and these include patient education (Simpson, 2006), structural support such as
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patient reminders (Simpson, 2006), and more frequent clinic visits or telephone calls
from healthcare providers (Simpson, 2006). Some other scholars have suggested that, in
order to improve medication adherence and assist patients to follow prescribed regimen,
more studies with innovative approaches would be beneficial to patients (Kripalani et al.,
2007; McDonald et al., 2002). Therefore, the purpose of this study was to assess the
effectiveness of different educational methods applied to improve medication adherence.
Problem Statement
Poor adherence to prescribed medications has been identified as a barrier in
controlling chronic illnesses including hypertension, hyperlipidemia, diabetes, asthma,
and Chronic Obstructive Pulmonary Disease (COPD; Bandura, 2004). These chronic
illnesses are contributing factors for increased morbidity and mortality, and poor quality
of life when these illnesses remain uncontrolled because of poor adherence to prescribed
medications (Schoenthaler et al., 2008). Furthermore, African Americans have the
highest prevalence of these chronic illnesses, especially high blood pressure. When
patients do not take medications as prescribed they suffer with severe consequences that
lead to a poor quality of life (Bandura, 2004; Schoenthaler et al., 2008). Factors that
could contribute to non-adherent behavior are race, marital status, substance abuse, low
health literacy, poor understanding, a lack of confidence, complexity of prescribed
medications, and poor socioeconomic status (Bandura, 2004; Schoenthaler et al., 2008;
Vlasnik, Aliotta, & DeLor, 2005).
The author Bandura, in 2004, had expressed greater concern as to how healthcare
expenditure was utilized because of current economic pressure. Bandura (2004) stated
that current health practices focus more on the medical supply side because of growing
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economic pressure on the healthcare system to control cost, resulting in reducing,
rationing, and delaying appropriate healthcare to people including health education
promotion on the prevention of chronic illnesses. Scholars have identified major
problems with written prescriptions that lead to one third of the prescriptions being never
filled, whereby medication nonadherence becomes a pervasive problem in the United
States (O’Reilly, 2011; Vlasnik et al., 2005). The high cost of medications imposes an
epidemic of poor adherence, especially for socioeconomically disadvantaged people who
could not afford to pay for those medications, resulting in failure of treatment (Bandura,
2004; Vlasnik et al., 2005). Many scholars have expressed concern that poor medication
adherence leads to poorer health (Bandura, 2004; Schoenthaler et al., 2008) and frequent
hospitalization, and increases the risk of death (Vlasnik et al., 2005).
Ogedegbe et al. in 2007 addresses that researchers also have to shoulder certain
amount of responsibility in controlling nonadherent behavior through their scholarly
work. Ogedegbe et al. (2007) claimed that a successful intervention designed to improve
medication adherence in African Americans with chronic illnesses requires an effort from
the researcher to incorporate their beliefs and concerns about their health and seek to
include a variety of strategies to promote adherence. Poor adherence to prescribed
medications has been identified as a barrier in controlling chronic conditions, reducing
morbidity and mortality, and improving quality of life for African Americans (Bandura,
2004).
Poor adherence to medications with chronic illnesses imposes a physical and
economic burden not only on the individuals, but also on the USA as a whole (Bandura,
2004). Poor medication adherence leads to increased morbidity and mortality, poor
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quality of life (Schoenthaler et al., 2008), poorer health, and increased hospitalization
(Bandura, 2004; Schoenthaler et al., 2008; Vlasnik et al., 2005). The present healthcare
system focuses more on cost cutting based on reducing, rationing, and delaying care,
which has led to patients’ poor adherence to prescribed medications (Bandura, 2004).
Several scholars, who have emphasized patient education on medication adherence, have
not explained effective use of different educational methods, and scholars, who have
done studies on medication adherence, have provided their study findings based on a
single chronic illness such as hypertension (Ogedegbe et al., 2007), hyperlipidemia
(Kripalani et al., 2007; McDonald et al., 2002), diabetes (Adams et al., 2008), asthma
(Wells et al., 2008), and congestive heart failure (Granger et al., 2005). Bandura (2004)
explained that many chronic illnesses come in clusters and there is a gap left for further
inquiry as to how to confront this significant problem (Bandura, 2004). The purpose of
this study was to investigate the effects of using different educational methods to increase
knowledge, self-efficacy, and change in health beliefs, leading to a social change in
medication adherence behavior.
Nature of the Study
This study was a single, randomized controlled trial with a pretest/posttest design.
Both experimental and control groups received education on medication adherence on
chronic illnesses such as hypertension, hyperlipidemia, diabetes, asthma, and COPD.
The experimental group received education through lectures, video presentations, role
plays, and group discussions, whereas the control group only received regimen education.
Both inferential and descriptive statistical analysis methods were used to examine the
differences between the two groups and to compare and assess the relationship between
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the independent variable, which was educational methods, and the dependent variables,
which were knowledge gain, increase in self-efficacy, and change in health beliefs. I also
determined which educational method becomes more effective in promoting medication
adherence with African Americans.
Research Questions and Hypotheses
Central Question
Is there any significant effect of using different educational methods in enhancing
medication adherence in African Americans with chronic illnesses?
Subquestions
1. Do different educational methods have significant effects on knowledge gain
in medication adherence in African Americans with chronic illnesses?
H01: There will be no significant difference in knowledge gained on
medication adherence between the intervention group and the control
group
H11: There will be a significant difference in knowledge gained on
medication adherence between the intervention group and the control
group
2. Do different educational methods have a significant effect in increasing selfefficacy on medication adherence in African Americans with chronic
illnesses?
H02: There will be no significant difference in self-efficacy on
medication adherence between the intervention group and the control
group
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H12: There will be a significant difference in self-efficacy on
medication adherence between the intervention group and the control
group
3. Do different educational methods have a significant effect in changing health
beliefs in African Americans with chronic illnesses?
H03: There will be no significant difference in health beliefs on
medication adherence between the intervention group and the control
group
H13: There will be a significant difference in health beliefs on
medication adherence between the intervention group and the control
group
A more detailed discussion is included in Chapter 3.
Purpose of the Study
The main purpose of this quantitative study was to analyze the effectiveness of
using different educational methods to enhance medication adherence. I examined how
these educational methods enhanced knowledge, self-efficacy, and change in health
beliefs on medication adherence. I assessed the responses of the experimental group and
the control group. I analyzed the relationship between the independent variable, different
educational methods, and the dependent variables, knowledge gain, increase in selfefficacy, and change in health beliefs.
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Theoretical Framework
Social Cognitive Theory
The theoretical framework for this study was drawn from the social cognitive
theory (SCT; Bandura, 1977) and the theory of planned behavior (TPB; McKenzie,
Neiger, & Thackeray, 2009). The SCT is comprised of a core set of determinants
(Bandura, 2004). These determinants include (a) knowledge of health risks and benefits
of different health practices (Bandura, 2004), (b) perceived self-efficacy that an
individual can exercise control over his or her own health habits (Bandura, 2004), (c)
outcome expectations about the expected costs and benefits for different health habits
(Bandura, 2004), (d) the health goals people set for themselves and the concrete plans and
strategies for realizing them (Bandura, 2004), and (e) the perceived facilitators and social
structural impediments to the changes they seek (Bandura, 2004).
According to Bandura (2004), knowledge on health risks and benefits set the
stage for behavioral change. If people lack knowledge of chronic health conditions and
its consequences on their life, they have little reason to change (Bandura, 2004). It is the
knowledge that acts as a mechanism to influence people (Bandura, 2004) and causes
behavioral change by overcoming impediments through perceived self-efficacy (Bandura,
2004). In this way, perceived self-efficacy enables individuals to seek and to practice
healthy behaviors (Bandura, 1977, 2004).
Self-efficacy is drawn from the SCT (Bandura, 1977). Bandura (1977) defined
self-efficacy as the conviction that a person can successfully execute the behavior
required to produce outcome. Perceived self-efficacy is defined as peoples’ beliefs about
their abilities to produce designated levels of performance in events that affect their lives
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(Bandura, 1994). Perceived self-efficacy challenges individuals to approach difficult
tasks with confidence (Bandura, 1994), and allows them to make a commitment to
challenging goals and to maintain such goals (Bandura, 1994, 2004). In addition, selfefficacy affects motivation and self-determination (Bandura, 1977, 2004).
Self-efficacy is influenced from four models (Bandura, 1977, 1994): (a) mastery
experiences or good performance influences in which a person finds success of his/her
performance that further leads to increased self-efficacy (Bandura, 1977, 1994); (b)
vicarious experiences in which someone else models how to perform a task or to handle a
situation that is difficult to perform without adverse consequences (Bandura, 1977,
1994); (c) verbal persuasion (Bandura, 1977, 1994) in which individuals are convinced,
encouraged, and persuaded through positive reinforcement or feedback to accomplish the
task with great confidence (Bandura, 1977, 1994); and (d) the physiological status of a
person such that anxiety, nervousness, or emotional arousal could influence efficacy
expectations (Bandura, 1977, 1994). A high level of anxiety and fear can have a negative
impact on self-efficacy expectations (Bandura, 1977, 1994).
Self-efficacy affects an individual in all aspects of life, including educational
aspects (Bandura, 2004). Beliefs about a person’s competence to successfully perform a
task can affect motivation, interest, and achievement (Bandura, 2004). The higher the
perceived efficacy, the higher the goal aspirations people adopt, and the firmer their
commitment will be to achieving those goals (Bandura, 2004). Health promotional
activities should foster self-efficacy through different educational strategies (Bandura,
2004). By doing so, the learning environment is structured to deemphasize competition
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(Bandura, 2004), and to highlight self-evaluation of progress to build a sense of selfefficacy, and to promote behavioral change (Bandura, 2004).
Theory of Planned Behavior
The Theory of Planned Behavior is an extension of the theory of reasoned action
(TRA; Ajzen & Fishbein, 1980; Fishbein & Ajzen, 1975; McKenzie et al., 2009). A
central factor in the TPB is the individual’s intention to perform a given behavior, such as
taking medications for chronic health conditions (Ajzen, 1991). The stronger the
intention to engage in a behavior, the more likely that someone will engage in it (Ajzen,
1991). According to Ajzen (1991), some behaviors’ performance depends on nonmotivational factors such as money, skills, time, and resources, and these factors
represent people’s actual control over behavior (Ajzen, 1991; McKenzie et al., 2009).
According to Ajzen (1991), a person’s behavioral achievement depends jointly on
motivation or intention (Ajzen, 1991) and ability to perform a behavior or behavioral
control (Ajzen, 1991). Motivation or intentions can influence performance to the extent
that the person has behavioral control, and performance should increase with behavioral
control to the extent that a person is motivated to try (Ajzen, 1991; McKenzie et al.,
2009).
Ajzen (1991) explained that perceived behavioral control plays a part in the TPB.
In fact, it differs from the Theory of Reasoned Action in its addition of perceived
behavioral control (Ajzen, 1991; McKenzie et al., 2009).
Ajzen (1991) explained that perceived behavioral control is consistent with an
emphasis on factors that are directly linked to a particular behavior. Perceived behavioral
control refers to people’s perception of their ability to perform a given behavior (Ajzen,
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1991; McKenzie et al., 2009). Ajzen explained that perceived behavioral control refers to
the perceived ease or difficulty of performing the behavior, and is assumed to reflect past
experiences as well as anticipated impediments, and obstacles (Ajzen, 1991; McKenzie et
al., 2009).
The more favorable the attitude and subjective norm with respect to a behavior,
and the greater the perceived behavioral control, the stronger should be the individual’s
intentions to perform the behavior under consideration (Ajzen, 1991; McKenzie et al.,
2009). This view of perceived behavioral control is considered similar to Bandura’s
(1997) concept of perceived self-efficacy (McKenzie et al., 2009). Successful
performance of the behavior depends not only on a favorable intention, but also on a
sufficient level of behavior control (McKenzie et al., 2009).
Operational Definitions
African Americans: This term usually refers only to American-born Blacks,
excluding foreign-born Blacks (Kline & Huff, 2007).
Blacks: The US bureau of census uses this term to denote the race of individuals
(as cited in Kline & Huff, 2007).
Chronic illness: The term chronic comes from the Greek chronos (time), and
means lasting a long time (Shiel & Stoppler, 2008). Thus, an illness that persists for a
long period of time is considered a chronic illness (Shiel & Stoppler, 2008).
Medication adherence: Osterberg and Blaschke (2005) defined medication
adherence as the extent to which patients take their medications as prescribed by their
healthcare providers.
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Research Design
I conducted a single-blind randomized controlled trial using a pretest/posttest
design with 142 African Americans between the ages of 18 to 65 years in a southwest
community of Chicago. The participants were diagnosed with and prescribed medications
for hypertension, high cholesterol, diabetes, asthma, and COPD. I assessed the
effectiveness of different educational methods such as lectures, video presentations, role
plays, and group discussions as to how these educational methods could enhance
medication adherence with chronic illnesses by increasing knowledge, self-efficacy, and
change in health beliefs. Three validated tools on medication adherence were used as the
pretest/posttest method. The study findings were analyzed using SPSS software to see
the relationship between the independent variable (educational method) and the
dependent variables (knowledge, self-efficacy, and health beliefs). The interpretation of
the study findings will help readers to understand which educational method is more
effective in improving medication adherence with chronic illnesses in African
Americans.
Study Assumptions
The study assumptions were determined for this particular study from scholarly
works that various scholars presented. Health promotion on medication adherence for
inner city African Americans will bring a greater benefit to their health, and improve
their quality of life. Applying different educational methods such as role play, watching
videos, classroom lectures, and telephone reinforcements may enhance their medication
adherence due to gaining knowledge, increasing their self-efficacy, and changing of their
beliefs. In addition, African Americans may develop a greater interest in their own
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personal health through this educational program, and learn to control chronic illnesses
through the application of those skills that they develop in this program. Also, through
this educational program, they will change their health beliefs, take their medications as
prescribed, and see the benefits of it by experiencing improvements in their quality of
life.
Study Limitations
This study was limited to inner city African Americans between the ages of 18 to
65 years. The study was limited to five chronic illnesses: hypertension, diabetes, high
cholesterol, asthma, and COPD. The study could have been influenced by potential bias
because I was a nurse practitioner providing primary care and was aware of what was
happening in the communities.
Delimitation of the Study
This study was a single-blind randomized control trial and the population
included African Americans with chronic illnesses living in Chicago. The study was
delimited to African Americans who participated in the study on a voluntary basis and
were willing to provide consent. In addition, the study was delimited to participants who
took medications for hypertension, diabetes, high cholesterol, asthma, and COPD.
Significance of the Study
Cardiovascular disease (CVD) is one of the leading causes of death in the United
States (Nichol et al., 2009). Both hypertension and high cholesterol are associated with
CVD (Nichol et al., 2009) and patients with a comorbid diagnosis of the two diseases are
at an increased risk for coronary heart disease events (Nichol et al., 2009). Even though
significant improvement could be demonstrated in controlling blood pressure and lipid

19

profile in the clinical settings (Nichol et al., 2009), long-term adherence and persistence
with prescribed medication regimen remains a common problem in both conditions
(Nichol et al., 2009).
Gerin et al. (2007) explained that untreated high blood pressure is a risk factor for
heart disease and stroke (Gerin et al., 2007), and it places a tremendous financial burden
on US healthcare costs (Gerin et al., 2007). The American Heart Association (AHA,
2004) estimated the direct and indirect costs of untreated high blood pressure to be 55.5
billion dollars (as cited in Gerin et al., 2007). Despite every effort taken to control high
blood pressure, the rate of blood pressure control continues to be poor (Gerin et al., 2007)
and only 30% of hypertensive patients are adequately controlled (Gerin et al., 2007).
According to the Seventh Joint National Committee (JNC-7) guidelines on the
management of hypertension, poor adherence to prescribed antihypertensive medications
is a barrier in achieving adequate blood pressure control (as cited in Gerin et al., 2007)
and the national goal that was set for 2010 still remains far out of reach (Gerin et al.,
2007).
Janson, Earnest, Wong, & Blanc (2008), in their study on asthma medication nonadherence, found that the causes of non-adherence to asthma medication are thought to be
due to a lack of clear understanding of medication directions (Janson et al., 2008) and a
lack of understanding of the roles of control and rescue medications (Janson et al., 2008).
Many people with chronic asthma do not adhere to prescribed treatment (Janson et al.,
2008); either they overuse or underuse inhaled corticosteroids (ICS; Janson et al., 2008;
Krishnan et al., 2004). Other factors that have been identified associated with nonadherence in asthma include beliefs about asthma (Janson et al., 2008), doubts about the
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usefulness of ICS medications (Janson et al., 2008), fear of side effects (Janson et al.,
2008), and among African Americans, distrust of the healthcare system (Janson et al.,
2008). Adherence to asthma medications depends on the type of healthcare providers
such as physicians and non-physician providers (Janson et al., 2008).
Krishnan et al., (2004) described the problems related to frequent urgent care
visits by people with asthma who live in major cities in the US. Krishnan et al., (2004)
explained that medication adherence with asthma is a significant problem among innercity African American populations resulting in worse asthma control. It affects 15 to 20
million people in the United States and is characterized by chronic airway inflammation
and episodic respiratory symptoms (Krishnan et al., 2004) resulting in 465,000
hospitalizations (Krishnan et al., 2004) and nearly 5,000 deaths per year (Krishnan et al.,
2004); the expenditure for hospitalizations represents the single largest portion of the
estimated annual 12.7 billion dollars in asthma-related expenditures (Krishnan et al.,
2004). Also, severe asthma serves as a marker for a poor quality of life (Janson et al.,
2008; Krishnan et al., 2004) and predicts repeated exacerbation (Krishnan et al., 2004),
readmission, and near fatal asthma episodes (Krishnan et al., 2004). These poor
outcomes are particularly common among African Americans and inner city patients and
hospitalization and deaths are two to three times higher among inner city African
Americans than any other population (Krishnan et al., 2004). In this way, the scholars
have expressed their concern that inner-city African Americans suffer with asthma at a
much higher rate that results in early death.
Bolman, Arwert, & Völlink (2010) have asserted that patient adherence to
prophylactic asthma medications (PAM) is critical to successful asthma management
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(Bolman et al., 2010) because non-adherence to medications increases the risks of severe
asthma (Bolman et al., 2010; Krishnan et al., 2004). Non-adherence to PAM are most
likely because of the complexity of treatment due to the type of PAM inhalers with aero
chambers that people are not able to handle effectively and the duration of asthma
symptoms (Bolman et al., 2010). In addition, other patient-related factors that play a
significant role in non-adherence include potential side effects of inhalers, perceived
unpleasantness of inhaling steroids, and insufficient knowledge to recognize early
symptoms (Bolman et al., 2010). Apter, Reisine, Affleck, Barrows, & zu Wallack (1998)
suggested that poor adherence to asthma medication is mainly because of poor
communication between the patient and the healthcare provider (Apter et al., 1998) and
lack of a significant impact of health locus of control on adherence (Apter et al., 1998).
In this way, poor adherence to asthma medications regimens may be contributing to the
recent increase in asthma morbidity and mortality (Apter et al., 1998; Bolman et al.,
2010).
Type 2 diabetes is another chronic illness that affects African Americans
disproportionately (Adams et al., 2008; Hill-Briggs et al., 2005). African Americans with
Type 2 diabetes have an increased rate of blindness as a result of retinopathy (Adams et
al., 2008; Hill-Briggs et al., 2005), a threefold-to-sixfold higher rate of kidney failure
(Hill-Briggs et al., 2005), end-stage renal disease that requires dialysis (Adams et al.,
2008; Hill-Briggs et al., 2005), and non-traumatic lower-limb amputation at a threefold
rate (Adams et al., 2008; Hill-Briggs et al., 2005). Hill-Briggs et al., (2005) cited the
American Diabetic Association (2001) in that the prevalence of Type 2 diabetes in
African Americans is much higher than in European Americans at each level and an
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increased poor glycemic control among African Americans may be a key factor for this
racial disparity (Adams et al., 2008).
The reason for this increased diabetic burden in the African American population
is not well understood (Adams et al., 2008; Hill-Briggs et al., 2005). Many scholars have
suggested that African Americans do not use medical services adequately (Adams et al.,
2008; Hill-Briggs et al., 2005). Geuder-Fredrick, Cox, & Ritterbaud (2002), in a study on
medication-taking behavior in African Americans with type 2 diabetes, showed an
increased association between medication-taking behavior and good metabolic control.
There are many reasons as to why African Americans show lesser adherence to
medications when compared to European American counterparts (Adams et al., 2008;
Hill-Briggs et al., 2005). These reasons include lack of access to a pharmacy in their
communities (Hill-Briggs et al., 2005), patients easily manipulating pill counts through
combining several medications in one pill bottle (Hill-Briggs et al., 2005), racial
differences in medication adherence and other self-management practices (Adams et al.,
2008), and the inability to make decisions (self-efficacy) when circumstances under
which mediations might be missed (Adams et al., 2008; Hill-Briggs et al., 2005). In this
way, diabetes as a chronic condition is greatly dependent on medication adherence
(Schectman, Nadkarni, & Voss, 2002), and this adherence behavior is suboptimal in
African Americans (Schectman et al., 2002).
Gaps in the Research
Choosing appropriate educational methods to enhance medication adherence with
chronic illnesses is a priority in health promotion (Coulter & Ellins, 2007). Scholars have
explained that medication adherence is pertinent and paramount to control chronic
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illnesses (Bandura, 2004; Osterberg & Blaschke, 2005) but have not adequately
explained as how to educate people to enhance medication adherence by increasing
knowledge, self-efficacy, and change in health beliefs (Bandura, 2004, 1977; Osterberg
& Blaschke, 2005). Furthermore, there is a lack of evidence in explaining as to how
educational methods such as lecture, video presentations, role play, and group discussions
could make an impact to improve health outcomes with chronic illnesses (Coulter &
Ellins, 2007; Ogedegbe et al., 2007).
Ogedegbe et al. (2007) explained in their study that there is a lack of evidence for
a successful intervention to be designed to improve medication adherence in African
Americans with chronic illnesses because this requires diligent effort from the
researchers and healthcare providers to incorporate their beliefs and concerns about their
health, and to seek to include a variety of strategies to promote adherence (Ogedegbe et
al., 2007). In addition, many scholars have explained that patient-focused education on
medication adherence is vital, but have not explained as to how the education could
impact an individual to improve health outcomes in bringing social change in reducing
chronic illnesses and their consequences, especially in African Americans (Coulter &
Ellins, 2007; Ogedegbe et al., 2007).
Scholars have suggested that African Americans suffer with poor health status
(Coulter & Ellins, 2007), have increased rates of hospitalization (Ogedegbe et al., 2007),
are less likely to adhere to prescribed treatments and self-care plans (Bandura, 2004;
Schectman et al., 2002), and make less use of preventive services (Coulter & Ellins,
2007). A well-designed educational program, targeting the concerned population, could
bring out relevant positive health outcomes (Bandura, 2004; Coulter & Ellins, 2007).
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Relevant outcomes of education for African Americans include an increase in knowledge,
understanding chronic illnesses, and increase in self-efficacy by managing their
conditions confidently and changing their health beliefs, which results in improved
quality of life (Bandura, 2004; Coulter & Ellins, 2007).
The National Institute of Health (NIH), the Institute of Medicine (IOM), and the
Agency for Healthcare Research and Quality (AHRQ) have recommended and supported
health promotion in various ways, but large gaps still remain about how it could be
improved to bring out relevant health outcomes through different educational methods
(Coulter & Ellins, 2007). Furthermore, despite the large number of studies carried out by
many scholars on medication adherence (Brunton, 2011; Chodosh, et al., 2005; Ogedegbe
et al., 2007), the evidence base still has large gaps (Coulter & Ellins, 2007). Most
scholars have reported some improvement in their studies; however, that improvement
did not last long (Ogedegbe et al., 2007).
The purpose of this study was to assess the effectiveness of using different
educational methods to enhance medication adherence with chronic illnesses in African
Americans. This educational program would be an advantage to African Americans
because the program focuses in helping African Americans to gain knowledge, increase
self-efficacy, and change their health beliefs. Furthermore, this educational program will
enable healthcare providers to increase their competency in health promotion. The study
would further provide compelling evidence to other scholars in health science and health
promotion to carry out further research work. Also, the study will inform policymakers
about the need for promoting educational methods in different ways in order to bring
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better health outcomes, improve quality of life through positive social change, and the
need for adequate funding for health promotion.
Summary of Chapter 1
In Chapter 1, I reviewed the effectiveness of applying educational methods and
their association in enhancing medication adherence with chronic illnesses among
African Americans who live in Chicago. The study participants were inner city African
Americans, both men and women, who are diagnosed with hypertension, diabetes,
hyperlipidemia, asthma, and COPD. In addition, these individuals were prescribed
several medications for each of the illnesses. However, for various reasons, taking these
prescribed medications has become a real challenge to African Americans in that
medication adherence is a significant problem among this group. Scholars have
suggested that chronic illnesses are major contributory factors for increased morbidity
and mortality, and African Americans have the highest prevalence of chronic illnesses.
Furthermore, poor adherence to prescribed medications has been identified as a major
barrier in controlling chronic illnesses, reducing morbidity and mortality, and improving
quality of life for African Americans.
It is necessary to educate people about their illnesses and the importance of taking
medications. Many scholars have suggested that education on medication adherence
requires more innovative approaches in which people’s ideas and beliefs could be
incorporated, thereby increasing knowledge and self-efficacy and changing their health
beliefs. Despite many efforts in educating African Americans on medication adherence,
African Americans consistently demonstrate inadequate knowledge on chronic illnesses
and medications when compared with other racial groups. Current medical evidence
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suggests that it is time now to educate people on chronic illnesses and in selfmanagement of their illnesses through health promotion by applying different educational
methods. Several scholars have proposed various health promotional theories that can be
used in preparing health promotional programs to improve health outcomes. For this
particular study, the application of the social cognitive theory (SCT) and the theory of
planned behavior (TPB) would fit well with the entire study.
Nonadherence behavior rates have remained unchallenged in the last decade
because the theories on chronic illnesses and adherence concepts have not been effective
in leading to behavioral change. The theories of SCT and TPB should be applied in this
educational program to cause behavioral change in inner city African Americans with
chronic illnesses.
An in-depth literature review on chronic illnesses and medication adherence will
be explained in Chapter 2. In Chapter 3, the overall study methodology will be discussed
in detail. This section includes an explanation on study population, randomization
procedures, MMAS, SEAMS, BMQ-18 instruments, pretest/posttest design, and the
analytical process. In Chapter 4, actual study will be presented with necessary tables,
graphs, and other statistical techniques. In Chapter 5, a summary of the entire research
will be undertaken, and there will be discussions and recommendations for future study.
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Chapter 2: Literature Review
Literature Search Strategy
Many scholars wish to study the impact of chronic illnesses on people’s life. The
presence of multiple chronic illnesses increases the burden of the illnesses themselves
(Bandura, 2004; Chodosh et al., 2005; Morisky, Kominski, Afifi, & Kotlerman, 2005).
Chronic illnesses have a negative influence on health status beyond the sum of the effects
of each single illness (de Groot et al., 2003; Tong & Stevenson, 2007; Verbrugge et al.,
1989; Williams, 2004). It is important to manage coexisting chronic illnesses in all
people of all ages, especially in vulnerable populations (Williams et al., 2008). It is
critical to slow down the progression of chronic illnesses, prevent further risks involved,
and to avoid unnecessary costly duplication with conflicting treatments that will have
more adverse effects on health outcome rather than desired outcomes (Williams et al.,
2008).
Ogedegbe et al. (2007) and Schoenthaler et al. (2009) focused on African
Americans’ medication adherent behavior. These scholars examined why medication
adherence is no panacea for African Americans (Ogedegbe et al., 2007; Schoenthaler et
al., 2009). The problem of nonadherence is chronic, pervasive, and continuous in the
African American population (Ogedegbe et al., 2007), leading to medical and health
consequences resulting in unemployment, higher morbidity, and mortality, and poor
quality of life (Ogedegbe et al., 2007; Schoenthaler et al., 2009).
The review of this literature was drawn from empirical findings on the conceptual
framework and research question that guided the study’s hypothesis and research
methodologies. In addition, I examined the literature to determine how different scholars
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have employed different educational methods to enhance medication adherence with
chronic illnesses in African Americans and the relationships between (a) education and
gaining knowledge, (b) education and increasing self-efficacy, and (c) education and
changing health beliefs. I also examine the randomized controlled trials on medication
adherence with chronic illnesses among African Americans and its negative
consequences on their quality of life. The search included empirical findings that have
scholarly descriptions on behavioral components related to medication adherence where
many scholars have documented that medication adherence is a complex behavior
(Morisky, Kominski, Afifi, & Kotlerman, 2009), and the outcome of chronic illnesses
depends on the extent to which people adhere to prescribed medications (Bandura, 2004;
Morisky et al., 2009).
The review of the literature includes the writings of several scholars who have
provided descriptions on chronic illnesses and its impact on African Americans and their
quality of life. Scholars have documented that African Americans experience chronic
illnesses at a much higher rate when compared with other racial and ethnic groups, and
these chronic illnesses include asthma, diabetes, hypertension, and coronary heart disease
(Morisky et al., 2009). Chodosh et al. (2005) identified seven most common chronic
illnesses that are highly prevalent among African Americans: hypertension, heart disease,
diabetes mellitus, respiratory diseases, stroke, arthritis, and cancer.
The literature review consists of an exhaustive search of the literature using
Walden University’s Library asa primary resource. The affiliated academic institution
database indexes were used to identify germane literature for this study. Included are
scholarly writings of Bandura, and many other authors, whose work delved in the
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management of chronic illnesses. The work of these scholars have provided insights into
health disparities among African Americans diagnosed with many chronic illnesses and
the difficulties that they experience with medication adherence (Ogedegbe et al., 1999).
In addition, these authors raised the national consciousness on chronic illnesses (Bandura,
2004) in that medication adherence behavior is the basic requirement in controlling and
reducing the ill effects and the burden of chronic illnesses (Bandura, 2004; Morisky et al.,
2009). Tong and Stevenson (2007) claimed that the management of chronic illness and
its prognosis depends on adherence behavior.
I used the MEDLINE, Academic Premier (EBSCO), Psych Articles (Psyc INFO),
Education Resource Center (ERIC) databases, PubMed, Google plus, OVID, CINAHL,
and Science direct databases to find articles for the literature review. Articles were also
selected from the Journal of the American Medical Association. International studies on
chronic illness management, Lancet, archives of internal medicine, medical care, health
education and behavior, health psychology, vocational behavior and advanced nursing,
and clinical epidemiology were also examined. In order to add credibility and clarity to
this study, I focused on randomized controlled trials on medication adherence with
asthma, COPD, diabetes, hypertension, and hyperlipidemia. In addition, only peerreviewed journal articles that had African Americans as the study participants, and
published after 2000, were chosen. I did not find any study on different educational
methods to enhance medication adherence in any setting with any group of people.
The search terms for this literature review included African Americans, inner city,
chronic illnesses, medication adherence, diabetes, asthma, COPD, hypertension,
hyperlipidemia, self-efficacy, knowledge, health beliefs, barriers to adherence, health
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promotion, health education, and randomized controlled trials. Many of the
epidemiological studies included variation in levels and nature of chronic illnesses and its
health outcomes among different ethnic groups. In this study, I focued on assessing the
effectiveness of using different educational methods to enhance medication adherence
among inner city African Americans who have chronic illnesses.
Different Educational Methods to Improve Medication Adherence
There is no single particular educational method that will bring behavioral change
to improve medication adherence among patients with chronic illnesses (DeYoung,
2009). The problem of medication nonadherence is present among all groups of people
(DeYoung, 2009), and educating culturally diverse learners presents a challenge to health
promotion (DeYoung, 2009). Many scholars have recognized that chronic illnesses such
as diabetes, hypertension, hyperlipidemia, asthma, and COPD are public health problems
(Farmer, 2008; Fitzgerald, 2011) that require multiple medications to bring the conditions
under control (Farmer, 2008; Fitzgerald, 2011; Morisky et al., 2002), and educating
people on medication adherence is critical ( Farmer, 2008; Fitzgerald, 2011; Morisky et
al., 2002).
The extant research on educational methods to improve medication adherence
requires multifaceted approaches (Brunton, 2011; Morisky et al., 2002). Chodosh, and
colleagues (2005) have explained that, because there is no accepted single educational
method that has shown improvement in medication adherence, there is a need for a
combination of educational approaches to convince people to change their behavior
(Chodosh et al., 2005). Education on medication adherence with chronic illnesses should

31

be tailored to meet the individuals’ specific needs and circumstances, such that they
derive benefits from this educational program (Chodosh et al., 2005).
Educating people through group settings, which are affected due to the same
conditions or illnesses, would be culturally appropriate to promote medication adherence
(Chodosh et al., 2005; Ogedegbe et al., 2007). While promoting medication adherence, it
is critical for the educator to realize that individual patients have their own perspective of
their illnesses, and they make decisions based on their beliefs, and illness experiences
(Ogedegbe et al., 2007; Brunton, 2011). In this way, successful educational methods
involve patients’ active participation (Ogedegbe et al., 2007).
Educating through feedback mechanism is an added benefit to patients by
reviewing educational interventions such as reporting on pill counts, blood pressure
readings, and monitoring blood sugar levels (Chodosh et al., 2005; Brunton, 2011)
followed by some form of individual review (Chodosh et al., 2005). These individual
reviews motivate people to change their behavior by helping them to recognize their own
failures and to resolve such failures by setting their personal goals and values for their
own health (Ogedegbe et al., 2007; Chodosh et al., 2005). Motivating through feedback
increases self-efficacy of individuals because this method emphasizes patient
centeredness (Bandura, 2004; Ogedegbe et al., 2007).
A counseling approach is another educational method in which patients must feel
convinced that taking medications will improve their wellbeing (Ogedegbe et al., 2007).
A patient may feel self-efficacious about his/her ability to make changes (Ogedegbe et
al., 2007). Rask et al. (2009) found in their randomized controlled trial with African
Americans (N = 5,000) that counseling, combined with a patient activation method,
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allows patients with chronic illnesses to make sound decisions and to promote their own
health if they are engaged, well informed, and feel confident in their ability to care for
themselves. Ponnusankar, Surulivelrajan, Anandamoorthy, and Suresh (2004), in a
randomized controlled trial (N = 90) in South India, found that patients with a chronic
illness who received counseling showed a significant increase in medication knowledge
and adherence. The counseled group scored 88.10 % in the posttest when compared with
the control group that scored 62.33 % (p < 0.05). The counseling method increases
knowledge and adherence to medications (Ponnusankar et al., 2004).
Education that uses technology and interactive methods is considered to be highly
innovative and revolutionary; this advanced technology can increase the scope, and
impact of health promotion, especially on medication adherence with chronic illnesses
(Bandura, 2004). According to Bandura (2004), using advanced technology and
interactive computer-assisted education provides a convenient means for informing,
enabling, motivating, and guiding people in their efforts to make lifestyle changes
(Bandura, 2004). Meigs and colleagues (2003), based on their randomized controlled
trial on web-based diabetic disease management educational program (N = 307 in the
intervention group, and N = 291 in the control group), found that a web-based diabetic
educational program was effective, and that the intervention group showed a significant
improvement in several clinical areas such as increased rate of testing for AIC levels,
LDL cholesterol levels, and screening foot disease. The levels of AIC decreased by 0.2
in the intervention group, and increased by 0.1 in the control group (p = 0.09) (Meigs,
Cagliero, Dubey, Murphy-Sheehy, Gildesgame, Chueh … Nathan, 2003).
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Vervloet and colleagues (2011), in a randomized controlled trial on improving
medication adherence with type 2 diabetic patients, used the electronic method to monitor
real time medication monitoring (RTMM) by sending short message service reminders
(SMS). The group was randomized to two intervention arms, and one control arm. The
intervention group Arm 1 received both RTMM and SMS, Arm 2 only received RTMM,
and the control group received usual care, and no RTMM, and only SMS. The group that
received both RTMM, and SMS showed increased adherence with oral diabetic
medications, when compared with the other two groups, and the difference between the
intervention group (arm 1), and the control group was ten percent. Power analysis
showed, using a one-sided‘t’ test (alpha = 0.05) for a ten percent difference (SD = 20),
with a power of 0.90. Each group had sixty-nine patients (Vervloet, van Dijk, SantenReestman, van Vlijmen, Bouvy, & de Bakker, 2011).
Ramadas and colleagues (2011) explained in their systematic review of recent
evidence on web-based intervention in the management of type 2 diabetes that emails,
and short message services (SMS) could be used to remind patients to monitor their blood
sugar levels, and to send that information to the provider; this was found to be an
effective method because it has a positive way of giving reinforcement to patients on selfmanagement of their blood sugar levels (Ramadas, Quek, Chan, & Oldenburg, 2011).
Factors Related to Poor Medication Adherence
Poor medication adherence with chronic illnesses is a serious public health issue
(Kocurek, 2009). Non-adherence to prescribed medication is significant because it
results in more harm to one’s health, and wellbeing (Elliott, Ross-Degnan, Adams,
Safran, & Samurai, 2007). According to the Cochrane review of randomized controlled
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trials (RCT) on medication adherence with commonly occurring chronic illnesses such as
diabetes, hypertension, hyperlipidemia, asthma, mental health problems, and arthritis,
scholars Williams, Manias, and Walker (2008) have cited authors (Haynes, Degani,
Kripalani, Garg, & McDonald, 2005; Haynes, McDonald, Garg, & Montague, 2002),
who have done systematic review of medication adherence, and have suggested some key
reasons for non-adherence that include adverse effects of medications, poor instructions
by healthcare providers, poor memory, inability to pay for medications, disagreement
about the need for treatment, and poor relationships between consumers, and healthcare
professionals (Williams et al., 2008).
The national council on patient information and education (NCPIE) is a coalition
of more than 125 organizations whose main task is to improve communication and
information between patient and healthcare providers to improve medication adherence
(Kocurek, 2009), and they have explained that poor adherence is due to poor health
literacy in that many do not understand or comprehend directions to take medications
(Kocurek, 2009).
Kocurek (2009) summarized that medication non-adherence is due to 1)
perception about the nature and severity of the illness, 2) fear of side effects or concern
about becoming drug dependent, 3) worries about social stigma associated with taking
medications, 4) beliefs about the effectiveness of medications, 5) lack of acceptance of
taking medications for preventive purposes and for symptomless conditions, 6) denial of
illness, and 7) the assumption that they can discontinue the medication because they feel
better or symptom-free (Kocurek, 2009). Other factors include polypharmacy
(Fitzgerald, 2011) and medication inertia (Fitzgerald, 2011), and other barriers include
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social and economic factors (Hill, Miller, DeGeest, & American society of hypertension
writing group, 2010). The economic factors include unemployment, lack of insurance,
cost of medical care and medications, and lack of transportation (Hill et al., 2010). Social
factors include lack of social support, multiple co-morbidities, lack of choices in
choosing treatment protocols within their own beliefs (Elliott, Ross-Degnan, Adams,
Safran, & Soumerai 2007; Hill et al., 2010), social isolation (Russell, 2006), and low
health literacy (Ho, Bryson, & Rumsfeld, 2009).
The World health organization (2003) categorized factors affecting medication
adherence into five dimensions: 1) social-economic dimension, 2) healthcare system, 3)
illness/condition-related, 4) therapy related, and 5) patient related (Ho et al., 2009;
Osterberg & Blaschke, 2005; Hill et al., 2010). The socioeconomic dimension includes
low literacy, higher medication cost, and poor social support. The healthcare system
dimension includes poor quality of provider-patient relationship, poor communication,
lack of access to healthcare, and lack of continuity care. The illness condition dimension
includes asymptomatic chronic illnesses, and mental disorders such as depression
associated with chronic illnesses. The therapy dimension includes complexity of
regimen, and medication side effects. The patient-related dimensions include physical
and sensory impairments, cognitive impairment, psychosocial and behavioral problems, a
younger age, and non-Caucasian ethnicity (Hill et al., 2010; Ho et al., 2009; Osterberg &
Blaschke, 2005).
Adherence Factors Specific for African Americans
Many researchers have suggest that low adherence to prescribed medications is
associated with increases in morbidity, mortality, and increased healthcare costs
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(Bandura, 2004; Gerber, Cho, Arozullah, & Lee, 2010; Bogner & DeVries, 2010), and
African Americans bear the brunt of this disproportionate morbidity, and mortality,
especially with cardiovascular diseases associated with diabetes, hypertension,
hyperlipidemia, and stroke (Gerber et al., 2010; Lewis et al., 2010).
In 2002, the Institute of medicine (IOM) report ‘unequal treatment confronting
racial, and ethnic disparities in health care’, which the United States congress
commissioned, reported that African Americans with diabetes have received lower
quality care, visited emergency care centers frequently, and made less visits to primary
care (Bogner & deVries, 2010). In a pilot randomized controlled trial with inner city
African Americans with diabetes (N = 58, Age range of 50-80 years) in Philadelphia,
medication adherence was assessed at baseline, and at two, four, and six weeks using the
medication event monitoring system. The study also included an assessment of
depression associated with diabetes using the center for epidemiologic studies depression
scale (CES-D). In all, fifty-eight participants were randomly assigned to an integrated
intervention (N = 29), and to usual care (N = 29) groups. The study findings include that
the intervention group had lower levels of AIC at 6.7 percent when compared to the
group that received usual care, and whose AIC level was 7.9 percent, (p < .05). Also, the
intervention group had fewer depressive symptoms at 6.9 vs. usual care at 16.6, (p = .04).
Based on these study findings, the authors interpreted that African Americans suffer with
depression and chronic illnesses such as diabetes, and this depression may be a potential
factor leading to poor medication adherence. The same scholars warned that previous
studies targeting African Americans have not addressed depression as a factor for poor
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medication adherence, and undertaking larger studies may be worthwhile (Bogner &
deVries, 2010).
There are other factors that could potentially affect medication adherence in
African Americans other than medication cost resulting in racial disparity (Gerber et al.,
2010). Based on a number of studies, these scholars have suggested that low health
literacy is associated with poor medication adherence (Gerber et al., 2010). The same
scholars (2010) have cited Osborn, Paasche-Orlow, Davis, and Wolf (2007), who have
done an extensive study on HIV health literacy in African Americans, have suggested
that health literacy may mediate the relationship between the African American race, and
adherence to HIV therapy (Gerber et al., 2010).
A survey on medication adherence by face-to-face interview with Medicare
recipients of age sixty-five years, and above was conducted in Chicago on three principal
adherence questions: 1) running out of medications before refilling the prescription, 2)
following physician instruction on how to take medications, and 3) forgetting to take
medications. A total of 489 participants responded to the survey, and 266 of them were
African Americans (59 percent with a mean age of 78.2 years), and 189 were Caucasians
(41 percent with a mean age of 76.8 years). The findings of the survey included that
Caucasians were more likely than African Americans to report never running out of
medications before refilling them at 90.2 percent versus 75.3 percent, and were more
likely to follow physician instructions on how to take medications (90.1 percent vs. 77.6
percent). However, there was no significant difference between African Americans, and
Caucasian participants in forgetting to take their medications (Gerber et al., 2010). From
these survey findings, the authors have suggested that there are factors such as health
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literacy, depression, and health beliefs of African Americans that could have potential
influence on their medication adherence behavior (Gerber et al., 2010), and it may be
worthwhile to explore their health beliefs to have a greater insight, and understanding of
their medication adherence behavior.
Health Beliefs of African Americans
Fears of being exploited for the sake of medical research have affected African
Americans’ health beliefs (Gamble, 1997). One of them is that they will be used as
guinea pigs, just like the men who were used in the Syphilis study from 1932 to 1972 in
Tuskegee, Alabama. Those men in that study were deliberately denied treatment for
syphilis in order to study the natural history of syphilis (Gamble, 1997). Due to the fear
of being used as guinea pigs in such fashion, African Americans have refused treatment
for HIV/AIDS with protease inhibitors (Gamble, 1997), and many scholars have argued
that the Tuskegee Syphilis Study is frequently described as the singular reason behind
African Americans’ distrust of the institute of medicine, and public health (Gamble,
1997).
African Americans also believe in folklore, and according to them, Caucasian
medical students would kidnap African American people, usually at night in urban areas
and take them to hospitals to be killed and used in medical experiments (Gamble, 1997).
Gamble (1997) has cited anthropologist Gladys Marie Fry (1984, p.171) who had
explained that the term “night doctor” or “night riders” is derived from the stories that
victims were sought only at night by Caucasian medical students who were believed to
have stolen cadavers for medical educational purposes and for medical research, even
though anthropologist Fry (1984) did not find any evidence-based documents to prove the
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existence of such night riders (Gamble, 1997). Gamble (1997) cited folklorist Patricia
Turner (1993) who contended in her writings on African American beliefs that Caucasian
Americans historically have been, and continue to be ambivalent, and perhaps are even
hostile to the very existence of African American people (Gamble, 1997).
The other beliefs include what some African Americans perceive as racial
discrimination in their healthcare (Piette, Heisler, Herand, & Juip, 2010), and may more
likely mistrust their healthcare providers when compared to Caucasian patients (Piette et
al., 2010). Piette and colleagues (2010) have cited scholars Boulware, Cooper, and
Ratner (2003), who have done extensive studies on African Americans’ health beliefs on
medical treatment, explaining that African Americans’ medication-related beliefs are
formed within their broader experience with the social institution (Piette et al., 2010), and
as a result of undesirable past experiences with the medical community, African
Americans may pose an ongoing barrier in gaining a desirable common understanding
with their healthcare providers about the role of medications in the management of
chronic illnesses (Piette et al., 2010).
Piette and colleagues (2010) have conducted a study by following survey
methodology, and using a face-to-face interview guide. The survey took place in Flint,
Michigan, an economically distressed city with type 2 diabetic patients who also received
prescriptive medications from physicians, nurse practitioners, and physician assistants.
The main purpose of this survey was to assess if there was any association between
patients’ race, and concerning medication-related beliefs. A total of 806 patients with the
diagnosis of type 2 Diabetes participated in the study (N = 806; African Americans = 470
(58.3 percent), and Caucasians = 336 (41.7 percent)). The researchers used two types of
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questionnaires: 1) Beliefs about medication questionnaire (BMQ) (alpha reliability =
0.66), and 2) Beliefs about generic medications (alpha reliability = 0.87). A pilot survey
with twenty-five participants from a diverse group was carried out prior to the full survey
in order to establish validity, and reliability of these instruments. Patients reported their
beliefs on a three-point Likert scale of agree, unsure, and disagree (Piette et al., 2010).
Findings of the study included that a large number of patients from both African
Americans, and Caucasians expressed serious skepticism about the safety, and necessity
of their prescription medications, and forty-two percent of patients believed that generics
are not real medications, brand-name medications are safer than generics, and that
insurance plans push generics to save themselves money at the expense of their health
(Piette et al., 2010).
After controlling all potential confounding variables, the authors summarized the
survey findings about the main differences in health beliefs between African Americans,
and Caucasians that African American patients expressed more concerns about their
prescription; nearly twice as many African Americans agreed that people who take
prescription medications, should stop the treatments for a while every now, and again (20
percent vs. 11 percent, p = .0005), that most prescriptions are addictive (40 percent vs. 28
percent, p = .0003), prescription medications do more harm than good (25 percent vs. 17
percent, p = .003), and generic medications contain dangerous addictives (21 percent vs.
8 percent, p < .0001) (Piette et al., 2010). The authors, based on this survey’s findings,
have explained that beliefs about generic medications is troubling, and it may be a major
potential barrier for medication adherence, and the differences in patients’ medicationrelated beliefs did not help to explain racial differences. Also, it may be necessary to
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undertake further studies on patients’ beliefs on medications to gain a greater insight on
medication adherence behavior (Piette et al., 2010).
In another face-to-face research interview by scholars Aikens and Piette (2009) in
Flint, Michigan, by using well-validated scale “beliefs about medication questionnaire”
(BMQ) with patients diagnosed with hypertension, and diabetes (N = 806) on satisfaction
with medication information, and medication underuse, found out that those with the
strongest concerns about medication harmfulness tended to underuse both types of
medications because of cost, and other factors. The authors, from this study, explained
that perceived necessity, and harmfulness are two different determinants in that perceived
necessity was found to be related to a number of co-morbidities or illnesses, and the
number of medications used, but perceived harmfulness was found to be related to
psychosocial factors such as functional health literacy, and dissatisfaction with
medication information received, and this perceived harmfulness was related to
medication adherence, and its outcome (Aikens & Piette, 2009).
The authors further have explained that medication underuse was found to be
related to more perceived medication harmfulness, and African Americans are generally
more concerned about medication harmfulness than their Caucasian counterparts, and this
notion prevails regardless of income, medication costs, and functional health literacy
level (Aikens & Piette, 2009).
Lewis, and colleagues (2010) have explained in their qualitative study with
community-dwelling African Americans with hypertension, that African Americans
believe that hypertension is a stress-related illness promoted by emotional, and
psychological stress, and controlled by stress reduction (Lewis, Askie, Randleman, &
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Shelton-Dunston, 2010). They also believe that hypertension medications have more
adverse effects such as frequent urination, lethargy, ankle edema, and are more physically
debilitating than having hypertension (Lewis et al., 2010). In this way, African
Americans believe that medications cause more adverse effects rather than healing
(Lewis et al., 2010).
Health Literacy: An Important Factor for Medication Adherence
Kalichman and colleagues (2008) have suggested that several factors have
potential influence on medication adherence behavior that can impede patients with
chronic illnesses to take medications (Kalichman, Pope, White, Cherry, Amaral, Svetzes
… Kalichman, 2008). These potential influencing factors include physical side effects,
emotional distress, substance use, internalized stigma, and poor social support
(Kalichman et al., 2008). The same scholars however, based on a number of studies on
patients with HIV/AIDS medication adherence, have suggested that medication
adherence greatly depends on patients’ health literacy, and health literacy is particularly
in demand for improving patients’ knowledge, and comprehension on health messages,
and prescribed medications. Furthermore, low health literacy skills are closely associated
with inadequate knowledge on health, and poor comprehension of the treatment protocols
(Kalichman et al., 2008).
The same scholars, in order to affirm that low health literacy is a potential factor
for poor medication adherence, conducted a study based on two hypotheses: 1) lower
health literacy would predict non-adherence with medications, and 2) lower health
literacy is associated with poorer adherence over, and above other influencing factors.
The study participants included a total of 145 patients diagnosed with HIV/AIDS, and
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given antiretroviral oral medications, and they were recruited through referrals, and word
of mouth, were willing to participate in the study, and give voluntary consent for the
study as well as unannounced pill counting through the telephone. Among these 145
participants, 100 were men, 44 were women, and one was transgender. According to
ethnicity, ninety-three percent were African American, six percent Caucasian, and the
remaining one percent included other ethnicities (Kalichman et al., 2008).
The study protocol included a reading comprehension testing using the validated
instrument ‘test of functional health literacy in adults’ (TOFHLA), an office-based pill
counting training, and calling participants at three intervals between 21-35 days for
unannounced pill counting. In addition, pharmacy information from pill bottles was also
collected for verification. Adherence was calculated as the ratio of pills counted relative
to pills prescribed, and dispensed. Data analysis was done using logistic regression
analysis to test hypothesis 1, and hierarchical logistic regression to test hypothesis 2. In
addition, a sensitivity analysis to examine the same hierarchical association was done
using 80 percent, and 90 percent adherence as the model-dependent variable. The
authors reported odds ratios (OR), and 95 percent confidence intervals (CI) for each
variable tested.
Based on this study, the authors confirmed hypothesis 1 that participants with
lower literacy were significantly less likely to have taken medications at three different
levels of clinically meaningful adherence: 80 percent, 85 percent, and 90 percent of pills
taken. The hierarchical logistic regression model entered these characteristics: a)
demographic, and health characteristics, b) emotional distress, internalized stigma, and
social support, c) alcohol use, and d) literacy scores as predictors of 85 percent
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antiretroviral therapy (ART) adherence. The authors confirmed hypothesis 2 by the
hierarchical logistic regression model that lower literacy was associated with poorer
adherence over, and above all other factors entered into the model, including years of
education. Based on these study findings, Kalichman et al., (2008) suggested that there is
a reliable association between health literacy, and self-reported medication adherence
even though the study had its methodological limitations (Kalichman et al., 2008).
In a cross-sectional randomized controlled trial with 152 study participants (N =
152) with proven cardiac health problems, Kripalani, and colleagues (2006) evaluated the
effects of low literacy, medication complexity, and socio-demographics by measuring
medication management capacity (MMC). The measures of MMC included functional
skills such as these: 1) identifying medications correctly, 2) being able to open the
containers or medication bottles, 3) describing the dose correctly, and 4) taking the
medication at the right time. MMC complements measures of adherence were provided
by self-report, pill count, and medication refill schedule. From this study, scholars were
able to explain that the concept of medication management capacity and its application in
a clinical study demonstrated ample evidence that low MMC predicts an increase in the
utilization of emergency visits (ER), functional decline, and subsequent residence in
assisted-living facilities. In addition, adults with low literacy were unable to identify
their medications (Kripalani, Henderson, Chiu, Robertson, Kolm, & Jacobson, 2006).
The study participants included 94.1 percent African Americans, of whom 50.7
percent had inadequate literacy skills, and 28.9 percent had marginal skills. The other
study participants included Caucasians (3.9 percent), Asians (0.0 percent),
Hispanic/Latino (1.3 percent), and other (0.7 percent). In a univariate analysis,
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medication management capacity (MMC) was significantly associated with literacy (p <
.001). In a multivariate analysis, patients with inadequate literacy skills had 10-18 times
the odds of being unable to identify all their medications when compared to patients with
adequate literacy skills (p < .05) (Kripalani et al., 2006).
Based on these study findings, these scholars suggested that adults with
inadequate or low literacy skills have poor abilities to identify their medications, and low
literacy skills may be a potential risk factor for poor comprehension of their medications,
and adherence behavior. Furthermore, patients with poor literacy skills require varieties
of methods or techniques to educate about their medications as a potential strategy to
enhance medication adherence (Kripalani et al., 2006).
Thai and George (2010) have suggested from their systematic review of
literatures on literacy, and self-management of asthma that low health literacy level is
associated with poorer health status, less knowledge about chronic disease management,
and lower rates of medication adherence (Thai & George, 2010). Some other scholars
have suggested that lower health literacy is also correlated with higher rates of acute
hospitalization, an increased utilization of emergency care, and acute care facilities for
patients with asthma, and other chronic illnesses (Thai & George, 2010; Prasauskas &
Spoo, 2006). Low literacy is strongly linked with other vulnerable factors including nonCaucasian race, older age, less formal education, and low socioeconomic status (Thai &
George, 2010).
In addition, scholars have suggested that low health literacy in vulnerable
populations is also associated with low numeracy skills (Thai & George, 2010), and this
health literacy, and numeracy skills are paramount in asthma self-management, to count
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the peak flow measurements, and to manage other chronic illnesses (Thai & George,
2010; Prasauskas & Spoo, 2006). Based on their in-depth literature review on asthma
self-management, and health literacy, Thai, and George (2010) have strongly
recommended that knowledge transmission on any health condition does not depend on
the written words of the literature, but greatly depends on as to how the knowledge is
transferred, and how the skills are demonstrated (Thai & George, 2010). The same
scholars have suggested that health literacy transmission requires effective
communication tailored to the individuals based on their age, reading level, culture,
health literacy ability, and numeracy skills (Thai & George, 2010).
Evidence suggests that there are numerous problems related to health because of
lower health literacy (Marks, 2009; Wagner, Steptoe, Wolf, & Wardle, 2009). Problems
arise because of low health literacy, including these: 1) difficulties in understanding
health concepts, 2) difficulties in understanding the importance of medication adherence,
3) difficulties in doing health-related tasks such as monitoring blood pressure, and blood
sugar levels, 4) difficulties with refills of medications, and 5) problems in keeping up
with clinic appointments (Marks, 2009). In addition, low health literacy can affect one’s
listening abilities (Marks, 2009).
Marks (2009) cited scholar Wilson (2003) who has suggested that asking patients
to restate the health information in their own words would facilitate, and increase one’s
ability to listen, and process the information (Marks, 2009). This teach-back mechanism
would be helpful to both educator, and the patients, and if necessary, the information can
be repeated until the patient is able to comprehend, and process the information (Marks,
2009). Providing health education that is culturally, and linguistically appropriate with

47

clarity empowers patients to process the information with accuracy in the decision
making process (Marks, 2009; Wagner et al., 2009).
Literature suggests that limited literacy may contribute to racial disparities in
health (Osborn, Paasche-Orlow, Davis, & Wolf, 2007). To test this hypothesis, a total
number of 204 patients, diagnosed with HIV/AIDS, and on medications, were recruited
from the HIV/AIDS clinics by trained research assistants from Northwestern Memorial
Hospital, Chicago, and the Louisiana State University Health Science Center at
Shreveport, Louisiana. Participants, who fit with study criteria, were administered two
kinds of tests, one to test their medication adherence, and the second one to test their
literacy level (Osborn et al., 2007).
The first test was a “patient medication adherence questionnaire” (PMAQ) in
which study participants had to report the missing HIV/AIDS medication, as to whether
they had missed a dose of medication “yesterday,” “the day before yesterday,” “3 days
ago,”, and “over the past weekend.” Participants, who reported a missing dose within
this short period of time, were considered to be non-adherent, but participants who
reported “no missing dose,” were then considered to be in full adherence. The second
test was to assess the literacy level in which the study participants were administered
“rapid estimate of adult literacy in medicine” (REALM) in which the study participants
were asked to read aloud as many words as they could from a word-recognition list,
composed of sixty-six health-related words that were arranged in the order from simple to
complex. The scoring index was based on the total number of words pronounced with
accuracy. The scoring index was as follows: 0-18 words pronounced correctly = third
grade level or less, and 19-44 words pronounced correctly = fourth to sixth grade reading
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levels. The range 0-44 were considered to have a low literacy while 45-60 words
indicated the seventh or eighth grade reading level, and were considered to have marginal
literacy, and 61-66 words equaled the ninth grade or above, the reading level considered
to be adequate.
To confirm the association between race, and literacy, regression analyses were
performed with the African American race as the independent variable, and low literacy
skills was the dependent variable. After controlling for age, and study size, the study
confirmed a significant association between the African American race, and low literacy.
In the same way, in regression analyses with the African American race as the
independent variable, and medication adherence as the dependent variable, the study
confirmed that African Americans were 2.40 (95 percent CI = 1.14-5.08; C statistic =
0.67) times more likely to be non-adherent to HIV medications than non-African
Americans. However, when a literacy variable was added with the medication variable,
the effect estimates of race diminished from 25 percent to non-significance.
The study confirmed that literacy remained a significant independent predictor of
non-adherence with an adjusted odds ratio (ADR) = 2.12 (95 percent CI = 1.93-2.32).
Also, African American patients were more likely to possess marginal or low literacy
skills when compared to non-African American patients (52.1 percent vs. 14.3 percent, p
< 0.001), and were significantly less likely to report adherence to their medication
regimens in the past four days (60.1 percent vs. 76.8 percent, p = 0.014). The final report
of the study was patients with low literacy were more likely to be non-adherent (52.2
percent) than patients with adequate literacy (30.0 percent, p = 0.01), and that low
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literacy is a significant problem in African Americans when compared with non-African
Americans (Osborn et al., 2007).
In 2003, the National assessment of adult literacy board indicated that
approximately half of the US population is either marginally or inadequately literate on
health information that has a direct impact on health outcomes (Levinthal, Morrow, Tu,
Wu, & Murray, 2008). Especially, for older adults with chronic illnesses, health literacy
plays a crucial role in that they could navigate the essential health information related to
their health, and utilize them in their self-management (Levinthal et al., 2008).
Based on this national literacy information, Morrow, and colleagues (2007)
developed a pharmacy-based educational intervention including concepts of patientcenteredness, and patient preferences for patients with congestive heart failure (CHF).
The patient-centered educational information was made simple, written in bigger font
sizes of twelve to fourteen, and presented with a limited total of 251 words. Also, it
included verbal counseling, a discussion on clinically relevant side effects of
medications, and drug information with each intervention patient. Whereas in the
standard pharmacy, instructions contain information written in smaller font sizes of eight
to ten, and has too many words, with a minimum of 558 words, and included with these is
a list of potential side effects of different medications, and drug interactions that may not
be relevant to the patient. The presentation of patient-centered information was also
relevant to patients’ own schedule, timing, and schemas for organizing medication
information. The presentation looked like this: 1) Identify medication, 2) How to take the
medication, and 3) Possible Outcomes. Patients remembered these types of instructions
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better, and these instructions also contained pictorial memories with medication name,
dose, and time information (Morrow, Weiner, Steinley, Young, & Murray, 2007).
The study participants included 236 community-dwelling volunteers who were
diagnosed with congestive heart failure (CHF), and were taking medications for it. The
volunteer sample was drawn from Wishard health services, Indianapolis, Indiana. The
participants were randomly assigned to the patient-centered education intervention group
(N = 83), and the pharmacy-based education control group (N = 153). The control group
had a larger number of people because this group was selected, and planned for another
cohort study to assess risk factors associated with deterioration of CHF. Both groups
participated in the “short test of functional health literacy application” (STFHLA) that
required seven minutes to administer, and measured the ability to read, and understand
actual health-related passages with readability levels of 4.3, and 10.3 grade levels. Based
on the Gunning-Fog index range, the scores were to be as follows: 0-16 = inadequate
health literacy, 17-22 = marginal literacy and 23-26 = adequate literacy.
To assess the differences between the two groups based on a patient’s
preferences, patients were asked seven questions: 1) taking a missed dose, 2) side effects
of the medication, 3) what the medication was used for (purpose), 4) medication name, 5)
drug interactions, 6) how many tablets to take in a twenty-four hour period (daily dose),
and 7) number of times to take the medication (schedule). In addition, patients were
asked to indicate as to how familiar they were with standard pharmacy instructions at the
rating scale of 1-3 from not familiar at all to very familiar. Statistical analyses included
factorial analysis in order to present correlations between individual preference variables,
and the common factor. Larger positive values of the composite measure indicated
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greater preferences for the patient-centered instructions over the standard pharmacy
instructions across the seven individual preferences questions (Morrow et al., 2007).
In further regression analysis on patient preferences, and characteristics, the
authors explained that the patient-centered instructions were more likely to be preferred
by African Americans than by other participants. For African Americans, preferences
also depended on familiarity with the instructions. Also, patient-centered instructions
were more preferred by participants with lower levels of health-related literacy. In
addition, older adults with CHF preferred the patient-centered instructions to learn more
on medication adherence, and desired to know more on side effects of the medications.
The authors suggested that these study findings have greater implications on design for
patient education, that the design construction must include patient preferences,
familiarity of the health topic, patients’ comprehension level, and that patients with lower
levels of health-related, and general cognitive abilities would be benefitted with pictorial,
larger prints, and other characteristics of patient-centered instructions that support
comprehension (Morrow et al., 2007).
Levinthal, and colleagues (2008) conducted a study as an extension of Morrow et
al, (2007), study on cognition, and health literacy with patients who were diagnosed with
hypertension (Levinthal et al., 2008). The main objective of this study was to investigate
whether there was any association between cognitive ability, and health literacy in a
population with diagnosis of hypertension, and with a wider age range (Levinthal et al.,
2008).
A total of four hundred, and ninety-two community dwelling adults (N = 492)
diagnosed with hypertension, aged twenty-one to ninety-two years, and taking an average
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of 7.8 prescribed medications, who fit with the inclusion, and exclusion criteria were
recruited in the study. Among these participants, seventy-three percent were female, and
sixty-eight percent were African American. After completing the collection of baseline
data, study participants were randomly assigned to the pharmacy-based patient education
program, the intervention group, and to the usual care, which was the control group.
Prior to random assignment, all the participants completed STOFHLA, which has the
score index of 0 to 36, in which 0-16 equals inadequate health literacy, 17-22 equals
marginal literacy, and 23-36 is adequate literacy. Many scholars believe that STOFHLA
is an instrument with good validity, and reliability, and that it is generally associated with
health outcomes, indicating lower scores for older adults (Levinthal et al., 2008; Morrow
et al., 2007).
Based on multivariate regression analyses, the study findings were suggestive of
that health literacy was related to age, education, and race. When a cognitive variable
was added as an additional twenty-four percent of variance, it greatly reduced the
influences of age, education, and race at 75 percent, 40 percent, and 48 percent
respectively. The authors concluded that when controlling for cognitive and sensory
variables, the STOFHLA scores that were associated with age and education were
reduced to a greater level. The findings indicated that while planning for future
interventions at improving self-care for patients with a low literacy level, the planning
should not impose, and demand on the patients’ cognitive abilities, but must rather be
tailored to the patients’ strengths using familiar and simple concepts (Levinthal et al.,
2008).
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Friedman & Hoffman-Goetzl (2008), in their systematic review on literacy, and
health literacy, found that most healthcare providers tend to overestimate patients’
literacy skills, and knowledge, and assume that patients have full comprehension of
verbal, and written instructions provided to them (Friedman & Hoffman-Goetzl, 2008).
The same scholars have further explained that healthcare providers might not even
understand, and consider patients’ literacy, and comprehension abilities; likewise,
patients with limited literacy skills do not want to or are reluctant to convey their
inabilities to understand the instructions by their healthcare providers (Friedman &
Hoffman-Goetzl, 2008). Adequate health literacy includes skills like reading, counting
numbers, writing, and comprehension; without comprehension, reading, and other skills
would become ineffective (Friedman & Hoffman-Goetzl, 2008).
Health literacy is a two-way process between patients, and healthcare providers,
and it is an ongoing process (Friedman & Hoffman-Goetzl, 2008). In this way, adequate
health literacy is greatly dependent on provider and patient relationships in that the
healthcare provider remains proactive by searching current evidence-based information,
accessing, and translating them into patients’ language that will have a greater influence
on patients’ health behaviors, and bring better health outcomes (Friedman & HoffmanGoetzl, 2008). In the next segment, patient-provider relationship will be explored to gain
a greater understanding as to how this relationship could have a great impact on
medication adherence in African Americans.
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Provider-Patient communication is an important determinant of medication
adherence
The role of communication between patient, and provider plays a vital role in
establishing trust between patient, and provider (Benkert, Peters, Tate, & Dinardo, 2008),
and allows the patient to make a high quality decision on his/her own healthcare
(Wagner, Riopelle, Steckart, Lorenz, & Rosenfeld, 2010). Building a trusting
relationship is paramount between a patient, and provider, and this is the central feature
in health promotion, and communication (Benkert et al., 2008). Some other factors are
also influenced positively because of this trusting relationship between patient, and
provider whereby the patient has willingness to seek care, the level of satisfaction
increases, and the patient remains adherent to medications, and treatment protocols, and
returns to follow up clinic visits (Benkert et al., 2008). In addition, this trusting
relationship is greatly dependent on providers’ etiquette including constancy, caring,
commitment, honesty, and maintaining confidentiality as prescribed by HIPAA standards
(Benkert et al., 2008).
Wagner and colleagues (2010) have explained that patients are expected to make
serious decisions in the context of chronic, and serious illnesses including cancer,
HIV/AIDS, congestive heart failure (CHF), diabetes, uncontrolled hypertension, and
stroke (Wagner et al., 2010). Even though patients will have a general understanding of
their illnesses, they do not have an in-depth understanding or full comprehension of their
illnesses, and their prognosis (Wagner et al., 2010), and this poor understanding is
because of poor communication between the patient, and provider (Wagner et al., 2010).
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Benkert, and colleagues (2007) have explained some of the problems in research
findings related to a trusting relationship between the patient, and the provider in that the
research was focused on the Managed care model in which the provider relationship was
limited because of limited time given to care for their patients, and the studies’ main
focus was on resident physicians, and not on real healthcare providers (Benkert et al.,
2008). Based on these study findings, these scholars have suggested that many providers
did not recognize that African Americans suffer significant health disparities, and that
they were assigned to dominant physicians who believed that African Americans were
less intelligent, engage in highly risky behaviors such as substance abuse, and are less
likely to adhere to treatment recommendations (Benkert et al., 2008). In some other
research findings, physicians were found to be too dominant in their communication, and
demonstrated less patient-centered communication with African Americans when
compared with Caucasian patients (Benkert et al., 2008).
Cultural mistrust is another concept of patient-provider relationship in which
African Americans have a tendency to distrust Caucasian healthcare providers because of
a long history of racism, and unfair treatment that they had endured from the Caucasian
people (Benkert et al., 2008; Benkert, Hollie, Nordstrom, Wickson, & Bins-Emerick,
2009). Benkert, and colleagues (2007) cited a previous scholar’s work by Freedman
(1998) on a counseling relationship in which African Americans’ cultural mistrust
resulted in negative consequences in counseling relationships, primary care relationships,
and that especially African American women tend to be more critical of Caucasian
physicians (Benkert et al., 2009).
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Schoenthaler, and colleagues (2009) cited from the report of the Institute of
Medicine (IOM) (2003) on unequal treatment in which the authors explained that the
perceived quality of interpersonal communication within the patient-provider relationship
is a potential mechanism for the worse health outcomes observed in minority populations
(Schoenthaler, Chaplin, Allegrante, Fernandez, Diaz-Gloster, Tobin, & Ogedegbe, 2009).
In addition, patients’ perception of their providers greatly depends on providers’
communication, and listening skills, showing respect while confronting negative
behaviors, encouraging patients’ active participation in decision making, and involving
them in the technical aspects of their care (Schoenthaler et al., 2009).
Schoenthaler and colleagues (2009) conducted a cross-sectional study with
African Americans with hypertension, and this cross-sectional study was part of an
ongoing randomized controlled trial on counseling African Americans to control
hypertension (CAATCH Trial) in the New York metropolitan area. Purpose of the study
was to assess the patients’ perception of their providers’ communication on medication
adherence in a cohort of patients who were enrolled in the CAATCH Study. A total of
439 African Americans (N = 439) were recruited for this study, whose blood pressure
was either poorly controlled or remained uncontrolled, and a total of seventy-two
healthcare providers that included physicians, nurse practitioners, and physician
assistants were recruited from different races including Caucasians, African Americans,
Hispanics, Asians, and East Indians.
The authors used a well-validated thirteen-item communication scale taken from
the Health communication model, which has the ability in assessing patients’ perception
of their healthcare providers’ communication, and the extent to which the providers
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encourage patients’ participation in the treatment process. The responses to questions 111 were scored on a Likert Scale as follows: 1 = not at all to 4 = very much, questions 1213 were scored as 0 = no or 1 = yes, and categorical measurement was used for items 12,
and 13. All the responses on this thirteen-item scale were finally converted to a “z”
score. By employing different statistical procedures, the authors standardized the
measure, and preserved the nature of distribution for parametric analysis. From this
analysis, the authors concluded that African American patients with hypertension who
experience low income tend to rate providers’ communication as more collaborative, and
this collaborative communication facilitates better adherence to antihypertensive
medications (Schoenthaler et al., 2009).
Halbert and colleagues (2009), based on their observational study that was
conducted in the Pennsylvania Cancer Medical Center between 2003 to 2007 with
patients who were newly diagnosed with prostate cancer by biopsy, and the Gleason
Score, explained that lack of trust in healthcare providers, and the medical system is a
significant barrier to effective communication, and use of clinical services, and this
mistrust may contribute to poor health outcomes in racial minority patients (Halbert,
Weathers, Delnoor, Mahler, Coyne, Thompson, … Lee, 2009). The authors described
that the concept of trust explains the quality of relationship between the healthcare
provider, and the patients (Halbert et al., 2009). The key influencing factors that affect
this relationship include perceptions of healthcare providers’ interpersonal skills, and
technical abilities, suspicion of healthcare systems, and providers, expectation of unfair
treatment, and perceived support from providers (Halbert et al., 2009). The same
scholars further explained that African Americans, who have less experience with
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healthcare providers, tend to report low levels of trust of their providers (Halbert et al.,
2009).
Another important determinant that influences trust includes patients’ collectivism
(Halbert et al., 2009). The construct of collectivism is drawn from the concept of culture
that describes the extent to which interdependence, relationships, and cooperation with
other is valued (Halbert et al., 2009), and individuals with lower levels of collectivism
tend to place greater faith, and priority on their autonomy, independence, and selfdirection (Halbert et al., 2009). The authors have cited scholars Gudykunst, Matsumoto,
Ting-Toomey et al., (1996), and Devos, Spini, & Schwartz (2002) who have explained
from their in-depth empirical work on human values, trust, and cultural individualismcollectivism, and individual values on communication in that it is possible that men with
lower collectivism tend to be more skeptical of their healthcare providers, and system,
and their communication style, and preferences may not have any clinical significance
related to their health (Halbert et al., 2009).
The main objective of this observation study was to identify factors that have
significant independent associations with mistrust among both African Americans, and
Caucasians diagnosed with prostate cancer (Halbert et al., 2009). A group-based medical
mistrust scale (GBMMS) was employed to evaluate mistrust in healthcare providers, and
systems. The GBMMS is a twelve-item Likert-style scale that has the ability to measure
suspicion on healthcare providers, and the healthcare system, expectation about racial
discrimination by healthcare providers, and perceived support from providers. The
authors reported that GBMMS had good face validity with validated measures of trust,
and good internal consistency in this sample (Cronbach = .86). Higher scores indicated
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greater mistrust (Halbert et al., 2009). In addition, the authors included the religiosity
scale with nine Likert-style items, and the collectivism scale with six Likert-style
questions. The authors reported that these scales had acceptable internal consistency in
this sample (Cronbach a: collectivism, a = .64; religiosity, a = .94). Higher scores
indicated greater levels of collectivism, and religiosity (Halbert et al., 2009).
This study included a total of 196 participants including African Americans (n =
71), and Caucasians (n = 125) who had a face-to-face interview with trained researchers.
All participants who were eligible for the study completed a baseline survey at the
recruitment sites. Following the baseline survey, study participants were interviewed
through the telephone by using a structured survey on socio-demographics, race, and
treatment status, and assessed cultural factors, and mistrust, at three months, six months,
and at twelve months in thirty minute interviews.
The study findings included socio-demographic variables by bivariate analysis in
that African Americans reported a significantly greater mistrust on healthcare providers,
and healthcare system. African Americans, who had a high school education or less, and
who had been seeing their healthcare providers for more than three months, reported
significantly greater mistrust when compared with their Caucasian counterparts on a
multivariate analysis. In addition, lower levels of collectivism were associated
significantly with greater mistrust. Also, there was a significant effect due to marital
status in that the married Caucasians reported greater mistrust when compared with their
African American married counterparts. The authors concluded from this study that it
might be possible that men become disappointed with repeated interactions with
healthcare providers when their concerns are not addressed with clarity. In addition,
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collectivism has a greater role and effect on mistrust in that when collectivism is
decreased, mistrust is increased (Halbert et al., 2009).
In another prospective study, scholars Heckman, and colleagues (2009)
investigated race-related differences in the treatment of headaches (migraines) by using
longitudinal design (Heckman, Holroyd, Tietjen, O’Donnell, Hamada, Utley … Stillman,
2009). The authors, based on a number of studies, hypothesized that Caucasians who
receive treatment for headaches, would respond to treatment better by showing greater
reduction of headaches in frequency, severity, and disability, and a greater increase in
quality of life (QOL) when compared with African Americans who received the same
treatment (Heckman et al., 2009).
A total of 230 participants (N = 230) were recruited from four headache specialty
care clinics throughout the state of Ohio. Out of these 230 participants, Caucasians were
171 (n = 171), and African Americans were 113 (n =113). The study participants who
satisfied the criteria prescribed by the International headache society (HIS) were
recruited. The authors reported that because of underrepresentation of African
Americans for this study, physicians who recruited the study participants approached
every African American who attended headache clinics and recruited them for the study,
but among Caucasians, every fifth person was recruited (Heckman et al., 2009). Initial
pre-assessment was done with all 230 participants, and reassured by the same physicians
at one month, two months, and six months for follow up visits. Also, all the study
participants completed a 23-item Headache Disability Inventory (HDI), and a fourteenitem migraine specific quality of life questionnaire (MSQL) at initial pre-assessment,
one-month, two-month, and six-month follow up visits. They were also instructed to
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maintain a diary of their headache occurrences, and to bring the diary at one month, two
months, and six months follow up. During the second clinic visit, all the participants
were given preventive treatment for the headache with clear instructions to maintain a
headache diary, and to bring the diary for analysis during the sixth month visit. By using
the “intent-to-treat” approach, scholars analyzed the diaries on two specific measures: 1)
headache specific quality of life, and 2) headache disability. SAS 9.1.3 version statistical
software was used for all analysis with alpha level of 0.05 (Heckman et al., 2009).
Based on the analysis of these diaries, the authors concluded that African
Americans had significantly poorer headache-specific quality of life, and more frequent
severe headaches at pretreatment compared to Caucasian participants (p < 0.05).
However, after the treatment, both African Americans, and Caucasians reported
significant improvement in headache, frequency, disability, and quality of life, and
African Americans reported reduction in headache severity; scholars further explained
that these study findings did not support their hypothesis that Caucasians would respond
more favorably to treatment than would African Americans, and this similar pattern was
observed in other chronic conditions such as HIV/AIDS, diabetes, and cancer (Heckman
et al., 2009).
The authors interpreted these study findings in that if African Americans and
Caucasians have access to specialty care in a similar manner, both groups will respond to
headache treatment equally, and in similar manner. The authors further contended that
previous research studies that were done have shown poor clinical outcomes with African
Americans, and these treatment outcome differences may be because of factors that have
potential influence on African Americans, that include financial barriers, and delayed
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access to care, less trust in healthcare providers, and the healthcare system, poor patientprovider communication, and lack of health centers in their communities (Heckman et al.,
2009). The same authors further explained that if African Americans are given equal
access to healthcare regardless of their socioeconomic status, and healthcare providers
speak their language, they would develop a trusting relationship with their healthcare
providers resulting in improved healthcare outcomes (Heckman et al., 2009).
In a review on population issues on clinical trials, scholar Mosenifar (2007)
explained that despite the efforts taken through legislation by the National Institute of
Health (NIH) (1993) to include study participants from the underrepresented groups of
people for clinical trials, the problem remains unresolved in that minority populations,
diagnosed with multiple chronic illnesses, are not adequately represented in clinical trials
(Mosenifar, 2007). While describing issues related to African Americans, disparities that
exist based on their race must be consciously perceived, and acknowledged in clinical
trials (Mosenifar, 2007), because this barrier exists at different levels that include patient,
healthcare provider, the healthcare system, and the community, and this has a powerful
impact on healthcare provider-patient relationships (Mosenifar, 2007). For example,
African Americans perceive providing consent for any clinical trials is a prejudicial
attitude towards African Americans because obtaining consent is mainly to protect the
medical researcher, and at the same time, the patient’s autonomy is sacrificed at the altar
of medical research (Mosenifar, 2007). In this way, mistrust towards medical
researchers, and the healthcare system becomes a tyrannical issue in clinical trials,
resulting in poor adherence to medications, and medical therapy (Mosenifar, 2007).
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To explore individuals’ attitude on medical research and the differences in
perception between African Americans and Caucasians in a cardiovascular study,
Braunstein and colleagues (2008) conducted a self-administered survey in outpatient
clinic settings at different sites in Maryland. Main purpose of the survey was to gain an
understanding on individuals’ attitudes about medical research, and physicians who
conduct such drug trials, and their main reason for participating or refusing to participate
in clinical trials. A total of 717 participants consented for the study, and followed
through the survey protocol (N = 717). The survey explored whether African Americans
differ in their perceptions related to risks, and benefits of participating in clinical trials,
and distrust of medical researchers, and whether these factors together play a vital role in
their perceptions preventing them from participating in clinical trials. The study key
variable was “willingness to participate” (WTP) in clinical trials, and the other variables
were attitudes, and perceptions. The study participants included 460 Caucasians (n =
460) = 64 percent, and 257 African Americans (n = 25) = 36 percent (Braunstein,
Sherber, Schulman, Ding, & Powe, 2008).
All statistical analyses on all study variables were done using the Strata V 7.0
program. The important study variable “willingness to participate” (WTP) was measured
on a five-point Likert Scale: very likely, likely, moderately likely, unlikely, and very
unlikely by using the Wilcoxon rank sum statistical procedure (p value = 0.0002). By
using a multiple regression analysis, the relationship between race, and WTP was
analyzed, and the variables of perception, and attitude became more powerful influencing
factors through multiple stepwise logistic regression analyses (Braunstein et al., 2008).
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Based on these study findings, the authors concluded that African Americans
expressed greater mistrust towards medical research, and the researchers at a much higher
level, and perceived that joining any clinical trial would do more harm to them, and cause
more injuries. In addition, African American women were more skeptical, and believed
that scientists cannot be trusted at all. This mistrust ratio between African Americans,
and Caucasians was 8:1 (33 percent vs. 4 percent; Braunstein et al., 2008).
The authors further explained that this greater mistrust in African Americans on
clinical trials was caused by the Tuskegee Syphilitic Study (1932-1972) (Gamble, 1997;
Benkert et al., 2009; Braunstein et al., 2008), and their past experiences with racism,
ethnic biases, and social stigma (Gamble, 1997; Benkert et al., 2008; Benkert et al., 2009;
Braunstein et al., 2008). Based on a number of previous qualitative studies on
institutional racism (IOM, 2002), the authors further suggested that the healthcare system
embraced perpetual, racial, and ethnic biases in a subtle manner (IOM, 2002; Halbert et
al., 2009; Braunstein et al., 2008). To the best of their knowledge, no quantitative studies
could be found to study WTP (Braunstein et al., 2008), and in the same manner scholars
Benkert et al., 2007, and Benkert et al., 2009 have expressed that studies on medical
mistrust were done using more qualitative methods with a very small sample population
(Benkert et al., 2008; Benkert et al., 2009), and there is a greater need for quantitative
studies to justify medical mistrust (Braunstein et al., 2008).
Related to attitudes about racism, medical mistrust, and satisfaction with hospital
care among African Americans, and Caucasian cardiac patients, LaVeist, Nickerson, &
Bowie (2000) conducted a telephone survey with patients who had multiple
hospitalizations for cardiac health problems in 1995, and 1997. Purpose of the survey
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was to explore patients’ attitude, and satisfaction of their hospitalization. Based on their
medical needs report, these scholars identified 7,929 eligible participants. According to
the guidelines of the American Heart Association (AHA), and the American College of
Cardiology (ACC), patients were classified into Class 1 who must have coronary
angiography (CA) (n = 2039, 29 percent), Class 2 who may or may not need CA (n =
344, 6 percent), and Class 3 who did not require CA (n = 5276, 67 percent). Trained
researchers contacted class 1, and class 2 patients at six months, and twelve months of
post hospitalization for a thirty-minute telephone survey (LaVeist et al., 2000).
According to the survey report, 15 percent were deceased, 1.1 percent could not
be contacted, and 9.1 percent declined to enroll in the survey. In this way, the final
sample size was 1784. All the consented participants were asked four survey questions,
and requested to indicate their responses on a four-point Likert Scale: strongly disagree,
disagree, agree, and strongly agree. The survey questions included these: 1) Do doctors
treat African Americans and Caucasians the same? , 2) Is racial discrimination in doctors’
offices common? , 3) In most hospitals, do African Americans and Caucasians receive
the same kind of care? , & 4) Can African Americans receive the care they want as
equally as Caucasians? (LaVeist et al., 2000)
Using bivariate and multivariate analytical methods, the authors concluded the
survey findings. These findings include that both Caucasian, and African American
patients indicated considerable mistrust of the medical care system; however, African
Americans were more likely to report mistrust across all measures at a significant level (p
< .001) when compared with Caucasians. In the bivariate analysis, African American
patients showed dissatisfaction with the quality of care that they had received in the
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healthcare system at a significant level (p < .001). Both Caucasian, and African
American patients did not agree with the statement of racism existing in the medical care
system, but African Americans could easily acknowledge this statement, and go along
with it in a significant way (p < .001). Related to patients’ attitude on multivariate
analysis, the existence of racism in the medical care system, and patients’ level of
dissatisfaction were found to be significant predictors of patients’ satisfaction (p < .001).
In other words, patients, who reported less satisfaction with medical care, were those who
perceived racism in the medical care system, and were more distrustful of medical care
(LaVeist, Nickerson, & Bowie, 2000).
The authors interpreted these findings that this persistent medical mistrust in
African Americans was caused by the Tuskegee Syphilitic Study (Gamble, 1997) and
their experiences with racism, ethnic biases, and social stigma (Gamble, 1997; Benkert et
al., 2008; Benkert et al., 2009; LaVeist et al., 2000). In addition, LaVeist, and colleagues
cited a number of scholars who have done qualitative studies on racism, and medical
mistrust in African Americans (Ayanian et al., 1993; Ford et al., 1989; Franks et al.,
1993; Gastonis et al., 1995; Giles et al., 1995; Whittle, et al. 1993), and who have
suggested that African Americans undergo fewer medical procedures that are preventive
in nature because of their mistrust in the healthcare system (LaVeist et al., 2000). While
it may be very true that African Americans experienced racism, and social stigma that
had led them to establish a strong pattern of negative heath belief systems, it would still
be possible to cause a change in their attitudes, and health beliefs by increasing their selfefficacy through various ways of educating them on their healthcare (LaVeist et al., 2000;
Benkert et al., 2008; Benkert et al., 2009). Self-efficacy, as described by author Bandura
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(1977), is the people’s conviction of their strength, and ability to bring change in their
beliefs, attitudes, and performance (Bandura, 1977), and this concept will be discussed in
the following section as to how it brings changes in African Americans with medication
adherent behaviors with chronic illnesses.
Self-Efficacy enhances Medication Adherence
In the context of chronic illnesses, self-efficacy plays a vital role in that an
individual requires a firm belief, and confidence in his/her abilities that he/she can
manage their illness on their own with confidence (Kralik, Paterson, & Coates, 2010).
Bandura (1977) defined self-efficacy as the conviction that one can successfully execute
the behavior required to produce the outcomes (Bandura, 1977, p.79). For Bandura
(1977), the concept of self-efficacy is a major determinant of people’s health behavior in
chronic illness management (Kralik et al., 2010; Bandura, 1977, 2004) in that the strength
of one’s belief in his/her capabilities (not necessarily true capabilities) to care for
themselves with confidence is a good predictor of future health outcome (Kralik et al.,
2010).
The author Bandura (1977) further explained that outcomes and self-efficacy are
two different concepts (Bandura, 1977). The concept of “outcomes” specifically
indicates that an individual believes that a particular course of action will produce a
certain outcome; for example, individuals believe that taking medications for high blood
pressure, diabetes, and asthma will control those illnesses, but the question is whether the
individual can perform those actions with confidence (Bandura, 1977, 2004). However,
the concept of “self-efficacy” indicates people’s conviction in their own effectiveness
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that it allows them to face difficult challenges with confidence or cope with difficult
situations such as taking medications for their chronic illnesses (Bandura, 1977, 2004).
Quite often, people are afraid of facing challenges in their lives (Bandura, 1977),
and try to avoid such threatening situations (Bandura, 1977). This phenomenon is
particularly true with African American people in that they are afraid of participating in
any clinical trial (Benkert et al., 2008; Benkert et al., 2009; Gamble, 1997) or taking
medications for chronic illnesses because of their past painful experiences (Gamble,
1997). Bandura (1977) explained that self-efficacy establishes a standard as to how
people will use their efforts, and to how long they will continue persistently in the face of
challenges, and especially in aversive situations (Bandura, 1977). People with more
expectations and stronger efficacy will demonstrate active efforts even in the midst of
difficulties (Bandura, 1977), remain persistent by actively engaging in their efforts, and
ultimately gain mastery of their actions (Bandura, 1977). But in the face of difficulties,
individuals who give up in a very early stage in a premature manner, retain their fears
resulting in negative consequences (Bandura, 1977), and these fears become debilitating
factors in their lives preventing them from accomplishing their desired goals (Bandura,
1977).
The important feature of self-efficacy is that it allows individuals to identify
issues, set goals, and build commitment to actions by using problem solving methods
(Kralik et al., 2010). According to Bandura (1977), self-efficacy beliefs provide a
foundation for human motivation, wellbeing, and personal accomplishment. Also, people
believe that their actions can produce the outcomes they desire to persevere in the face of
difficulties (Bandura, 1977). The key argument on the role of self-efficacy belief is that

69

it is human functioning, and is capable of evoking motivation, and these actions are based
more on what they believe rather than on what is objectively true (Bandura, 1977). For
this reason, peoples’ behavior can be predicted better often at times by their beliefs that
they hold about their own capabilities of accomplishing, because these self-efficacy
perceptions help to determine what individuals with knowledge, and skills have
(Bandura, 1977).
The authors Kralik, and colleagues (2010) explained that future health status, and
health behaviors in people with chronic illnesses are greatly dependent on their selfefficacy, and changes in self-efficacy. The same authors further described that living
with a chronic illness is an ever challenging experience, and people have to make
considerable adjustments and adaptation to daily life that in turn requires changes in selfefficacy (Kralik et al., 2010). People with a higher level of self-efficacy have a higher
level of confidence in their ability to follow medical recommendations (Gherman,
Schnur, Montgomery, Sassu, Veresin, & David, 2011), and to expect a more meaningful
positive relationship with their healthcare providers (Gherman et al., 2011). For this
reason, a few scholarly studies on self-efficacy and chronic illness management will be
explained in the next section.
Chen and colleagues (2010) conducted a randomized controlled trial in Taiwan by
using the Pretest/Posttest design for a period of six weeks. The main purpose of the study
was to assess the effects of self-efficacy intervention in self-care behaviors with asthma,
and the self-efficacy of adult asthma (Chen, Shen, Chang, Wang, & Huang, 2010). The
study participants were recruited through the adult asthma clinics in Taiwan from March
2, 2009 to January 31, 2010. A total of sixty patients, who fit with the inclusion, and

70

exclusion criteria, were randomized to intervention, and control groups. Each group had
thirty participants diagnosed with adult asthma, and both groups completed the pretest
questionnaire prior to the study (Chen et al., 2010).
The intervention group received a self-efficacy intervention program that included
watching a DVD for fifteen to twenty minutes, reading a self-efficacy education booklet,
sharing their experiences with a support group of eight-to-twelve people, and a telephone
interview. The illness-sharing support group lasted for forty-five minutes, and this
support group offered support, shared information, fostered feelings of belonging, and
provided a forum for discussion. In addition, the researcher spent fifteen minutes with
each study participant to evaluate his/her confidence level (Chen et al., 2010).
The control group received conventional health education that included
individualized oral health lessons, introduction to asthma medications, handling daily
issues related to asthma such as avoiding upper respiratory infection, and antigens, and a
telephone follow up at the fifth week of study. Both groups completed a posttest at the
sixth week (Chen et al., 2010).
A descriptive statistical analysis method was designed using version 17.0 of
Statistical package for the social sciences (SPSS) software. The authors reported their
study findings in that participants, who received the self-efficacy intervention program,
showed better self-care behaviors than participants in the control group who received the
conventional outpatient educational program. The study findings included a significant
difference in the intervention group in medication adherence (p = .008), self-monitoring
(p = .000), avoidance of antigen (p = .001), regular follow up visits (p = .000), and
regular exercise (p = .016). Also, self-efficacy improved significantly in this group in
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terms of both asthma attack prevention (p = .030), and management during asthma
attacks (p = .017) (Chen et al., 2010).
The authors concluded their study findings that self-confidence that was built
based on vicarious learning methods, and persuasive techniques (Bandura, 1977) played
an important role in providing self-motivation, and adjusting to self-behaviors. Also, the
DVD was a powerful persuasive tool. A self-efficacy booklet containing stories of other
asthmatic patients’ condition, and their coping mechanisms served as a powerful
vicarious learning experience. The authors’ final conclusion included that asthma selfcare greatly depends on a patient’s self-efficacy that emphasizes behavior change. In
addition, self-efficacy must be incorporated in a patient educational program with any
chronic illness (Chen et al., 2010).
Another study related to self-efficacy, and social support was conducted by using
a two-group comparative descriptive design by scholars Chlebowy, and Garvin (2006).
The purpose of the study was to investigate the relationship between psychosocial
variables that included social support, self-efficacy, and outcome expectations to diabetic
self-care behaviors, and glycemic controls in both Caucasians, and African Americans
who lived in the southeastern states of the United States (Chlebowy & Garvin, 2006).
The authors used a convenient sample for recruitment for this study. A total of ninetyone patients with type 2 Diabetes were recruited for this study. The study design
included an educational program on type 2 Diabetes at three different locations or called
sites A, B, and C. At site A, participants attended a diabetic educational program taught
for two consecutive days by a multidisciplinary team. At site B, participants were
scheduled for outpatient clinic visits, and taught by a physician, and a registered nurse or
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a clinical dietician. At site C, participants were recruited for an outpatient educational
method by dialogue with a registered nurse or a clinical dietician (Chlebowy & Garvin,
2006).
The authors used four instruments for data collection, and those instruments
included the social support questionnaire (AAQ), the self-efficacy questionnaire (SEQ),
the outcome expectation questionnaire (OEQ), and the diabetic activities questionnaire
(TDAQ) (Chlebowy & Garvin, 2006). All the study participants completed these four
questionnaires. At site A, these four questionnaires were sent by mail to their residence
with a self-addressed stamped return envelope prior to the first day of the educational
program. At site B, participants completed those questionnaires immediately after the
educational program at the clinic site. At site C, participants completed those
questionnaires during the time of education. At A, and C, hemoglobin AIC levels were
obtained from the participants’ medical records, and at site B, the hemoglobin AIC level
was obtained during the time of clinic visit.
The study results were analyzed by using the Pearson-product-moment
correlation, and the findings included these: 1) on relationship between social support,
and self-care behaviors: there was no significant relationship, among Caucasians or
African Americans when the group was considered total, 2) on relationships between
self-efficacy (SC), and self-care behaviors: there was no significant relationship, among
Caucasians or African Americans when the group was considered as total or by race, 3)
on relationships between outcome expectancy (OE), and self-care behaviors: there was a
significant relationship between outcome expectation, and self-care behaviors. The OE
score was significantly correlated with self-care behaviors (r = 0.27, p = .01). When
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compared with Caucasians, and African Americans, there was no significant relationships
between OE, and self-care behaviors for Caucasians, but there was a significant
relationship for African Americans between OE, and self-care behaviors (r = 0.43, p =
.03), 4) in the relationship between social support, and glycemic control, there was no
significant relationship when the group was considered total, and by race, 5) in the
relationship between self-efficacy (SE), and glycemic control, there was no significant
relationship when the group was considered total, and by race, and 6) in the relationship
between outcome expectation (OE), and glycemic control, there was an insignificant
relationship between outcome expectation, and glycemic control when the group was
considered total, and by race (Chlebowy & Garvin, 2006).
Based on these study findings, the authors concluded in their report that social
support was not significantly related to self-care behaviors, and glycemic control in both
Caucasians, and African Americans. There was no significant relationship between selfefficacy (SE), and self-care behaviors, and glycemic controls. The authors cited scholars
Ludlow, and Gein (1995) who found in their studies that there was no significant
relationship between exercise self-efficacy, and glycemic control, and medication selfefficacy, and glycemic control (Chlebowy & Garvin, 2006). In the same way, another
scholar Allison (2003), cited by Chlebowy, and Garvin (2006), found no significant
relationship between self-efficacy, and glycemic control (Chlebowy & Garvin, 2006).
However, the cited authors Ludlow, and Gein (1995) found in their study that participants
with higher levels of general management self-efficacy, and diet self-efficacy had lower
glycosylated hemoglobin levels (AIC) (Chlebowy & Garvin, 2006). The authors
acknowledged that these differences in different studies might possibly be that different

74

scholars might have used different self-efficacy scales for their studies. Also, the study
participants were possibly exposed to previous diabetic education. Furthermore,
increased self-efficacy will enable diabetic patients in overall diabetic management
(Chlebowy & Garvin, 2006).
In another self-efficacy study, Schoenthaler, and colleagues conducted a
randomized controlled trial with African Americans diagnosed with hypertension. The
main purpose of the study was to assess whether self-efficacy mediates relationship
between depressive symptoms, and medication adherence (Schoenthaler, Ogedegbe, &
Allegrante, 2009). A total of 167 African American with hypertension were recruited by
trained research personnel from twenty community health clinics in New York City who
fit the research criteria. One week after recruitment, a baseline assessment was done on
all study participants on demographics, hypertension history, and measures of self-report
on medication adherence, self-efficacy, and depressive symptoms. In addition, patients’
charts were reviewed for baseline blood pressure readings, and co-morbidities.
Following baseline assessment, study participants were randomly assigned to the
intervention group who received motivation guidance, and to the control group who
received usual care. All participants from both groups were given three-month follow up
appointments. The intervention group, after completing three months of a follow up visit,
attended a motivational interview with those same trained researchers (Schoenthaler et
al., 2009).
The study analyses included demographic data, co-morbidities, baseline
depressive symptoms, self-efficacy, and medication adherence at the three-month follow
up. By applying four regression statistical models, the authors tested these: 1) the effects
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of baseline depressive symptoms on three months of medication adherence, 2) the effects
of baseline depressive symptoms on three months of self-efficacy, 3) the effects of three
months of self-efficacy on three months of medication adherence, and 4) the combination
effects of baseline depressive symptoms, and three months of self-efficacy on three
months of medication adherence. Statistical significance was set at p < .05. Also,
demographic variables, and co-morbidities were included in the Meditational Pathway
Model if they were significant at p < .05. The authors found that the mediation effect
was significant between depressive symptoms at baseline, and medication adherence at
three months, and the combined effects of baseline depressive symptoms, and three
months of self-efficacy on three months of medication adherence. The authors also used
the Arioan version of the Sobel test to determine if the mediating effect of self-efficacy
was statistically significant, and it proved statistical significance (Schoenthaler et al.,
2009).
Based on their study findings, the authors explained that self-efficacy mediated
the relationship between baseline depression symptoms, and medication adherence.
Also, an individual’s negative view of self and negative interpretation of their current
experiences, and future events can explain as to how those negative attributes affect an
individual’s self-efficacy, and motivation. In those situations when those individuals are
forced to meet the difficulties because of depression, they cast doubts on their abilities or
evaluate their capabilities negatively, resulting in low self-efficacy. Furthermore, the
authors found through this study, that lower educational attainment was a significant
independent predictor of worse medication adherence (Schoenthaler et al., 2009).
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The authors described that self-efficacy in the African American population plays
a vital role in explaining their depressive symptoms, and its negative effect on medication
adherence. This is because those depressed individuals do not recognize their depressive
symptoms, and their influence on medication adherence, and they experience low selfefficacy resulting in poor medication adherence. The same authors suggested that these
problems must be addressed through proper patient education targeting low self-efficacy,
and depressive symptoms, thereby increasing their confidence to participate actively in
their healthcare, and in medication adherence. The authors further challenged the
healthcare systems, and healthcare providers to monitor their patients carefully for any
signs of depression because of their co-morbidities, and chronic illnesses, and to provide
patient-centered health education, thereby increasing their confidence in medication
adherence (Schoenthaler et al., 2009). In the next section, the effects of education on
medication adherence will be discussed.
A Special Note on the Mediation Variable
Scholars Baron and Kenny (1986) described this special statistical analysis
method that can be used when a researcher applies a regression model for their analysis
(Preacher & Hayes, 2004). Using the mediation variable could help to indirectly assess
the effect of a proposed cause on some outcome through a proposed mediator (Preacher
& Hayes, 2004). In the previous study by scholars Schoenthaler, and colleagues (2009),
they proposed in their study, depression in African Americans as a causative variable,
medication adherence as an outcome variable, and self-efficacy as a mediation variable
(Schoenthaler et al., 2009). According to Preacher & Hayes (2004), a mediation variable
can be any variable; however, a necessary component of a mediation variable is that it
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should show a statistically, and practically significant indirect effect on the causative, and
outcome variables (Preacher & Hayes, 2004). The usefulness of a mediation variable is
that it allows the researcher to go beyond merely descriptive analysis to a more functional
understanding of the relationships among variables (Preacher & Hayes, 2004). The SPSS
and SAS software will allow this computation because the Sobel formula is built into
these pieces of software (Preacher & Hayes, 2004).
Educational Methods Pertinent for this Study
Providing education about chronic illness is a challenging task for every
healthcare provider, and is a fundamental responsibility of every healthcare provider
(McKenzie et al., 2009). Health education is a process of informing people about their
illness, the need for taking medications, and the necessary steps to be implemented to
prevent unnecessary negative consequences because of their illness (McKenzie et al.,
2009).
It is essential on the part of every healthcare provider, taking measures
beforehand to educate patients about their illness, especially with those patients who
demonstrate fears, anxiety, disbelief, and concerns about taking medications because of
inadequate knowledge about their illness, and severity of it (Brunton, 2011). In addition,
the education should be reciprocal in which the healthcare provider actively listens to the
patient’s concerns, receives feedback from the patient, and includes education about their
illness, the reason for taking medications, short, and long-term goals, and benefits, the
potential side effects of medications, what could be done to minimize those effects, and
prevention of further complications because of illness (Brunton, 2011).
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Furthermore, healthcare providers must maximize the opportunity given to them
for health education by presenting the information in such a way that it really fits with the
patient’s literacy, and comprehension levels, by presenting the information at a fifth
grade level to some patients (Brunton, 2011). It would be appropriate to use multiple
formats to educate patients about their illness, by using visual aids, flip charts, brochures,
and technology that provides information with clarity about illness, and medications
(Brunton, 2011; Houston, Allison, Sussman, Horn, Holt, Tombaugh … Hullett, 2011).
DVD Method
Houston and colleagues (2011) conducted a randomized controlled comparison
study with African Americans with hypertension (Houston et al., 2011). Before
implementing the study, the authors collected stories about hypertension from African
Americans who live in the inner cities of Alabama. Trained researchers carefully
collected stories on hypertension from fourteen different African Americans. The stories
were carefully recorded, listened to intently, and made into documentary DVDs to be
used for educational purposes for African Americans. Prior to use, those DVDs were
tested for cultural sensitivity, and appropriateness. Main hypothesis of this study was
that patients in the intervention group would experience more favorable changes in blood
pressure than those in the comparison group (Houston et al., 2011).
A total of 299 African American patients, between the ages of eighteen to eighty
years, and having a proven diagnosis of hypertension from medical records were
recruited for the study. All study participants were randomly assigned to intervention,
and control groups, irrespective of their blood pressure control. The intervention group
(n = 147) received DVDs that contained hypertension stories such as living with
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hypertension, the lesson on patient physician communication, and strategies to improve
medication adherence. The control group (n = 152) received DVDs on health topics such
as sodium-restriction diet, exercise, and dietary changes. All the study participants
received their DVDs at baseline after their initial blood pressure was recorded. Patients
were followed at three months, and at six-to-nine month period of time, and at each visit,
their blood pressure was recorded three times at thirty-minute intervals (Houston et al.,
2011).
In addition, the authors conducted another separate random assignment with
patients whose blood pressure remained uncontrolled. The group was assigned to a group
of ten, either to intervention or control group (comparison group). The comparison
group, whose blood pressure remained uncontrolled, attended a DVD educational
program in the clinic on “healthy habits action minute.” This DVD was specifically
designed to bring a change in attitudes, and behavior, and they watched this DVD in the
clinic (Houston et al., 2011).
The study was analyzed by using several statistical methods. Key findings in this
longitudinal study included these: 1) Patients with baseline controlled blood pressure
experienced no significant differential changes at three months, and at six-to-nine
months, 2) Among patients with uncontrolled hypertension, reduction from baseline to
three months favored the intervention group for both systolic, and diastolic blood
pressure (p = 0.012), 3) Also, in this same group of patients, blood pressure reduction
from baseline to six-to-nine months favored intervention group in both systolic, and
diastolic blood pressure (p = 0.119), and 4) In the subgroup whose blood pressure
remained uncontrolled, study participants experienced a slightly increased reduction in
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blood pressure levels, but the different responses were not significant (Houston et al.,
2011).
In this longitudinal randomized controlled comparison trial in a sample of 299 (N
= 299), the authors found that differences in blood pressure favored that intervention
group. Also, participants who received DVDs on hypertension stories benefited because
of the visual presentation. In this way, the authors concluded that real life stories
combined with technology would be of great value in health promotion (Houston et al.,
2011).
Lecture and Pamphlet Educational Methods
Powers and colleagues (2009) conducted a Cholesterol, Hypertension, and
Glucose Education (CHANGE) study using a randomized controlled study design. The
main goal of the study was to educate African Americans as to how they could modify
cardiovascular risk factors, thereby reducing cardiovascular disease outcome (Powers,
King, Ali, Alkon, Bowlby, Edelman, … Bosworth, 2009). The study participants
included four hundred African Americans (N = 400) who provided consent for the study,
and had high cholesterol, hypertension, and diabetes, proven by medical records (Powers
et al., 2009). All study participants received an educational pamphlet on cardiovascular
risk factors at the baseline interview before randomization. Following the baseline
interview, study participants were randomized to intervention (n = 200), and control (n =
200) groups (Powers et al., 2009).
The intervention of the study was a combination of both behavioral, and
medication management, an educational program administered by trained nurses who
underwent cultural competency, and motivational interviewing training. The intervention
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also included monthly telephone calls educating patients with tailored information that
was relevant, and pertinent specifically to this intervention group. This tailored
information provided flexibility in educating patients on cardiovascular risk factors,
monitoring blood sugar, and the importance of medication adherence. Also, these nurses
served as liaisons between the primary care provider, and patients, and arranged for every
three-month clinic visit with their primary care providers including laboratory
appointments. The control group received normal primary care visits every three months
(Powers et al., 2009).
Analyses of the study focused on testing the primary and secondary hypotheses.
The primary hypothesis was that African Americans in the intervention group, who
received a nurse-managed educational program, would have a reduction in systolic blood
pressure by 5 mmHg, AIC by 0.5 percent, and LDL-D by 20 mgm/dL over a twelvemonth period when compared with the control group who received education on
cardiovascular risk factors by pamphlets at baseline interview. The secondary hypothesis
was to analyze treatment group differences in baseline to twelve months, and change in
the CVD-related health behaviors such as taking Aspirin, and other prescribed
medications, diet, and exercise as well as changes made with CVD risk factors (Powers et
al., 2009).
The statistical power was set at eighty percent through using SAS software. To
detect a significant difference between the intervention, and control groups on systolic
blood pressure by five mmHg, AIC by 0.5 percent, and LDL-C by twenty mgm/dL over
twelve months, the Type I error was set at a = .05 level, and Type II error was set at b =
.20 to get a statistical power of eighty percent. Based on this statistical analysis, the
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authors concluded that patients who received a nurse-managed educational program,
demonstrated a significant difference in CVD-related health behaviors, and reduction in
systolic blood pressure, AIC, and LDL cholesterol levels. In this way, using educational
pamphlets and telephone reinforcements would be greatly beneficial to patients with
chronic illnesses (Powers et al., 2009).
Peer Support with Group Discussion and Role Play
Heisler and colleagues (2010) described that peer support groups would allow
patients to share their experiences with chronic illnesses, and to receive encouragement,
and feedback from their peers (Heisler, Vijan, Makki, & Piette, 2010). The same
scholars (2010) cited other scholars that include (Hayward, Manning, Kaplan, Wagner, &
Greenfield, 1997; Saadine, Caldwell, Gregg, Engelgau, & Vinicor, 2006; and Vijan,
Hayward, Ronis, & Hofer, 2005) who have suggested in their epidemiological studies
with diabetic patients that an effective educational model is one that has a combination of
both peer support groups, and one-on-one clinical teachings, and this combination
module would improve clinical outcome, and can be used in all clinical settings where
more chronic illnesses are taken care of (Heisler et al., 2010), while individuals with the
same kind of illness meeting a group in a social setting are more relaxed, and willing to
share their experiences with each other (Heisler et al., 2010). At these settings, people
are more relaxed, and willing to talk openly when the group is guided by a nurse or a
non-physician healthcare provider because they perceive that they all face the same
challenges in their daily lives (Heisler et al., 2010).
To demonstrate that support groups can be more effective in increasing
autonomous motivation, self-efficacy, and self-management care with diabetes, and
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thereby potential improvement in glycemic control, Heisler, and colleagues (2010)
conducted a randomized controlled trial at two United States Veterans Healthcare
facilities with 244 male patients. The authors’ main objective was to compare two
different support groups that included these: 1) reciprocal peer support (RPS), and 2)
program with nurse care management (NCM). Following the consent signal, study
participants were evaluated for their initial blood pressure, and hemoglobin AIC. Also,
all the participants were requested to take a self-administered survey. Among these 244
participants, 216 (89 percent) completed laboratory work, and 231 (95 percent)
completed the self-administered survey. Then, the study participants were randomly
assigned to either the RPS or the NCM group (Heisler et al., 2010).
Following randomization, because the RPS group needed to have an even number
of study participants, randomization algorithms were employed in order to have an equal
number of participants who were closer in age. In addition, all study participants,
researchers, and care managers were blinded. Also, the protocols for both support groups
were concealed until all baseline information was obtained completely (Heisler et al.,
2010).
In order to assess the effectiveness of the support groups, a total of fifteen care
managers (nine in one VA, and six in second VA) were provided training in motivational
interviewing, and in the application of empowerment to facilitate group discussions,
encourage patients to identify diabetes-related behavioral goals, and values that are
culturally competent, and to develop short-term goals of specific action to meet these
plans. In addition, these care managers were given an additional two one-hour booster
sessions, and encouraged to apply behavioral components while interacting with patients
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throughout the VA system. All study participants were educated on algorithms with
insulin management but not with oral hypoglycemic medications (Heisler et al., 2010).
A total of 119 participants (n = 119) were enrolled in the NCM support group.
The intervention in this support group included an enhanced version of usual care with
care manager-led group sessions for 1.5 hours, assessment, and discussion of their blood
pressure, laboratory values on AICs, encouragement to schedule follow up telephone
calls or face-to-face meetings with their care managers, and educational materials on
diabetic self-management (Heisler et al., 2010).
In the same manner, a total of 125 participants (n = 125) were enrolled in the RPS
support group. The intervention for this support group comprised of care managers, and
research assistants who led three-hour sessions, the evaluation, and discussion of their
blood pressure readings, and their blood sugar levels, and a brief communication skills
training. After the training, participants were paired with age-matched people, and
encouraged to call their partners using the telephone interactive method once a week.
Special communication tools were set up in such a way that they were not in need of
exchanging their telephone numbers. These telephones recorded call initiation,
frequency, duration of use, and initiated automated reminders once in seven days if they
had not called each other. These telephone systems allowed them to leave voice mail
messages to research staff or care managers. In addition, the participants received a DVD
on communication skills, and a diabetes self-management workbook that would guide
them with their peer telephone conversation. Furthermore, they were given options of
attending three sessions for 1.5 hours in which study participants were actively involved
in sharing their concerns, encouraging their group members, and planning new strategies
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in their action plans. The researchers, and care managers, who remained passive,
facilitated these sessions thus allowing the group to lead, and be more actively involved.
The study findings were analyzed by mixed commands or simple linear multiple
regressions in STATA 11.0 version statistical software because of its capabilities for
advanced statistical procedures that include multilevel mixed-effects, linear regression
models. The analyses included all the measurements taken at baseline and during
intervention at three months, and at six months when the study was completed. The
sample size was estimated prior to the study to provide eighty percent power with a twosided a level of 0.05 to detect difference in Hemoglobin AIC level of 0.5 percent between
groups. The key component of this intervention was pairing partners by age matched to
form a real peer support group in the RPS intervention group. According to these
scholars, previous studies that were done on support group interventions used qualitative
methods whereas this present intervention that was based on randomized controlled trial
was the first one to use a quantitative method, thus becoming an important study to
explain as to how a peer support group becomes an essential part in the self-management
of chronic illnesses (Heisler et al., 2010).
The study findings included that there was no significant difference in baseline
characteristics among study participants in both groups (P < 0.100). In the HbAIC
measurements, the RPS support group had a significant reduction from 8.02 percent to
7.73 percent, but the NCM support group had an increase from 7.93 percent to 8.22
percent at six months. These measures indicate that there was a 0.29 percent decrease in
the RPS group, and 0.29 percent increase in the NCM group. By stratified analyses of
HbAIC, the RPS support group had a mean decrease of 0.88 percent at six months,
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whereas the NCM group had a mean decrease of 0.07 percent. In addition, eight
participants in the RPS group began their insulin therapy, whereas only one participant in
the NCM group began insulin therapy (P = 0.20). Along with Insulin therapy, the RPS
study participants reported increased adherence with oral hypoglycemic agents. At six
months, the RPS support group reported greater increase in telephone conversation with
their peers, thus receiving greater encouragement, and social support related to diabetic
care when compared with NCM support (Heisler et al., 2010).
The authors, based on these study findings, concluded that people with chronic
illnesses need more support in self-management, and this type of support could be
provided through support groups (Heisler et al., 2010). Also, peer support groups,
according to these scholars, are more cost-effective when compared with usual classroom
lectures that are offered in the clinics (Heisler et al., 2010).
Summary
In this chapter, the body of evidence-based literatures on medication adherence
with chronic illnesses has been explored. The primary population focus was inner city
African Americans who live with chronic illnesses such as hypertension, hyperlipidemia,
diabetes, and asthma/ COPD. Many randomized controlled studies on various topics,
related to medication adherence by various scholars, were critically examined to explain
the behavioral component of medication adherence, and to shed light on potential
influencing factors that had contributed to non-adherence with medications. These
potential influencing factors included 1) perception of chronic illnesses, and illness
dimensions, 2) socioeconomic factors, 3) mistrust of healthcare, and the healthcare
system, 4) depression due to chronic illnesses, 5) African Americans’ health beliefs, 6)
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Patient-Provider communication, 7) Poor health literacy, 8) racism, 9) low self-efficacy,
and 10) failure of providing culturally competent health promotion, and lack of peer
support.
The review of several literatures has demonstrated that medication adherence is a
complex behavior subjected to human and environmental determinants. The literature
described the important aspect of human nature as to how it influences human behavior.
Many of these studies, and the statistical data reviewed concluded medication adherence
with chronic illnesses can be improved, especially among African Americans if they are
informed adequately with culturally competent health messages by providing education
according to their comprehension levels. Chapter three will present methods, and
interventions that will guide this research.
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Chapter 3: Research Methodology
Overview
The main focus of this proposed study was to assess the effectiveness of different
educational methods that include lectures, video presentations, role-playing, and group
discussions to promote medication adherence in African Americans with chronic illnesses
such as hypertension, hyperlipidemia, diabetes, asthma, and COPD. The study is based
on the theoretical framework of the SCT of (Bandura, 1977), and the TPB of (Ajzen,
1991).
Review of the literature included several randomized controlled trials by various
scholars who have explained that medication adherence is a paramount behavior to
control mortality, especially in African Americans (Granger et al., 2008; Kripalani et al.,
2007; McDonald et al., 2002). This study is particularly important for African Americans
because of higher prevalence of cardiovascular disease affecting African Americans in a
disproportionate manner when compared with other ethnic groups (Chobanian et al.,
2003).
Results of various clinical trials on medication adherence by several scholars have
demonstrated that there is a strong association between medication adherence with
chronic illnesses, and reduction in morbidity, and mortality (Chobanian et al., 2003;
Kripalani, Risser, Gatti, & Jacobson, 2009; Schoenthaler et al., 2009). To gain an indepth understanding on chronic illnesses, and as how African Americans are
disproportionately affected with chronic illnesses when compared with other ethnic
groups, several scholars have conducted randomized controlled trials in various clinical

89

settings, and have concluded that medication adherence becomes a significant
determinant in the control of chronic illnesses, thereby reducing morbidity, and mortality
(Chobanian et al., 2003; Kripalani et al., 2009).
Based on these scholars’ report, evidence is clear that promoting medication
adherence for patients with chronic illnesses is a major public health challenge, and these
challenges have to be dealt with multipronged approaches (Chobanian et al., 2003;
Kripalani et al., 2009; Levine & Green, 1985). For this reason, this chapter focuses on
explaining methods employed through a randomized controlled trial to educate inner city
African Americans with chronic illnesses, and who live in Chicago. The study purpose is
to assess the effectiveness of educational methods that include lectures, video
presentations, role-playing, and group discussions to promote medication adherence with
chronic illnesses that include hypertension, high cholesterol, diabetes, asthma, and
COPD.
Educational Methods: Lecture, Video, Role-Playing, and Group Discussions
The barriers for not taking medications have been studied and explained by
various scholars (Kelly & Jorgenson, 2012). Because the factors influencing medication
adherence are many and varied, various interventions are needed that will be appropriate
and culturally sensitive to enhance medication adherence (Murray et al., 2004). Scholars
Kelly and Jorgenson (2012) have explained that taking medications or not taking
medications is a complex issue and there is no set gold standard to describe this complex
behavior. Murray et al. (2004) explained that adults more than 50-years-old often have
multiple chronic illnesses requiring multiple medications and interventions needed to
increase and improve patient education. Therefore, increasing a patient’s knowledge
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about his/her medications and self-efficacy allows him/her to make positive changes in
health beliefs, increase adherence behavior, and learn to take responsibility for his or her
own health (Murray et al., 2004).
The National Council on Patient Information and Education (NCPIE; 2007) has
explained that in the United States, nonadherence affects people of all ages, both genders,
and well educated people as well as people with minimal education (NCPIE, 2007). The
NCPIE acknowledged that people in the United States have inadequate knowledge about
significance of medication adherence as a critical element of their improved health. This
non-adherence problem had been neglected and overlooked as a serious public health
problem, and as a result, it has become one of the major national health problems
resulting in approximately 177 billion dollars annually in total direct and indirect health
care costs (NCPIE, 2007). Recognizing these nonadherence problems with medications
is important, especially with chronic illnesses such as hypertension, diabetes,
hyperlipidemia, asthma, COPD, and glaucoma. The NCPIE (2007) has recommended
establishing a multidisciplinary approach to adherence education and management
(NCPIE, 2007) in which the patient becomes an active member in this educational
process (NCPIE, 2007).
The council further outlined strategies that could be implemented by healthcare
providers in order to enhance health promotional activities to promote medication
adherence (NCPIE, 2007). These strategies include using verbal discussion and written
materials based on evidence to help patients understand the chronic condition, the need
for taking medications, and value of taking medications (NCPIE, 2007), offering
counseling with clearly written pamphlets (NCPIE, 2007), providing written information
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in a patient’s own language (NCPIE, 2007), offering practical skills sessions such as
monitoring blood sugar, reading medication names, being able to open the pill bottles,
and reminders to take medications (NCPIE, 2007). Furthermore, application of these
strategies through lectures, video presentations, group sessions, and role-playing
involving community members will further strengthen adherence behavior (NCPIE,
2007). Some scholars have provided evidence for these educational methods in that they
had applied, through randomized controlled trials, to bring social change with medication
adherence.
This section explains a randomized controlled trial that took place in Sweden to
assess the effectiveness of peer group education on diabetes. Adolfsson and colleagues
(2006) conducted a randomized controlled trial at seven primary care centers for a period
of one year in Sweden. The purpose of the study was to evaluate the impact of peer
group education on empowerment with Type 2 diabetic patients, whether there will be an
increase in knowledge, self-efficacy, and improvement in daily life demonstrated by
laboratory values (Adolfsson, Walker-Engström, Smide, & Wikblad, 2006). A total of
101 patients were recruited and 88 patients agreed to participate in the study. The group
was randomized to intervention group (n = 42) and control group (n = 46).
The aim of the study was to evaluate the impact of group education on
empowerment on knowledge, self-efficacy, and satisfaction with daily life on patients
with Type 2 Diabetes. Patients in the intervention group met twice in a week for fortyfive minutes and were encouraged to share their experiences and problems that they
encountered in their daily life. A nurse, well-trained on diabetic control served as group
facilitator. The control group received routine diabetic care following Swedish national
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guidelines for diabetes, and they visited their provider twice a year. Both groups
completed a 27-item validated questionnaire before and after the study (Adolfsson,
Walker-Engström, Smide, & Wikblad, 2006).
The data analysis was done through SPSS Version 14.0. The scholars used
student t test, Mann-Whitney U test for continuous variables for comparison between the
groups, and ANCOVA to estimate between group differences in AIC and BMI. A twotailed p-value < 0.05 was considered statistically significant at a 95% confidence interval.
The authors reported that patients in the intervention group, after one year, demonstrated
the level of confidence in knowledge, which was significantly higher when compared
with the control group and no significant differences were found in self-efficacy and
satisfaction with daily life. Based on these study findings, the authors concluded that
education in group settings demonstrated significant increase in knowledge, but did not
show significant differences in self-efficacy and satisfaction with daily life. The authors
acknowledged all the study participants and all those who assisted with this study. The
authors have acknowledged the limitations and challenges of this study and have made
suggestions for improvement (Adolfsson, Walker-Engström, Smide, & Wikblad, 2006).
In another randomized controlled trial with African Americans diagnosed with
hypertension, Schoenthaler and colleagues (2011) have examined the effects of role play
in a group setting. The role play was about comprehensive lifestyle change with
hypertension and it was followed by group-based counseling and motivational interviews
(Schoenthaler, Luerassi, Teresi, Silver, Kong, Odedosu, … Ogedegbe, 2011). The role
play concepts included regular exercise, taking medications, choosing a diet, and weight
reduction. The study included a total number of 200 low income African Americans
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diagnosed with hypertension between the ages of 18 to 60 years old (Schoenthaler et al.,
2011).
The study participants, who satisfied the study protocol, were randomized to
intervention group (n = 100) and control group (n = 100) using SAS software. The
intervention group attended ten group sessions comprised of role-playing and counseling
within a period of three months. Each session lasted sixty to ninety minutes. The
participant’s blood sugar was monitored three times at five-minute intervals before each
group session and an average reading was taken for each group session. The intervention
group further received motivation through telephone contacts for another three months
after the group sessions were completed. The blood pressure readings were taken at sixmonth intervals after the motivation interview was completed. The control group
participants received regular blood pressure care and counseling through pamphlets and
were followed in regular primary care clinics. Prior to the study, all study participants’
blood pressures were taken as baseline readings for the study.
The data was analyzed using multivariate analyses of variance (MANOVA) and
intent-to-treat statistical methods. The authors, based on the study findings, concluded
that the intervention group’s blood pressure improved by six to seven mm Hg on systolic
blood pressure (SBP) and five to six mm Hg on diastolic blood pressure (DBP) when
compared with the control group. The same authors have reported that there were many
challenges with this study, especially with recruitment and retention of study participants
in spite of providing adequate incentives given to the study participants. The same
scholars further suggested that patient education on lifestyle changes require many
different strategies and these strategies include role plays, audio-video presentations,
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counseling in groups or on an individual basis, written pamphlets and materials,
motivation through peer group, and telephone reminders to be considered and included
while planning an educational program (Schoenthaler et al., 2011).
Hill et al. (2009) conducted a randomized controlled trial in a primary care clinic
in Canada with patients who were newly diagnosed with chronic obstructive pulmonary
disease (Hill, Mangovski-Alzamora, Blouin, Ginyatt, Heels-Ansdell, Bragaglia, …
Goldstein, 2009). The purpose of the study was to improve patient educational programs
in the primary care clinics on self-care management (Hill et al., 2009). A total of 131
people were identified for the study and were given Bristol COPD knowledge
questionnaire (BCKQ) to complete. Only ninety-three participants completed the
questionnaire, and they were randomized to intervention group (n = 50) and the control
group (n = 43) (Hill et al., 2009).
The intervention group received a special educational program by trained
personnel who used video presentation, lecture, and a demonstration of as how to handle
inhalers used in COPD. The education lasted sixty minutes and was repeated in the same
way after one month. The educators followed the same educational strategies with the
aim to increase a patient’s knowledge and self-efficacy on COPD self-management. At
the end of each educational program, the intervention group completed the Bristol COPD
knowledge questionnaire (BCKQ). Following the second month educational program,
the intervention group received a manual with the title of “Living well with COPD,”
which was written in simple language with several illustrations, with minimal medical
jargon. Individuals in the control group received the usual care from primary care
physicians without any special emphasis on education (Hill et al., 2010).
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At the end of the third month, both groups completed the Bristol COPD
Knowledge Questionnaire. Statistical analysis was performed using SAS software.
Between and within-group differences were analyzed using ‘t’ tests. From these
analyses, it was shown that the intervention group score increased from 27.6 to 36.5,
whereas the control group score remained statistically almost the same, varying from 29.6
to 30.2 in the Bristol COPD Knowledge Questionnaire, with p < 0.001 and a confidence
interval of 95%. The magnitude of change in the intervention group was greater when
compared with the control group. Based on these study findings, the authors concluded
that education on COPD self-management using videos, lectures, demonstration of skills,
and providing a manual on self-management was very effective with newly diagnosed
COPD individuals at the primary care clinic sites, in spite of providing education in a
short duration (Hill et al., 2010).
Hesselink and colleagues (2004) conducted a randomized controlled trial in the
Netherlands with patients diagnosed with asthma and chronic obstructive pulmonary
disease (Hesselink, Penninx, van der Windt, van Dain, de Vries, Tvisk, … van Eijk,
2004). The purpose of the study was to assess the effectiveness of patient education on
asthma and chronic obstructive pulmonary disease. A total of 663 patients were
identified with asthma and chronic obstructive pulmonary disease from the medical
records and they were invited to participate in the study. 276 patients responded and
agreed to participate in the study. Randomization was done using a blinding method and
patient allocation was done to both intervention and control groups. Prior to
randomization, baseline assessment was done on all patients, and after stratification by
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age, study participants were allocated to intervention (n = 139) and control groups (n =
137) (Hesselink, et al., 2004).
The intervention had an educational program based on the Dutch Asthma
Foundation that included information about disease, medications, inhaler techniques,
recognizing allergic symptoms, and ways to control those symptoms. The evaluation of a
patient’s knowledge and self-efficacy was measured at baseline, after one year, and after
two years. The intervention group received education on asthma and COPD symptoms,
medications to relieve symptoms and maintenance, inhaler techniques, social and
environmental triggers, and ways to recognize the allergic symptoms and to take prompt
action. Also, at the end of the educational program, they received the Dutch Asthma
Foundation booklet which had detailed patient information on asthma and COPD selfmanagement. The educational program was administered by general practitioner
assistants who used video presentations, role plays, and counseling, for thirty minutes
face to face. The control group received usual care from their general practitioners
(Hesselink, et al., 2004).
Statistical analysis was done to determine the effectiveness of the intervention,
with one year and two year follow ups, using linear and logistic multi-level analyses with
MIWIN software, the levels that were included being patients, general practitioners, and
general practitioner assistants. In addition, subgroup analyses were done to investigate
whether the treatment effect varied between patients with the diagnosis of asthma or
COPD, and COPD mixed with asthma, and between males and females. Based on these
statistical findings the authors concluded that patients in the intervention group had
shown significant improvement in inhalation technique, and medication compliance, but
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had no change in smoking cessation when compared with the control group (Hesselink, et
al., 2004).
The authors acknowledged the staff that provided their valuable service for this
research work, described the limitations of the study, and provided suggestions for future
improvement in methodology. The same scholars explained the challenges that they had
encountered with recruitment and retention of the study participants. Suggestions were
provided to improve patient educational methods with chronic illnesses with the focus of
bringing a social change through their self-care management (Hesselink, et al., 2004).
In this way, many scholars have described through their empirical study, the
effectiveness of using educational methods in a variety of ways in spite of challenges that
they had encountered in including group discussion (Adolfsson, Walker-Engström,
Smide, & Wikblad, 2006), and role plays with various health promotional concepts
(Schoenthaler et al., 2011); other methods they used included video presentations,
lectures, demonstration of skills, pamphlets, and an educational manual (Hill et al.,
2010); finally, lectures, videos, face-to-face counseling, and providing booklets could
also be helpful (Hesselink, et al., 2004). The same scholars have provided evidence with
clarity as to how these educational methods were effective in improving knowledge, selfefficacy, and change in health beliefs with chronic illnesses. The same scholars have
further suggested implementing a variety of educational methods to increase knowledge
and skills, and to improve health behaviors and self-management (Adolfsson, WalkerEngström, Smide, & Wikblad, 2006; Hill et al., 2010; Schoenthaler et al., 2011).
Bandura (1977), in his social cognitive theory, has explained that coping with the
demands of everyday life such as taking daily medications, self-monitoring weight and
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blood sugar, doing regular exercise, and other activities would be exceedingly trying
(Bandura, 1977, 2004). He has further explained that people can exercise some control
over their behavior and their own self-reinforcement plays a vital role in successful selfdirected behavior (Bandura, 1977). He firmly believes that higher cognitive capacities
enable people to conduct most problem solving, and that the application of different
pedagogical methods for teaching skills and imparting knowledge would become more
crucial (Bandura, 1977). In this proposed study, the application of lecture, video, role
play, and group discussion methods would be justified with a hope of bringing a social
change in medication adherence among patients with chronic illnesses. Bandura (2004)
had suggested using any educational method in health promotion to bring a social change
that would increase self-management behavior (Bandura, 2004).
In summary, chronic illnesses continue to weigh more heavily on healthcare
resources; thus educating on lifestyle changes, medication adherence and self-care
management have become factors of paramount importance (Bandura, 2004;
Butterworth, 2008). In this way, this proposed study would be justified in educating
African Americans with chronic illnesses using lectures, video presentations, role-plays,
and group discussions. Educating people, in addition to prescribing medications, should
be the first fundamental responsibility of any healthcare provider (NCPIE, 2007).
The explained study design furthermore includes randomization, recruitment,
selection of study participants, and inclusion, and exclusion criteria. The included study
instruments are these: 1) Morisky medication adherence scale (MMAS), 2) Self-efficacy
for appropriate medication use (SEAMS), and 3) Beliefs about Medication Questionnaire
(BMQ-18). The other components are the place of study, and settings, ethical procedures
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involved protecting the study participants, and the study, and statistical procedures
involved in analysis.
Research Design and Approach
Fisher (1935) for the first time introduced the concept of randomization (Pocock,
2009). Fisher’s primary interest was to draw a valid unbiased empirical conclusion while
working in the agricultural field that he treated experimental plots of lands with various
crops, and fertilizers, by using random assignments (Pocock, 2009). Fisher (1935)
explained that randomization in research yields two significant advantages: 1) it guards
against any use of judgment or systematic arrangements leading to one treatment, thereby
avoiding biases, and 2) it provides a basis for the statistical standard methods such as
significance tests (Pocock, 2009). Creswell (2009) explained that in a time experimental
design, the study participants are randomly assigned to groups, which means that the
study participants are randomly assigned to the intervention group, and the control group
(Creswell, 2009). This procedure eliminates potential biases among the characteristics of
the participants that could affect the study outcomes so that any differences in outcomes
can be attributed to the experimental treatment alone (Creswell, 2009). Scholar Marks
(2003) cited author Hill (1953) who firmly believed, and acknowledged that
randomization prevents biased estimates of the value of new therapies in clinical settings,
and that randomization is necessary for accurate, and valid interpretation of statistical
significance (Marks, 2003).
A single-blind randomized controlled trial with Pre-Test/Post-Test group design
will be implemented in this study to assess the effectiveness of educational methods that
include lectures, video presentations, role-playing, and group discussions to promote
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medication adherence with inner city African Americans who take medications for
hypertension, high cholesterol, diabetes, asthma, and COPD.
Design:

Group A R__________T0_______x____________T2
Group B R__________T0____________________T2

(Creswell, 2009)
A Single Blind Randomized Control Group Pretest/Posttest Design
In this randomized controlled design, all conditions are the same for both
experimental, and control group with the exception that the experimental or intervention
group is exposed to educational interventions whereas the control group is not exposed to
intervention, and receives regular education on medication adherence (Cresswell, 2009;
Dimitrov & Rumrill, 2003). The threats to internal and external validity will be
controlled by conducting the study by following strict random selection of the study
participants and informing the volunteers with clarity about the entire study methodology.
The study will be conducted in one of the southwest communities of Chicago in a church
that is predominantly attended by African Americans. The study participants will be
African Americans between the ages of 18 to 65, who are able and willing to give their
written consent. The study will use the same instruments as pretest and posttest to avoid
confusion with instruments. The study participants will be randomly assigned to
experimental and control groups to obtain the probability of being equally distributed in
both group. The blinding and randomization will be done by computer.
The study participants from both groups will meet in the same church at a
designated time but the volunteers carefully make sure that both groups are separated and
meet in different rooms for the entire study time. The control group will receive the same

101

education that was given to the experimental group after the study is completed and there
will be no pretest and posttest. The study participants, who remained in the study for the
entire period of study, would receive their incentives after the study was completed.
Randomized Pretest/Posttest Control Group Design
Randomly Assigned

Pre-Test

Treatment

Post-Test

Experimental

T1

X

T2

Group: Group A
Control Group:

T1

T2

Group B

Potential Bias in RCT
Bias is anything that sways away from the truth (Lewis & Warlow, 2004). In
statistics, bias means “a tendency of an estimate to deviate in one direction from a true
value” (Jadad & Enkin, 2008). Scholars Lewis & Warlow (2004) have argued that just
because a study is designed as a randomized controlled trial it does not mean that it is an
unbiased trial or will be without any bias (Lewis & Warlow, 2004). Some scholars have
explained that even though the randomized controlled trial is considered the most
powerful and strongest design for evaluating the effects of health information, the
potential for bias is still possible during allocation, selection, treatment, and reporting of
the study findings (Viera, Shrikant, & Bangduwala, 2007; Stolberg, Norman, & Trop,
2004). The authors have identified bias that includes allocation bias, selection bias,
ascertainment bias, choice-of-question bias, and IRB bias (Viera, Shrikant, &
Bangduwala, 2007; Stolberg, Norman, & Trop, 2004).
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Steps to Minimize Bias
The proposed study recognizes the potential bias that could occur in this
randomized controlled trial. For this reason, the processes of allocation concealment will
be implemented in which study participants will not know to which group they are
assigned to, and this allocation concealment will minimize potential selection bias and
protect the randomization sequence before and until the intervention is given to the study
participants.
The second step to minimize potential bias will be following blinding in which
the researcher will be unaware of the identity of the study group, and data will be
assigned codes such as intervention group data will be ‘A’ and the control group data will
be ‘B’. In this way, the ascertainment bias will be minimized during and after data
collection. The codes can be broken once the analysis is completed (Jadad & Enkin,
2008).
The third step will be stratification of study participants in which study
participants will be stratified according to their age and gender. Stratification according
to the illness category may not be possible because of its clustering pattern in that one
individual may have more than one diagnosis (Jadad & Enkin, 2008).
In summary, this proposed randomized controlled trial recognizes potential bias
that can occur before, during, and even after completing the study. Scholars Jadad &
Enkin (2008) have explained numerous types of potential bias that can hamper a
randomized controlled trial. The same scholars have emphasized that in a randomized
controlled trial, application of the allocation concealment process is pertinent and must be
done with great care in order to avoid selection throughout the study. Blinding reduces
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ascertainment bias and protects the randomization sequence after allocation. For this
reason, randomization will be done using computer technology (Jadad & Enkin, 2008).
Variables
The National High Blood Pressure Education Program that was presented along
with the complete Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) emphasized that
meeting medication adherence requirements is pertinent, and imperative in order to
improve quality of life, and to foster public health of a community in general (Chobanian
et al., 2003). Many scholars have explained that medication adherence deficits are
disproportionately high among the African American population (Schoenthaler et al.,
2009; Kripalani et al., 2009).
Based on a number of scholars’ report on medication adherence with chronic
illnesses, the city-dwelling African Americans experience morbidity, and mortality at an
increased rate when compared with other city-dwelling ethnic minority populations
(Schoenthaler et al., 2009) because of chronic illnesses, and a disproportionate higher
incidence of poor medication adherence (Schoenthaler et al., 2009; Kripalani et al.,
2009). For this reason, it would be worthwhile to investigate medication adherence
behavior with chronic illnesses in inner city African Americans because empirical studies
have shown compelling evidence that using different educational methods will improve
medication adherence.
The study dependent variables include gaining knowledge, increasing selfefficacy, and change in beliefs on medication adherence. The independent variable of
this study would be different educational methods such as lectures, video presentations,
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role-playing, and group discussions on medication adherence of patients with
hypertension, high cholesterol, diabetes, asthma, and COPD. The application of the PreTest/Post-Test design method would allow one to measure the effectiveness of different
educational methods as to if there would be any changes in cognitive skills, self-efficacy,
and in health beliefs related to medication adherence. Three instruments that have proven
validity and reliability will be used to measure these changes in the form of PreTest/Post-Test questionnaires. The details on validity and reliability of these instruments
are explained in later paragraphs under the subheadings of each instrument. These
instruments included are these: 1) Morisky Medication Adherence Scale (MMAS-8) to
measure cognitive skills changes (Morisky, Ang, Krousel-Wood, & Ward, 2008), 2) SelfEfficacy for Appropriate Medication Use Scale (SEAMS-12) to measure changes in selfefficacy (Risser, Jacobson, & Kripalani, 2007), and 3) Beliefs about Medicine
Questionnaire (BMQ-18) to measure changes in health beliefs (Horne & Weinmann,
1999).
Setting and Sample
This randomized controlled study will take place at Elim Christian Church, which
is geographically located in a southwest side community of Chicago. At the beginning of
the twentieth century, population growth in this community was very slow. After World
War II, and the development of nearby Ford City, population growth increased. The
initial population of the Southwest community was predominantly Irish Catholic until the
1990s. Initially, the neighborhood slowly grew with the construction of small coffee
shops, and catholic schools, and much later, in the 1990s, the neighborhood began to
diversify. In 1999, the New York Times published an article on this Southwest
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Neighborhood, and explained the plight of African American people in it, and the
difficulties that they were experiencing in integration within the communities. Thus, this
neighborhood became predominantly an African American community in the late 1990s.
The current population in this neighborhood is 39,558 African Americans (The Chicago
Fact Book Consortium, 1995).
Elim Christian Church is located in this southwest neighborhood of Chicago
serving the African American people in that neighborhood, and providing services in
various ways. The church participants include African Americans of all age groups, and
who come from diverse African American families. The church serves them in providing
spiritual help, promoting education, and helping families who have economic, and social
struggles. Step of Faith Ministries is a part of this church, and helps members of the
congregation who have difficulties, and struggles in various ways. The church
attendance falls within 200 to 300 people every week. Pastor Ford, who is a member,
and the Pastor for Step of Faith Ministries, graciously accepted my request that the study
be conducted in this church. The study problems will be drawn from this neighborhood.
The study targets the African American adult population from this southwest
neighborhood who attend Elim Christian Church. African Americans, who take
medications for hypertension, high cholesterol, diabetes, asthma, and COPD, will be selfidentified. It may not be possible to survey the entire population of this southwest
community who attend Elim Christian Church; it is necessary to conduct a test of power
analysis for a sample size of 142 people to identify a statistically significant relationship
(Frankfort-Nachmias & Nachmias, 2008).
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Sample Size Determination
Determining a sample size for any study is a priority in the early phase of design
construction when challenges are still possible. Thus, it has become necessary to
determine sample size for this proposed study. The study population for this study will
be African Americans from the southwest community of Chicago. According to the US
census reported in 2010, there are 16,451 African Americans living in this community.
However, the sample size for the study will be determined based on the
inclusion/exclusion criteria and the power analysis. The inclusion/exclusion criteria
specified the age group of the study population and who will attend this local church
where Step of Faith Ministry regularly conducts its meetings and worship.
Based on information gathered from the local pastor, the total number of people
attending this church regularly ranges from 250 to 320 and sometimes there are a few
more. This includes people less than eighteen years of age, approximately about 40 to 50
in number, and people of more than sixty-five years of age, about 8 to 10 in number.
Thus, for the sample size determination, it is appropriate to include only people who are
above eighteen years and less than 65 years of age. According to the above mentioned
numbers, the average number of people who attend this church weekly will be 285 out of
which, sixty people will not be included in the study because of the age limit criteria,
resulting in a total of 225 adults being available for the study, and sample size for this
proposed study will be determined from this total of 225.
Conventionally, alpha level and power are predetermined (Charles, Giraudeau,
Dechartres, Baron, & Ravaud, 2009). For this proposed study, sample size determination
was done using GPower analysis for both t test and ANOVA statistical measures, keep 

107

at 0.05 and CI at 95%, according to which, the sample size required for this study will be
140 to 145. The G Power Analysis for t test and ANOVA are shown in the next two
pages.

t tests - Correlation: Point biserial model
Analysis: A priori: Compute required sample size
Input:

Output:

Tail(s)

= One

Effect size |ρ|

= 0.27

α err prob

= 0.05

Power (1-β err prob)

= 0.95

Non-centrality parameter δ = 3.3179092
Critical t
= 1.6559704
Df
= 138
Total sample size
= 140
Actual power
= 0.9512123
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F tests - ANOVA: Fixed effects, omnibus, one-way
Analysis: A priori: Compute required sample size
Input:

Output:

Effect size f

= 0.25

α err prob

= 0.05

Power (1-β err prob)
Number of groups

= 0.64
= 5

Non-centrality parameter λ = 9.0625000
Critical F
= 2.4363175
Numerator df
= 4
Denominator df
= 140
Total sample size
= 145
Actual power
= 0.6500379

To compare different educational methods on the gain of posttest versus pretest score, we
can compare the difference as “Posttest-Pretest” for each method and then apply one-way
ANOVA test.
The one-way ANOVA is designed to test whether or not all teaching method effects
(deviation from the grand mean) are 0. This means that ANOVA tests the null
hypothesis:
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H0: µ1 = µ2 = µ3 = µ4
Versus Ha: µI ≠ µj for at least one pair i≠j
The test procedure may be summarized in an ANOVA table:
Source of
Variation
Between
(Treatments)
Within

Sum of
Squares
(SS)
SSTrt

df

a-1

Mean
Square
(MS)
MSTrt

SSE

N-a

MSE

SST

N-1

E(MS)

F

σ2 +
((Σniai2)/(a1))
σ2

(MSTrt)/(MSE)

(Error)
Total

Where “a” is the total number of education methods which is 4 here. “N” is the total
sample size.
Under H0, the test statistics
F = (MSTrt)/(MSE) ~ F(a-1, N-a)
And our test statistics becomes an F-test. We reject H0 for large values of F in
comparison to an F(a-1, N-a) distribution. The p-value will be reported, which quantifies
the strength of the evidence provided by the data against the null hypothesis.
Recruitment and Enrollment Procedure
Recruitment for the study will be done through posters, flyers, postcards, and
bulletins posted in this southwest neighborhood on the south side of Chicago. The
information will be posted in local businesses, Laundromats, schools, and local public
places where African Americans pay their visits frequently, and also in Elim Christian
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Church. A copy of the details of the study will be distributed to pastors of Elim Christian
Church, Step of Faith Ministries, a psychologist, and two public health nurses who have
agreed to assist with this study project. To facilitate recruitment of potential study
participants, my contact number, and Step of Faith Ministries contact number will be
given. Potential study participants who have met the study criteria irrespective of their
adherence levels will be recruited for the study.
The potential study participants will be informed about three different
questionnaires that they would be expected to answer before, and after each class.
Confidentiality will be maintained throughout, and after the study. A summary of the
final study findings will be shared with these study participants, and Step of Faith
Ministries. Twenty-five dollars will be awarded to the study participants who remain in
the entire study program. Healthy snacks, fruits, water, and drinks will be served to those
study participants after each class.
Eligibility Criteria
Eligibility criteria will be determined by face-to-face and prescreening interviews
that will be conducted at Elim Christian Church, and other locations in this southwest
neighborhood that are convenient to the potential study participants. Prescreening
information will include 1) Purpose of the study, 2) An explanation of voluntary nature,
3) Potential risks, and benefits of participating in the study, 4) Data collection method by
using three types of questionnaires as pre-test, and post-test, 5) Maintaining
confidentiality of the data collected, and compensation for participating in the study, 6)
An informed consent, and 7) Contact information of Walden’s representative with whom
concerns related to the study can be addressed.
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Other criteria will include that the potential participants will be between eighteento-sixty-five years of age, live in the southwest community, attend Elim Christian
Church, be diagnosed with, and prescribed medications for hypertension, high
cholesterol, diabetes, asthma, and COPD, willing to participate in the study for eight
weeks, be able to provide a written voluntary consent, and an educational level of sixth
grade. Elim Christian Church membership will not be required.
Exclusion criteria will include unwillingness to participate in the study, the person
be less than eighteen years old or more than sixty-six years old, inability to sign the
consent form, and those who do not have residence in the southwest side neighborhood.
Instrumentation and Materials
Promoting medication adherence with chronic illnesses has become a global
initiative (Morisky et al., 2008) because poor medication adherence is a significant
problem in clinical settings with chronic disease management (Morisky et al., 2008;
Viols, Hoyle, Thorpe, Maciejewski, & Young 2011; Dunbar-Jacob & MortisnerStephens, 2001). Many scholars have reported in their studies that it is necessary to
promote medication adherence to reduce cardiovascular morbidity, and mortality
(Ogedegbe, Tobin, Fernandez, Gerin, Diaz-Gloster, Cassells … Ravenell, 2009; Morisky
et al., 2008; Chobanian et al., 2003).
Scholars, who have done studies on medication adherence using the self-reporting
method, have suggested that there is no “gold standard” for measuring non-adherence
(Voils et al., 2011). Also, self-reporting methods lack validity, and reliability of
statistical measures with precision, and accuracy (Voils et al., 2011). In addition, selfreports on medication adherence are influenced by various human factors including age-
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related health problems, language barriers, a poor relationship between provider, and
patient, and various health beliefs (Williams et al., 2008). The other factors include
chronic illnesses in themselves, and therapeutic inertia because of polypharmacy
(Morisky et al., 2008; Fitzgerald, 2011), low literacy levels (Kripalani et al., 2009), and
healthcare system complexities, and failures (Morisky et al., 2008). The instrument’s
validity and reliability are explained in the following paragraphs.
Morisky Medication Adherence Scale (MMAS-8)
The MMAS-8 is a well-validated, and widely recognized eight-item scale that
Morisky, and colleagues developed (Morisky et al., 2008). Prior to this eight-item scale,
a four-item scale was developed as a self-reporting measure in order to measure
adherence behavior to prescribed antihypertensive medications (Morisky, Green, &
Levine, 1986). Also, the authors reported that the reliability of this four-item scale was
0.61 (Cronbach a = 0.61) (Morisky et al., 1986). Many scholars used this four-item scale
in a variety of clinical settings with various chronic illnesses because of the reported
validity, and reliability of the scale that specifically addressed adherence to prescribed
medication regimen (Ogedegbe et al., 2009).
This four-item scale was then further developed into an eight-item scale based on
compelling factors surrounding the adherence behavior (Morisky et al., 2008). This
eight-item scale was constructed based on the theory that explained failure to adhere to a
medication regimen could occur because of the factors that have much influence on
adherence behavior (Morisky et al., 2008). The authors established the validity, and
reliability of the scale through a randomized controlled pretest, and posttest study design
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with a total of 1,367 study participants (N = 1,367) with hypertension in an outpatient
setting (Morisky et al., 2008).
The authors reported that the current eight-item scale was significantly correlated
with the four-item scale that was developed prior to this eight-item scale, and the
correlation was 0.64, p < .05 on Pearson’s Correlation. The internal consistency of the
scale was 0.83 on Cronbach’s alpha reliability (a = 0.83). The authors further reported
that the sensitivity of the eight-item scale was found to be ninety-three percent, and the
specificity was fifty-three percent. In the multivariate analysis with the variables
including attitude, knowledge, patient satisfaction, coping, stress level, and medication
complexity, the authors found that each variable was found to be significantly associated
with adherence at level 0.05 (Morisky et al., 2008). Based on these findings, the authors
explained that there is a greater need for patient education to increase knowledge on
medication adherence (Morisky et al., 2008). Based on these scholars’ compelling
findings on validity, and reliability of this eight-item scale (MMAS-8), this scale will be
used in this proposed study to assess the effectiveness of different educational methods to
enhance medication adherence by testing knowledge gain using the pretest/posttest
design method.
The authors have given clear guidance as to how to use this eight-item scale, and
following their guidance strictly in this proposed study would facilitate the study to run
effectively, and smoothly. Krousel-Wood and colleagues (2010) have demonstrated the
usefulness of MMAS-8 in a cohort study of medication adherence among older adults
(COSMO) conducted with 2,180 older adults with hypertension. The instrument was
used at baseline, and after one year to determine if there were any associations between
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depressive symptoms, social support, and antihypertensive medication adherence in older
adults. The authors verified medication adherence using MMAS-8 instrument through
the self-report method on medication adherence with chronic illnesses. The authors have
explained that the scale had the capability in facilitating in identifying the barriers to, and
behaviors associated with medication adherence. The authors reported that MMAS-8
was reliable with alpha 0.83 (a = 0.83), and significantly associated with blood pressure
control (p = < 0.050) in individuals with hypertension, and low adherence levels were
associated with lower rates of blood pressure control. In this way, these scholars
demonstrated that MMAS-8 had good reliability (a = 0.83), and proved its usefulness in
assessing medication adherence with chronic illnesses (Krousel-Wood, Islam, Muntner,
Holt, Joyce, Morisky … Frohlich, 2010).
In Malaysia, the Morisky Medication Adherence Scale (MMAS-8) was translated
into the Malay natives’ spoken language using forward, and backward translation
procedure, and then the MMAS-8 Malay version was validated with a convenient sample
of 223 Type 2 diabetic patients (N = 223) in an outpatient clinic (Al-Qazaz, Hassali,
Shafie, Sulaiman, Sundaram, & Morisky, 2010). The authors reported that MMAS-8 had
an acceptable test-retest reliability of 0.816 (p < 0.001), a moderate internal consistency
with Cronbach’s a = 0.675, sensitivity = 77.61 percent, specificity = 45.37 percent, the
positive predictive value = 46.84 percent, and the negative predictive value 76.56 percent.
In this way, Al-Qazaz, and colleagues (2010) confirmed that the Malaysian version of the
MMAS-8 is a reliable and valid measure of medication adherence that can be used to
measure medication adherence with chronic illnesses (Al-Qazaz et al., 2010).
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In summary, many scholars have provided their evidence that the MMAS-8 has
its proven validity, and reliability, and that it is an effective reliable research tool to
measure medication adherence with chronic illnesses in the outpatient clinic settings
(Morisky & DiMattteo, 2011). The authors have reported that the MMAS-8 was useful
in assessing medication adherence with various chronic illnesses including ulcerative
colitis, hypertension, and depression, and in complementary, and alternative medicine
(Morisky et al., 2011). In this way, the MMAS-8 research tool was found to be a reliable
valid tool (Morisky et al., 2011), and because of its proven validity, and reliability, the
scale will be used in this proposed study. The scale will be used exactly as to how the
authors have established it (Morisky et al., 2008).
The Self-Efficacy for Appropriate Medication Use Scale (SEAMS)
The main purpose of developing the Self-Efficacy for Appropriate Medication
Use Scale (SEAMS) was to provide healthcare providers an effective assessment
medication adherence tool in the management of chronic illnesses in outpatient settings
with patients whose literary levels are inadequate (Risser et al., 2007). The theoretical
foundation for the development of the SEAMS research tool was based on the Social
cognitive theory; author Bandura (1977) has defined the concept of self-efficacy as
“one’s conviction to perform a required behavior successfully to produce an outcome”
(Bandura, 1977; Kripalani et al., 2009). Kripalani, and colleagues (2009) explained that
patients with inadequate literacy have serious difficulties to identify their own
medications, are unable to differentiate medications from one another, are most likely to
misinterpret medication labels, and their additional warning signs (Kripalani et al., 2009).
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Gazmararian and colleagues (2006) demonstrated in their studies with
antiretroviral medication adherence that patients with inadequate literacy were unable to
read medication terminologies, and to understand, and comprehend the need for
medication adherence. In addition, their responses on self-reporting of medication
adherence were biased (Gazmararian, Kripalani, Miller, Echt, Rent, & Rack, 2006).
Kripalani, and colleagues (2007) explained that patients with inadequate literacy have
difficulties in understanding, comprehending, and remembering medication names, and
instructions that are written on medication levels (Kripalani, Robertson, Love-Ghaffari,
Henderson, Praska, Strawder, … Jacobson, 2007).
The effects of inadequate health literacy and its consequences have impacted
many areas of healthcare, resulting in health disparities, low self-efficacy, poor self-care
management, and poor health outcomes (Kripalani et al., 2007). Kalichman, and
colleagues (2005) have explained in their study on assessing medication adherence, and
self-efficacy in low-literacy patients that a self-efficacy scale that would assess
medication adherence, and self-efficacy in low-literacy patients with clarity is lacking,
and the construction of a new tool would be very challenging (Kalichman, Cain, Fuhrel,
Eaton, DiFonzo, & Entl, 2005). Based on these compelling pieces of empirical evidence,
Scholars Risser, Jacobson, & Kripalani (2007) have developed a self-efficacy scale
(SEAMS), tested for its validity, and reliability, with the purposes that the scale would be
a valuable tool to healthcare providers in the assessment of medication adherence in
outpatient clinic settings, and as a research tool to be used by researchers to assess selfefficacy with medication adherence with chronic illnesses in a population with
inadequate literacy levels (Risser et al., 2007).
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Development of the SEAMS
Scholars from a multidisciplinary team who had specialized knowledge, and skill
in medication adherence, and health literacy, were involved in the development of the
SEAMS, including the analysis of its validity, and reliability (Risser et al., 2007). These
scholars were selected from the specialized fields of medicine, literature, health
education, medication use, and psychology, and they reviewed a large number of
literature on self-efficacy from the fields of medicine, and nursing with the focus of
identifying an instrument that could be effectively used to assess self-efficacy with
medication adherence with chronic illnesses in a population with low literacy (Risser et
al., 2007).
Unable to find an appropriate instrument that would fit well with this study, the
scholars selected questions from different self-efficacy instruments, and reviewed the
content of those selected questions with a critical lens to identify if there would be any
challenging questions that would place an undue hardship in patients with low literacy
who live with multiple chronic illnesses. The same scholars rephrased the difficult
questions, and simplified them in order to reflect the concepts of chronic illnesses,
medication adherence, and inadequate literacy levels. These scholars conducted a pilot
study in 2004 with ten volunteers with inadequate literacy, who received a cognitive
interview with the newly developed study questions, and they received feedback from
their study participants who provided their suggestions to change words, and
terminologies that would be appropriate for people with inadequate literacy, and at the
same time fit well with this newly developed instrument. In this way, scholars developed
the first set of SEAMS instrument with twenty-one (21) items (Risser et al., 2007).
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The same scholars who developed the scale, established a three-point Likert
response scale to indicate the level of confidence in taking medications: 1 = confident, 2
= somewhat confident, and 3 = very confident. The study participants were asked to
identify their confidence level correctly under different difficult circumstances using this
Likert response scale. The potential scores ranged from 21 to 63, and these scholars’
interpretation of scores suggested that higher scores indicated a high level of self-efficacy
for medication adherence.
Reliability, Validity Assessment, and Final Refinement of the SEAMS
To establish reliability and validity of the scale, the scholars conducted a
randomized controlled trial with 436 study participants (N = 436) who completed the
twenty-one items SEAMS at the baseline. The study population included predominantly
African Americans (91.1 percent), and women (55.7 percent), and the mean age was 63.8
years. Also, they were diagnosed with multiple co-morbidities including hypertension
(99 percent), high cholesterol (87 percent), diabetes (45 percent), and coronary heart
disease.
The reliability of the initial SEAMS was determined by Cronbach’s alpha
coefficient method for its internal consistency, and the scale overall showed a = 0.90.
The test/retest reliability was performed as a second approach with ninety-six study
participants from the control group who had completed the follow-up interview at three
months, and the performance of the scale was moderate by Spearman’s statistical method
(p = 0.62, P = 0.0001).
The Principal component factor analysis method was used to analyze the validity
of the twenty-one of the initial SEAMS. This method provided clarity to each item in the
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scale. Those items that did not perform well or did not show clarity on the concept of
self-efficacy were deleted because of their vagueness. In this way, the final SEAMS was
constructed with only thirteen items.
A factor analysis was performed again to test the validity of this final thirteenitem scale. The authors were able to identify with clarity the two dimensions of selfefficacy with medication adherence. Factor 1 showed self-efficacy for taking
medications under difficult circumstances, and Factor 2 showed self-efficacy for
continuing to take medications under certain conditions. Cronbach’s alpha was 0.86 for
factor 1, and 0.79 for factor 2.
Reliability analysis for the final SEAMS was performed, and the scale showed
inter-item correlations in this thirteen-item scale of 0.20 to 0.71, and Cronbach’s alpha of
0.89 (a = 0.89). The mean of the inter-item correlations in the thirteen-item scale was
0.28. The two subscales, taking medications in difficult circumstances, and in uncertain
conditions, were 0.46, and 0.39 respectively. The authors confirmed that the test-retest
reliability of the thirteen-item scale was adequate by Spearman’s method (p = 0.57, P =
.0001).
Criterion related validity of this thirteen-item scale was assessed by the Morisky
medication adherence scale (MMAS), and the scale showed a strong correlation with
medication adherence by Spearman’s p = 0.51, P = .0001 indicating the strong evidence
for the criterion-related validity of the self-efficacy scale. In this way, scholars from
different fields of expertise developed SEAMS-13, and analyzed it for its psychometric
properties. These scholars reported that the scale is valid, and reliable to assess self-
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efficacy for medication adherence with various chronic illnesses with patients with
different literacy levels.
The availability of SEAMS 13, and its use with chronic illnesses could have an
important implication for healthcare providers in that it can be used to assess self-efficacy
with medication adherence because of its proven validity, and reliability. The scale can
be used to assess self-efficacy with patients with multiple co-morbidities, and who take
multiple medications. SEAMS-13 is also a valuable tool in that it can be used with
patients with different levels of literacy. Finally, the scale can be used to assess selfefficacy along with the Morisky medication adherence scale (MMAS) because of its
contribution to the SEAMS in assessing Spearman’s criterion related validity (Risser et
al., 2007).
Beliefs about Medicine Questionnaire (BMQ)
The ‘beliefs about medicine’ questionnaire (BMQ) was developed by British
Scholars Horne, Weinman, & Hankins in 1999. The purpose of developing this
instrument was to assess people’s beliefs about medications or medicines (Horne et al.,
1999). The authors had two main reasons for developing this instrument: 1) To gain an
in-depth insight into the pragmatic factors that relate to the delivery of healthcare, and 2)
To develop psychological models based on the theoretical reasons that provide clarity in
understanding patients’ illness-related behaviors including medication adherence (Horne,
2000).
Some scholars have explained that healthcare delivery was based on the
biomedical model in the United Kingdom, and in other developing countries in which
illness is believed to be due to the disturbances in physiological functioning (Horne,
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2000). The author cited scholars Engel (1977), Kaplan (1990), Berkman & Breslow
(1983), Pennebaker (1982), Wilkinson (1990), and Marmot et al., (1984) who have
explained that the biomedical model tends to assume that diseases are manifested in the
body, and are separated from the psychosocial interactions of the mind, and the outcome
of the illness was greatly determined by the nature of the illness, extent of the disease,
and the efficacy of treatment. The same scholars have further suggested that
socioeconomic factors have strong powerful influence on the etiology of illness, and the
biomedical model failed to recognize psychosocial and economic determinants that could
have a profound influence in people’s beliefs on healthcare, and medicines (Horne,
2000).
Horne (2000) further cited scholars McGavak (1996), and Myers, and Midence
(1998) who have acknowledged the limitations of the biomedical model in that it did not
recognize the influences of human, and socioeconomic determinants when non-adherence
to medications was a significant health problem; instead, the model was applied to gain
more knowledge, and understanding of etiological factors of illness, and to explain the
treatment outcomes. In other words, the model did not address the real current health
problem (Horne, 2000). However, of the present time, the trend is changing, and there is
a greater emphasis placed in understanding as to how people make decisions about their
health based on their own beliefs, and the social context in which the decisions are made
(Horne, 2000).
Based on the previous scholars’ empirical findings, Gatti, and colleagues (2009)
explained that patients’ beliefs were significantly correlated with medication adherence
(Gatti et al., 2009). Some other scholars (2007), through a meta-analysis on medication
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adherence, reported that there was a significantly positive correlation between patients’
adherence, and their perception of disease severity (DiMatteo, Haskard, & Williams,
2007). The same scholars have further explained that peoples’ beliefs on medications
were more consistent in predicting medication adherence than demographic variables
(DiMatteo et al., 2007). Gatti, and colleagues (2009) reported, after reviewing many
scholars’ report on medication adherence, that approximately twenty percent of the
variance in adherence behaviors were to be attributed to a patient’s beliefs about
medications (Gatti et al., 2009), and their perceptions of medications, whether necessary
to take, and their concerns about the potential harmful effects of medications (Gatti et al.,
2009).
Taking medications as prescribed is dependent on two factors, one’s ability to
take medications, and motivation (Horne, 2000). The author explained that in previous
studies, scholars have focused more on unintentional non-adherence behaviors including
forgetfulness, inability to follow instructions, poor understanding, and physical
disabilities (Horne, 2000; Gatti et al., 2009). However, according to some scholars, nonadherence could arise from intentional reasons including negative health beliefs (Gatti et
al., 2009), and poor decision-making (Horne, 2000; Gatti et al., 2009). These scholars
have described that negative health belief often times leads to a conscious decision by
patients to not take medications (Gatti et al., 2009). The same scholars have further
explained that when patients are faced with self-management of their illnesses, they are
forced to make decisions in their own, and ultimately it is the patient who decides when
to adhere or not to adhere to the prescribed medication regimen (Gatti et al., 2009).
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Lehane and McCarthy (2007) have suggested that behaviors that are mediated by
irrational decision-making processes could also play a major role in the prevalence, and
persistence of non-adherence (Lehane & McCarthy, 2007). The same scholars (2007)
cited Brahm and Brahm (1981) who have explained the Theory of Psychological
Reactance that was tested in many areas of mental health fields (Lehane & McCarthy,
2007). By this theory, individuals may suffer with uncomfortable motivational reaction
to a threat or removal of an individual’s freedom to determine their own health status;
when the individuals are faced with uncomfortable motivational reaction, they tend to
make wrong choices, and do the opposite of what is required of them. In this way,
individuals, even with potential health risks, ignore therapeutic regimens resulting in nonadherence to medications (Lehance & McCarthy, 2007).
The concept of self-management of chronic illnesses has gained a great
momentum in this present healthcare management (Horne, Weinman, & Hankins, 1999;
Horne & Weinman, 1998; Horne, 2000; Bandura, 2004; Gatti et al., 2009) with an
emphasis on taking appropriate medications as being the key for successful management
of chronic illnesses (Horne & Weinman, 1998; Horne, 2000; Bandura, 2004). Horne
(2000) cited scholars Barker (1995), and Marinker (1997) who have explained that
patients have to be encouraged, and motivated to take part an active role in their
healthcare (Horne, 2000), and this concept has received broad support from many other
scholars (Horne & Weinman, 1998; Horne et al., 1999; Bandura, 2004). According to
these scholars, the role of the healthcare provider is to recognize, and to respect patients’
rights in treatment choices, his/her health beliefs, and decision-making processes, and to

124

move them forward towards a positive goal (Horne, 2000; Bandura, 2004; Gatti et al.,
2009).
Prescribing medications involves a prescriber’s responsibilities: discussion, and
explanation of medications to their patients, negotiating with integrity, and educating
patients on pharmacological factors including side effects of medications (Horne, 2000).
This course of health promotion work demands the prescriber to demonstrate greater
understanding to a patient’s health behavior, and beliefs (Horne, 2000). Based on a large
number of scholars’ report on health beliefs, Horne (2000) identified that an individual’s
health beliefs range from specific to general (Horne, 2000), and they interact with health
behaviors (Horne, 2000). To explain the interaction between health beliefs, and
medication-taking behavior on a scale, Horne (2000) suggested quantitative studies on
medication beliefs, and this very idea had led the scholar to develop an instrument
“beliefs about medicine questionnaire” (BMQ) to assess people’s beliefs about
medications (Horne, 2000).
Development of BMQ
The development of BMQ was based on the theory of planned behavior (TPB)
(Horne et al., 1999). The theory of planned behavior (TPB) is an extension of the theory
of reasoned action (TRA) (Ajzen & Fishbein, 1980; Fishbein & Ajzen, 1975). The core
concept of TRA is the individual’s intention to perform a behavior (Ajzen, 1991). The
concept of intention explains as to how individuals try their best to perform a behavior,
and this performance is based on the individual’s motivation (Ajzen, 1991). According
to Ajzen (1991), intentions would be expected to influence performance to the extent that
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the person has behavior control, and that performance should increase with behavioral
control to the extent that the person is motivated to try (Ajzen, 1991, p.183).
In the theory of TPB, perceived behavioral control is the central concept (Ajzen,
1991). The concept of perceived behavioral control plays an important role in an
individual’s judgment (Ajzen, 1991). Also, the concept of perceived behavioral control
is almost compatible to Bandura’s (1977, 1982) concept of perceived self-efficacy, which
is concerned with an individual’s judgment as to how well one can execute courses of
action required to deal with prospective situations (Ajzen, 1991; Bandura, 1977, 1982).
The theory of planned behavior explains a relationship among beliefs, attitudes,
intentions, and behavior (Ajzen, 1991). In this way, according to the theory of planned
behavior, perceived behavioral control along with behavioral intentions can be used to
predict behavioral achievement (Ajzen, 1991). In other words, performance of a
behavior is a joint function of intentions, and perceived behavioral control (Ajzen, 1991).
BMQ 18: Development and Analysis
Horne and colleagues (1999) generated a wide range of beliefs on medications
after reviewing a large number of empirical studies by various scholars on medication
adherence, and health beliefs, and simplified those beliefs into specific and general
beliefs by using the principal component analysis (PCA) method (Horne et al., 1999).
The authors further analyzed specific and general beliefs by the Confirmatory Factor
Analysis Method. To prove validity of specific, and general beliefs, the authors used the
PCA method again resulting in the development of thirty-five patients (N = 35) who were
receiving medications for their chronic illnesses; twenty patients with hemodialysis, and
fifteen with myocardial infarction participated in a qualitative study through an interview
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method. These patients were asked to mark their responses on those thirty-five belief
statements on a Likert Scale (1 = strongly agree, 2 = agree, 3 = uncertain, 4 = disagree,
and 5 = strongly disagree). These interviews were conducted in the clinics to obtain a
patient’s own perspectives on beliefs about medications, and not what was socially
desirable. After completing the interview, the authors further analyzed those responses
by using the PCA method, and eliminated the influences of other variables that were far
from the central theme. This procedure allowed the choosing of only those statements
that were fit with specific and general beliefs. In this way, the authors developed a new
BMQ scale with eighteen belief statements: Specific-necessity-5, Specific-concerns-5,
General-overuse-4, and General-Harm-4) (Horne et al., 1999; Horne, 2000).
Testing the Specific Belief Statements using the Exploratory PCA
By using the Exploratory PCA Method, the authors tested the sixteen specific
belief statements with 120 (N=120) cardiac patients. The goal was to identify a simple
factor structure from the responses of cardiac patients for a single diagnostic group of
illnesses, and to test whether the identified simple factor structure would fit with other
illness groups such as asthma, diabetes, and kidney failure (Horne et al., 1999). In
addition, the authors aimed at as to how to explore representation of medication as a
broad concept rather than beliefs that might be unique to a particular group (Horne et al.,
1999).
Testing the Simple Factor Structure
To test the Simple Factor Structure, the authors used confirmatory factor analysis
by applying Pearson’s correlations statistical method. The aim was to assess whether the
Simple Factor Structure that was identified through the exploratory PCA truly reflected
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the theoretical model. Using the repeated PCA method, the authors identified the
stability of Simple Factor Structure by testing the responses of cardiac patients to factor
items obtained from asthma, diabetes, and kidney failure. In addition, by using further
PCA general belief statements, specific belief statements were separated (Horne et al.,
1999). In this way, the PCA Method allowed the authors to identify those beliefs
pertaining to medications, and facilitated those beliefs to be grouped under four themes:
two under specific beliefs, and the remaining under general beliefs (Horne et al., 1999;
Horne, 2000).
General Beliefs about Medications (BMQ General)
The authors explained two major themes that they had identified in general
beliefs: 1) General-harm and 2) General-overuse. The beliefs about general-harm
included those beliefs that reflected the intrinsic nature of medications that people
perceive as harmful, addictive, prolonging dependence, and long-term use, and
poisonous. The beliefs, related to general overuse, included the beliefs that natural
medications are much safer than the allopathic medications, and that doctors tend to
overprescribe allopathic medications. In this way, by applying the PCA method, the
authors summarized the identified general beliefs into general harm, and overuse themes.
Specific Beliefs about Medications (BMQ Specific)
In the same way, using the PCA method, the authors identified two specific
themes from the specific beliefs: necessity, and concerns. The authors summarized those
specific beliefs from the responses of 524 patients who were diagnosed with a range of
chronic illnesses including asthma, diabetes, psychiatric illnesses from outpatient clinics,
cardiac, and general medical, and renal problems. The necessity beliefs included those
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beliefs that were perceived by people as necessary for maintaining or improving health
now, and in the future. The concern beliefs included those beliefs that cause concern
about adverse effects of medications, becoming too dependent on medications, and those
medications that would cause disruption in daily life (Horne et al., 1999; Horne, 2000).
Testing the Validity and Reliability of the BMQ
Horne (2000) cited scholar Babbie (1992) who had explained that the validity of
the questionnaire refers to the extent that it provides data that relate to commonly
accepted meanings of a particular concept; in other words, a questionnaire is said to be
valid when it correctly measures what it is supposed to measure (Horne, 2000). The
authors used criterion-related validity, and discriminant validity testing measure to
measure the validity of the BMQ-18.
Criterion-Related Validity
The assessment of criterion-related validity was done on each of the BMQ scale
items: specific-necessity, specific-concerns, general-harm, and general-overuse, and they
were done based on these assumptions:
1) Specific-necessity: Patients with stronger beliefs in the necessity of medications would
be less likely to believe that they can cope without medications; thus, specific-necessity
beliefs would be negatively correlated with the scores on the item, “I can cope without
medication.” Beliefs about the necessity of prescribed medications would also be
dependent on a patient’s perception of illness because of the time duration as to how long
the illness will continue. Patients, who perceive that their illness would last for a longer
period of time with increased symptoms, will have stronger beliefs in the necessity, and
the scores on specific necessity would be positively correlated.
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Evidence for the criterion-related validity of the specific-necessity scale was
shown by the authors to have negative correlation between scale scores, and responses to
the statement, “I can cope without my medications” (p = -0.44; n = 78; p < 0.001);, and
positive correlations with scores on the illness perception questionnaire on timeline (p =
0.49, n = 77; p < 0.001), and identity (p = 0.24; n = 76; p < 0.05).
2) Specific-concerns: The authors hypothesized that patients with grave concerns about
their medications exhibit doubt, and distrust, would seek more detailed information about
their prescribed medications, and make plans to alter their current treatment. Thus, there
would be positive correlation on the specific-concern scale on the items “lack of trust in
prescribed medications”, and “desire to change present treatment.” In addition, patients,
who perceive of themselves to be more susceptible to adverse reactions to their
prescribed medications, could possibly exhibit stronger concerns about medications.
Thus, the specific concern scale shows positive correlation with a score on the sensitive
soma scale, which assesses perceptions of personal sensitivity to the adverse effects of
medications.
Evidence on the criterion-related validity of the specific concerns scores on the
asthmatic group were positively correlated with the statements “I cannot always trust my
medications” (p = 0.33; n = 78; p < 0.005), and “I would like to change my present
treatment” (p = 0.37; n = 78; p < 0.001). The hypothesis on specific-concerns was
negatively correlated with responses to the statement “I have been given enough
information about my medications” (p = -0.45; n = 78; p < 0.001). Specific concerns on
adverse reactions were assessed by sensitive soma scale with general medicine, and
cardiac patients (p = 0.5, n = 211, p < 0.001).
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3) General-Harm: Patients, who believe that medications are essentially or intrinsically
harmful, believed that it was better for them to not take their medications. Thus, the
items on the scale “It is better to do without medication”, and “I can cope without my
medications” would be positively correlated on the General-Harm Scale. Those patients
also believed that they were more susceptible to adverse reactions to their medications.
Thus, scores on the General-Harm Scale would show a positive correlation with a score
on the sensitive soma scale.
4) General-Overuse: There would be a positive correlation on the General-Overuse Scale
with items “I can cope without my medicine”, and “It is better to do without
medications.”
Evidence on the criterion-related validity of the General-Harm, and GeneralOveruse Scales showed that there was a correlation on the General-Harm Scale with the
statement, “It is better to do without medications” with p value (p = 0.23, n = 78; p <
0.05). Also, the responses to the statement, “I can cope without my medication,”
correlated significantly in the predicted direction with both General-Harm (p = 0.24; n =
77; p < 0.05), and General-Overuse scales 9p = 0.34; n = 78; p < 0.005). Correlations
between the RAM Scale, and Specific Concerns (p = -0.28; n = 210; p < 0.001), GeneralOveruse (p = -0.19; n = 210; p < 0.01), and General-Harm (p = -0.06, n = 210; p > 0.05).
In this way, criterion-related validity demonstrated that these scales were in the direction
as to how the hypothesis was predicted, except that the General-Harm beliefs failed to
reach statistical significance on the RAM Scale (Horne et al., 1999; Horne, 2000).
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Discriminant Validity of BMQ-18
The discriminant validity of the BMQ-18 was done based on the patients’ abilities
as follows: 1) To differentiate between their illnesses, and treatment modalities and 2) To
take their prescriptions to a community pharmacy or to choose alternative or
complementary therapies (Horne et al., 1999).
1) Beliefs on specific necessity: Beliefs about the necessity for prescribed medications
would be influenced by the medications prescribed for their illnesses, and the effects of
medications on symptom relief would be very important to patients. The authors
compared diabetic, and asthma patients in that if they failed to take their medications,
they would become ill, but if they took their medications, their symptoms would be
relieved. In this way, the Specific Necessity Scores would differentiate patients with
different diagnoses, and the scores would be higher on the specific-necessity Scale for
those who take their medications, and had symptom relief.
2) Beliefs on specific concern: Beliefs about specific concern were associated with the
adverse side effects of medications, and also drugs such as steroids, and tranquilizers that
are necessary for symptoms relief in asthma, and psychiatric conditions, but at the same
time abused in sports that receive increased media attention. In this way, the assumption
was that specific-concern scores would discriminate among patients who would have
higher mean scores than other illness groups.
Discriminant Validity Testing on Specific Necessity and Specific Concern Beliefs
Discriminant validity testing was done on specific-necessity and specific-concern
belief statements by ANOVA with linear contrast, and post-hoc Turkey’s HSD statistical
methods. The mean scores on the BMQ were compared across illness samples including
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asthma, diabetes, renal failure, cardiac problems, psychiatric illness, and general medical
illness. By this method, the authors confirmed their assumptions that patients with
diabetes had significantly higher specific-necessity scores than all other groups of
patients, asthmatic patients had a higher mean score than the psychiatric group of
patients, the psychiatric group of patients had the lowest mean score on specific
necessity, and finally the asthmatic, and psychiatric groups had significantly higher
specific concern scores. The discriminant validity for specific-necessity was p < 0.01,
and for specific concerns was p < 0.01.
Discriminant Validity on General-Harm and General-Overuse
People, who believe that medications are essentially harmful, and seek
complementary or herbal medications, would have higher mean scores on generalharm, and general-overuse. The authors confirmed their assumptions by doing
ANOVA with linear contrast, and post-hoc Turkeys’ HSD that patients, who visit
complementary and herbal stores, would have significantly higher scores on both
the general-harm, and general-overuse than patients who take their prescriptions to
a regular pharmacy. The p value on post-hoc Turkeys’ HSD was (p > 0.05) a
correlation between BMQ scales p < 0.01 (Total N = 524) (Horne et al., 1999).
Reliability of the BMQ-18 Scale
The authors reported that the internal consistency of the scale was ranging
from 0.65 to 0.86 across the range of illnesses except that the three statements on
the General-Harm Scale of the diagnostic group include asthma, cardiac problems,
and general medicine. The Spearman correlations (p value) were used to assess
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test-retest reliabilities between initial scores, and repeated scores for each of the
scale (p < 0.001). Based on these statistical measurements, the authors confirmed
that Cronbach’s alpha (a) for each diagnostic group indicated that both the BMQ
specific, and general scales have satisfactory and acceptable internal consistency,
and test-retest reliability of the scale were encouraging, and the scale can be used
with flexibilities in a novel manner (Horne et al., 1999; Horne, 2000).
Summary of BMQ-18
Scholars Horne et al., (1999) developed BMQ-18 based on the theoretical
model of the theory of planned behavior (TPB) (Ajzen, 1985). Main purpose of
developing the scale was to gain a deeper understanding as to how people’s beliefs
play a vital role in medication adherence with chronic illnesses. The authors
acknowledged that patients make decisions about taking medications based on their
beliefs about illness, and treatment, and their expectations of outcome. The decision
to take or not to take medications greatly depends on patients’ beliefs, and
perception of their illnesses, and this decision identifies the role of medication
beliefs in treatment adherence. Based on this concept, the authors identified
specific and general beliefs, and developed a pool of thirty-four statements resulting
in the early development of the BMQ Scale.
By using the Principal Component Analysis or Factor Analysis Method, the
initial thirty-four statements were simplified. A qualitative study methodology was
employed with twenty hemodialysis patients, and fifteen myocardial infarction
patients (N = 35) in order to gain a deeper understanding of a patient’s perceptions,
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and beliefs on illness, and treatments. The authors applied PCA or factor analysis
method until they were able to identify with clarity the BMQ-18 with specific and
general beliefs. Specific beliefs were based on a patient’s concerns, and necessity,
whereas general beliefs were based on general-harm, and general-overuse.
Testing the validity of the scale was done by criterion-related validity, and
discriminant validity. The criterion-related validity was based on the predictions of
the scale, and it demonstrated that both of the specific and general scales were
related to constructs. The discriminant validity of the specific and general scales
demonstrated that the scale was able to distinguish between different illnesses and
treatment modalities.
The internal consistency of the scale was tested by Cronbach’s alpha, and
test-retest reliability statistical methods. The internal consistency of the scale was
found within the range of 0.65 to 0.86 across the range of illnesses except the three
statements on the general-harm scale of the diagnostic groups including asthma,
cardiac, and general medicine. The test-retest reliability was done using Spearman’s
correlations, and the p value was (p < 0.001). The authors explained that reliability
of the BMQ Scale was found to be within the acceptable limits (Horne et al., 1999;
Horne, 2000).
The authors acknowledged the limitations of the scale that the initial
interview method provided an ordinal rather than an interval measure of adherence
behavior. Secondly, though the beliefs and behaviors were closely associated, the
direction of causality could not be ascertained. Thirdly, medications were
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prescribed for many co-morbid conditions along with the primary diagnosis.
Fourthly clinical significance of non-adherence was not evaluated. In spite of all
these limitations, the authors suggested using the BMQ-18 Scale by a quantitative
study method in assessing patient’s beliefs about their medication would help to
identify the type of beliefs associated with adherence as medication adherence is a
complex phenomenon influenced by many factors (Horne & Weinman, 1998).
Data Collection and Analysis
Data Collection on Knowledge gained using Pretest-Posttest Methodology
Data will be collected on knowledge gained using the Morisky medication
adherence scale (MMAS) as the pretest-posttest method. The MMAS contains eight
items (Morisky et al., 1986). Response categories are Yes/No for each item with
dichotomous responses, and a five-point Likert response for question number 8.
The same authors have reported an alpha reliability = 0.83, and RMSEA < .01.
RMSEA = the root mean square error of approximation. RMSEA is one of the Factor
Analysis Methods to confirm validity, and reliability of the MMAS (Morisky et al.,
2008).
Data collection on self-efficacy using SEAMS as the Pretest-Posttest
Methodology (Risser, Jacobson, Kripalani, 2007)
The SEAMS contains thirteen items, and the responses will be given on a
three-point Likert scale: 1 = Not confident, 2 = Somewhat confident and 3 = Very
confident. Principal component factor analysis was used to prove the validity of the
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SEAMS. The thirteen-item SEAMS was proven with good internal consistency, and
Cronbach’s alpha = 0.89 (Risser, Jacobson, Kripalani, 2007).
Data Collection of Health Beliefs using the BMQ-18 Scale by using the PretestPosttest Methodology
The BMQ-18 Scale is an eighteen-item scale. The scale is an ordinal scale
using a five-point Likert Scale with the following given responses: 1 = Strongly
agree, 2 = Agree, 3 = Uncertain, 4 = Disagree, and 5 = Strongly disagree.
The authors have reported that the internal consistency of the scale was
within the range of 0.65 to 0.86 (Horne & Weinman, 1998; Horne et al., 1999; Horne,
2000).
Analysis
Goals
1.) To assess the effectiveness of educational methods including lectures, videos,
role-playing, and group discussions on medication adherence with African
Americans who take medications for hypertension, high cholesterol,
diabetes, asthma, and COPD.
2.) To compare the differences between the experimental, and control groups in
knowledge gained, self-efficacy, and change in health beliefs.
3.) To apply descriptive, and inferential statistical methods appropriately using
SPSS.
4.) To interpret the findings based on the analysis.
5.) To prepare the findings for presentation.
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Research Question
Central Question
Is there any significant effect of using different educational methods in enhancing
medication adherence in African Americans with chronic illnesses?
Hypothesis to be tested
Hypothesis 1: Knowledge gain; Pretest/Posttest-MMAS
Do different educational methods have significant effects on knowledge gain in
medication adherence in African Americans with chronic illnesses?
Independent Variable: Educational Methods
Dependent Variable: Knowledge Gain
H0: There will be no significant difference in knowledge gained on medication
adherence between the intervention group and the control group
H0 = m1 = m2
Ha: There will be a significant difference in knowledge gained on medication
adherence between the intervention group and the control group
Ha = m1 > m2
Hypothesis 2: Self-efficacy Pretest/Posttest SEAMS
Do different educational methods have a significant effect in increasing self-efficacy
on medication adherence in African Americans with chronic illnesses?
Independent Variable: Educational Methods
Dependent Variable: Increase in self-efficacy
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H0: There will be no significant difference in self-efficacy on medication adherence
between the intervention group and the control group
H0: U1 = U2
Ha: There will be a significant difference in self-efficacy on medication adherence
between the intervention group and the control group
H a: U1 > U2
Hypothesis 3: Health Beliefs Pretest/Posttest BMQ 18
Do different educational methods have a significant effect in changing health beliefs
in African Americans with chronic illnesses?
Independent Variable: Educational Methods
Dependent Variable: Change in Health Beliefs
H0: There will be no significant difference in change in health beliefs on medication
adherence between the intervention group and the control group
H0 = m1 = m2
Ha: There will be a significant difference in change in health beliefs on medication
adherence between the intervention group and the control group
Ha = m1 > m2
Educational methods = lecture, video presentation, role play, and group discussion
on chronic illnesses such as hypertension, hyperlipidemia, diabetes, asthma, and
COPD to enhance medication adherence
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Descriptive Statistics
Demographic Characteristics
1.) Age group categorization
Experimental Group

Control Group

Category

Category

Percent

18-35

18-35

36-45

36-45

46-55

46-55

56-65

56-65

Percent

2.) Frequency of distribution of age
Experimental Group

Control Group

3.) Gender Variable
Experimental Group

Control Group

Male Female

Male Female

Mean

Mean

Median

Median

Mode

Mode

S. D.

S. D.

4.) Income Variable in thousands
Experimental Group

Control Group

Male Female
0-15

Male Female
0-15
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16-20

16-20

21-25

21-25

26-30

26-30

31-35

31-35

5.) Educational Variable
Experimental Group

Control Group
Male Female

Male Female

High School Incomplete

HS Incomplete

High School

High School

Associate Deg

Associate Deg

College Deg

College Deg

Effect of educational methods on knowledge gain

Mean
Pretest
knowledge
score

(Item = MMAS)
SD
Mean
Posttest
Knowledge
score

SD

Control Group
Intervention
Group
Effect of educational methods on self-efficacy
(Item = SEAMS)
Mean
Pretest
Self-efficacy
Score
Control Group
Intervention
Group

SD

Mean
Posttest
Self-efficacy
Score

SD
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Effect of educational methods on health beliefs
(Item = BMQ 18)
Mean Pretest
on health
beliefs score

SD

Mean Posttest
on health
beliefs score

SD

Control Group
Intervention
Group
t statistical test will be applied if the distribution of scores is normal with
group comparison; if the distribution of scores with group comparison is
non-normal, use Mann-Whitney U Test (Cresswell 2009)
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Comparison of Educational Methods with Posttest
Experimental
Group

SD

Control Group

SD

Posttest x

Posttest x
Lecture

Routine
Education with
Pamphlets
Video
Routine
Presentation
Education with
Pamphlets
Role Play
Routine
Education with
Pamphlets
Group
Routine
Discussion
Education with
Pamphlets
To compare different educational methods on the gain of posttest versus pretest
score, we can compute the difference as “Posttest – Pretest” for each method, then
apply one-way ANOVA test.
The one-way ANOVA is designed to test whether or not all teaching method effects
(deviation from the grand mean) are 0. I.e., ANOVA tests the null hypothesis:
H0: µ1 = µ2 = µ3 = µ4
Versus Ha: µi ≠ µj for at least one pair i≠j
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The Test Procedure may be Summarized in an ANOVA Table:
Source of
Variation

Sum of
Squares (SS)

df

Between
(Treatment)

SSTrt

a-1

Mean
Squares
(MS)
MSTrt

Within
(Error)
Total

SSE

N-a

MSE

SST

Ε(MS)

F

σ2 +
((Σniai2)/(a1))
σ2

MSTrt/MSE

N-1

Where “a” is the total number of education methods, which is 4 here. “N” is total
sample size. Under Ho, the test statistics
F = (MSTrt)/(MSE )~F(a – 1, N – a)
And our test statistics becomes an F-test. We reject H0 for large values of F in
comparison to an F (a – 1, N – a) distribution. The p-value will be reported, which
quantifies the strength of the evidence provided by the null hypothesis.
Summary
Using SPSS software will allow this statistical analysis. The analysis will
include both descriptive and inferential statistical analysis methods. The
descriptive statistical analysis method will be used for univariate variables, and
inferential statistics will be used to analyze bivariate and multivariate variables.
Concept Clarification
•

Normal distribution of scores = The scores are normally distributed on a bellshaped curve when plotted on graph

•

Non-normal distribution of scores = The scores are not normally distributed
on a bell-shaped curve when plotted on graph
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Summary of Chapter 3
Chapter 3 includes a brief summary of the study, and a description of the
research design, and its approach through a randomized controlled trial. Also
explained are the potential study participants, place, setting, sampling method,
enrollment procedure, and the inclusion, and exclusion criteria for the study.
Furthermore, the study instruments are explained with clarity with its
psychometrics that includes the Morisky medication adherence scale (MMAS), the
self-efficacy for appropriate medication use scale (SEAMS), and the beliefs about
medications questionnaire (BMQ). Finally explained is the data collection method,
and the statistical procedures that would be possibly used to analyze the study
findings.
This randomized controlled trial recognizes potential threats to internal and
external validity such as history, maturation, diffusion, testing, and mortality
because of the nature of chronic illnesses and the interaction among the selected
population due to the setting, treatment, and history (Creswell, 2009).
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Chapter 4: Results and Analysis
Introduction
I conducted a single-blind randomized controlled trial on medication adherence
with the purpose of assessing the effectiveness of using different educational methods
with chronic illnesses such as hypertension, hyperlipidemia, diabetes, asthma, and COPD
with African Americans between the ages of 18 to 65 and who live in Chicago. The
study was built on the theoretical base of the SCT (Bandura, 1977) and the TPB (TPB)
(Ajzen 1991, 2007).
Scholars have emphasized that poor adherence to medications with chronic
illnesses is one of the barriers in controlling and reducing chronic illnesses, reducing
morbidity and mortality, improving quality of life, and reducing health care costs
(Bandura, 2004; Kripalani et al., 2007; Ogedegbe, et al., 2007; Österberg & Blaschke,
2005). Kelly and Jorgensen (2012) and Bandura (2004) argued that nonadherence to
medications is a complex behavior; therefore, it is necessary to provide appropriate
education on medications prescribed to control chronic illnesses to increase knowledge
and self-efficacy and to bring a change in health beliefs by implementing different
educational methods with an emphasis on prevention of consequences that chronic
illnesses cause and to learn self-management through medication adherence (Bandura,
2004; Kelly & Jorgenson, 2012; Murray et al., 2004).
Purpose
For the purpose of this quantitative study, a single-blind randomized controlled
trial, using the pretest/posttest design was chosen (Cresswell, 2009). Main focus of this
study was to assess the effectiveness of using different educational methods including
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lectures, video presentations, role plays, and group discussions to see if there would be a
significant effect in increasing knowledge and self-efficacy and a change in health beliefs
through these educational methods. Three well validated tools were used as
Pretest/Posttest to assess the effectiveness of these educational methods: Morisky
Medication Adherence Scale (MMAS; Morisky 2008) to assess knowledge gain, SelfEfficacy for Appropriate Medication use Scale (SEAMS; Kripalani et al., 2007) to assess
increase in self-efficacy, and Beliefs about Medicine Questionnaire (BMQ-18; Horne, et
al., 2000) to assess the change in health beliefs.
Research Questions and Hypotheses
A central research question was formulated based on this purpose of the study: Is
there any significant effect of using different educational methods in enhancing
medication adherence in African Americans with chronic illnesses?
Hypotheses
1. Knowledge Gain; Pretest/Posttest-MMAS
Do different educational methods have significant effects on knowledge gain in
medication adherence in African Americans with chronic illnesses?
H01: There will be no significant difference in knowledge gained on medication
adherence between the intervention group and the control group.
H11: There will be a significant difference in knowledge gained on medication
adherence between the intervention group and the control group.
2. Self-Efficacy; Pretest/Posttest-SEAMS
Do different educational methods have a significant effect in increasing self-efficacy on
medication adherence in African Americans with chronic illnesses?
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H02: There will be no significant difference in self-efficacy on medication
adherence between the intervention group and the control group.
H12: There will be a significant difference in self-efficacy on medication
adherence between the intervention group and the control group.
3. Health Beliefs; Pretest/Posttest-BMQ-18
Do different educational methods have a significant effect in changing health beliefs in
African Americans with chronic illnesses?
H03: There will be no significant difference in health beliefs on medication
adherence between the intervention group and the control group.
H13: There will be a significant difference in health beliefs on medication
adherence between the intervention group and the control group.
Preview of Chapter 4
This chapter begins with a brief review of the previous chapter, a description of
the study purpose, research questions, and the hypotheses of this randomized controlled
study. Data entry for the analysis was done using SPSS Version 21.0 for Windows.
Research questions were examined and the hypotheses were tested through ANOVA
statistical methodology. Descriptive statistical analysis was used to describe sample
demographics and the research variable. The study took place in a southwest community
of Chicago for a period of eight weeks with the African Americans. A total number 210
people agreed to participate in the study, 144 participants were randomized, 72 to the
experimental group, and 72 to the control group. The number of study participants varied
from week one to week five. From weeks, six to eight, the number of study participants
remained the same. The highest number of study participants was 44 in the experimental
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group and 17 in the control group. This chapter ends with findings of the study analysis
that are shown in tables and texts. In chapter 5, a further explanation will be given on the
analysis.
Data Collection
Recruitment
The recruitment process began after the Institutional Review Board (IRB) of
Cook County Hospital and Healthcare System gave their approval to conduct the study in
a south side community of Chicago. The volunteers, who were approved by the IRB to
assist in this study, posted the fliers in malls, marketplaces, laundromats, restaurants, bus
and train stops, politicians’ offices in the south side community, and in the churches of
the south side community of Chicago. The colorful flyer contained a brief description of
the study, purpose of the study, and the voluntary nature of the study and invited African
Americans who fit the study criteria to participate. The flyer also contained the telephone
numbers of volunteers to contact if they were willing to participate in the study. In
addition, the flyer assured confidentiality of the participants throughout the study.
Volunteers Profile
There were a total number of six volunteers, in addition to African Americans,
members of Step of Faith Ministries, and people who attended the Southside church,
regularly. These volunteers included two pastors, two nurses, one business manager, and
a pharmacy technician; they participated in the IRB testing and received a certificate
from the IRB that allowed them to assist in this study. Prior to the recruitment procedure,
these volunteers were fully informed about the study, the Pretest/Posttest questionnaires,
and the voluntary nature of the study; that they had to maintain confidentiality about the

149

study participants at all stages of the study. They were reminded not to use coercion at
any stage. Volunteers and the principle investigator (PI) had debriefing sessions together
once a week, from the beginning of the study until the study was completed. All the
sessions were held at the church where the study was conducted.
The recruitment phase lasted for eight weeks. A total of 210 African Americans
from this Southside community of Chicago consented to participate in this study. Study
volunteers obtained the information from these willing participants and submitted them to
a senior researcher who was authorized by the IRB to do randomization for this study.
This study required a total of 190 to 200 study participants. The volunteers informed
those study participants who were selected through randomization about the beginning
date of the study, time, and the place. The researcher (PI) passively remained active by
guiding those volunteers without getting involved directly in the recruitment process.
Randomization
Randomization was done through computer by a well-trained senior researcher
authorized by IRB. A total number of 144 willing participants were randomized and 72
participants each were assigned to the control and experimental groups. The PI did not
get involved with the randomization process (PI was blinded).
Data Analysis
Data were entered into SPSS version 21.0 for Windows. Descriptive statistics
were conducted to describe the sample demographics and the research variables used in
the analysis. Frequencies and percentages were calculated for nominal data, such as
gender and age. Means and standard deviations were calculated for continuous data, such

150

as knowledge and self-efficacy scores. Cronbach alpha reliability testing was conducted
on each of the subscales created (knowledge, self-efficacy, and health beliefs).
Research Question 1
Do different educational methods have significant effects on knowledge gain in
medication adherence in African Americans with chronic illness?
H01: There will be no significant difference in knowledge gained on medication
adherence between the intervention group and the control group.
H11: There will be a significant difference in knowledge gained on medication adherence
between the intervention group and the control group.
To examine Research Question 1, an analysis of variance (ANOVA) will be
conducted to assess if the difference in knowledge scores is significantly different by the
control and experimental groups. The ANOVA is the appropriate analysis to conduct
when the goal is to assess if there is a significant difference in a continuous variable by a
nominal variable (Pallant, 2010). The continuous dependent variable is the knowledge
difference score, created by subtracting the pretest knowledge score from the posttest
knowledge score. The nominal independent variable is group, with levels control and
treatment. Prior to analysis, the assumptions of normality and equality of variance will
be assessed.
Research Question 2
Do different educational methods have significant effects on increasing selfefficacy on medication adherence in African Americans with chronic illness?
H02: There will be no significant difference in self-efficacy on medication adherence
between the intervention group and the control group.
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H12: There will be a significant difference in self-efficacy on medication adherence
between the intervention group and the control group.
To examine research question 2, an analysis of variance (ANCOVA) will be
conducted to assess if the difference in self-efficacy scores is significantly different by
the control and experimental groups. The ANCOVA is the appropriate analysis to
conduct when the goal is to assess if there is a significant difference in a continuous
variable by a nominal variable (Pallant, 2010). The continuous dependent variable is the
self-efficacy difference score, created by subtracting the pretest self-efficacy score from
the posttest self-efficacy score. The nominal independent variable is group, with levels
control and treatment. Prior to analysis, the assumptions of normality and equality of
variance will be assessed.
Research Question 3
Do different educational methods have a significant effect in changing health
beliefs in African Americans with chronic illnesses?
H03: There will be no significant difference in health beliefs on medication adherence
between the intervention group and the control group.
H13: There will be a significant difference in health beliefs on medication adherence
between the intervention group and the control group.
To examine research question 3, a multivariate analysis of variance (MANOVA)
will be conducted to assess if there was a significant difference in the four health beliefs
difference scores by the control and experimental groups. The MANOVA is the
appropriate analysis to conduct when the goal is to assess if there were significant
differences in multiple dependent variables by a nominal independent variable (Pallant,
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2010). The continuous dependent variables are the four health beliefs (necessity,
concerns, overuse, and harm) differences scores, created by subtracting the pretest health
belief score from the posttest health beliefs score. Prior to analysis, the assumptions of
normality and equality of covariance matrices will be assessed. If the MANOVA is
significant, then the individual ANOVAs will be interpreted as well.
Results
Descriptive Statistics
A total of 263 observations (or data sets), including control and experimental
groups were taken. Participation in both groups varied on a weekly basis, with weeks six,
seven, and eight having the largest participant count (44, 17%). There were 150 (57%)
observations that were taken for the experimental group and 113 (43%) that were taken
for the control group. Due to the fact that the same participant could come multiple
weeks, frequencies and percentages of the demographics should be interpreted with
caution. Majority of the overall observations were from females (158, 60%). Most of the
observations came from participants who had high blood pressure (193, 73%) and had
high cholesterol (135, 51%). Majority of the observations were not from participants
with diabetes (145, 55%), from those with asthma (168, 64%), or from those with COPD
(203, 77%). The most-common age group of the observations was 56-65 years old (122,
46%). Frequencies and percentages for observation demographics are presented in
Tables 1 through 5.
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Weekly Participants
Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

Week 7

Week 8

50
45
40
35
30
25
20
15
10
5
0

Figure 1. Bar Graph on Weekly Participation
Table 1
Frequencies and Percentages for Observation Demographics (See Graph 1)
Demographic
n
Week
1
2
3
4
5
6
7
8
Total observations from all eight weeks

%

Participants
24
20
22
30
35
44
44
44
263

9
8
8
11
13
17
17
17

By control and experimental groups
Control group
Experimental group

113
150

43
57

By Gender
Female
Male

158
105

60
40
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Data sets collected by Chronic Illnesses
100.00%
90.00%
80.00%
70.00%
60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
HypertensionCholesterol Diabetes

Asthma

COPD

Figure 2. Bar Graph on Chronic Illnesses

Table 2
Demographics of Chronic Illnesses
By Blood Pressure levels
Not high
High
By Cholesterol levels
Not high
High
By Diabetes incidence
Does not have
Has
By having Asthma
Does not have
Has
By having COPD
Does not have
Has

n

%

69
194

26
74

128
135

49
51

145
118

56
44

168
95

64
36

203
60

77
23
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Data sets collected by age groups
140
120
100
80
60
40
20
0
Age 18-35

Age 36-45

Age 46-55

Age 56-65

Figure 3. Bar Graph on Age Group

Table 3

Demographics of Age Group

n

%

18 – 35

2

1

36 – 45

44

17

46 – 55

95

36

56 – 65

122

46

Note. Percentages may not total 100 due to rounding error. (This applies for all
demographic tables).
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Scores were created for knowledge, self-efficacy, and health beliefs at pretest and
posttest. The difference between the pretest and posttest was calculated by subtracting
the pretest score from the posttest score. Cronbach’s alpha test of reliability was
conducted on each of the pretest and the posttest scores. Reliability showed that all
subscales had at least good reliability (> .80) or excellent reliability (> .90; George and
Mallery, 2010). Table 4 below shows the descriptive statistics for the pretest, posttest,
and difference scores for each of the variables.

Table 4
Descriptive Statistics for Pretest, Posttest, and Differences Scores
Pretest
Variable

Posttest

Difference

M

SD

α

M

SD

α

M

SD

Knowledge

4.73

1.96

.87

5.31

1.88

.84

0.59

1.37

Self-efficacy

2.12

0.60

.86

2.37

0.47

.87

0.25

0.46

Health beliefs - necessity

2.48

0.90

.97

2.34

0.95

.80

-0.13

0.89

Health beliefs - concerns

3.09

0.91

.93

3.14

0.94

.79

0.05

0.84

Health beliefs - overuse

3.10

1.00

.91

3.13

1.03

.82

0.02

0.67

Health beliefs - harm

3.47

0.77

.92

3.70

0.80

.83

0.23

0.70

Prior to addressing the research questions, age and gender were assessed for as
covariates. A series of Pearson correlations were conducted for age and the difference
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scores while a series of point-biserial correlations were conducted for gender and the
differences scores. Results of the correlations showed that self-efficacy difference scores
were related to age (r = -.18, p = .003) and to gender (r = .12, p = .046), suggesting that
participants who were younger and those that were male tended to have a larger
difference in their self-efficacy score from pretest to posttest. Because these variables
were related to self-efficacy, they were used as covariates for research question two.
Gender was also related to health beliefs – harm (r = .19, p = .002), suggesting that male
participants tended to have a higher difference in health beliefs – harm scores from
pretest to posttest compared to females. Although gender was related to health beliefs –
harm, it was not treated as a covariate for the MANOVA for research question 3 as it was
not related to any other health beliefs scores. Results for the correlations are presented in
Table 5.

Table 5
Results for Covariate Correlations
Score

Age

Gender

Knowledge

-.08

.02

Self-efficacy

-.18**

.12*

Health beliefs - necessity

-.03

-.11

Health beliefs - concerns

.02

.05

Health beliefs - overuse

.10

-.03

Health beliefs - harm

-.01

.19**
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Research Question 1
Do different educational methods have significant effects on knowledge gain in
medication adherence in African Americans with chronic illness?
H01: There will be no significant difference in knowledge gained on medication
adherence between the intervention group and the control group.
Ha1: There will be a significant difference in knowledge gained on medication adherence
between the intervention group and the control group.
To assess research question 1, an analysis of variance (ANOVA) was conducted
to assess if there were significant differences in the difference scores for knowledge by
control and experimental groups. Prior to analysis, the assumption of normality was
assessed with a Kolmogorov Smirnov (KS) test. Results of the test were significant (p <
.001), suggesting that normality was violated. However, with a large sample size,
normality can be violated with little effect on Type I error (Stevens, 2009). The
assumption of equality of variance was assessed with a Levene’s test. The results of the
test were not significant (p = .911), meeting the assumption.
Results of the ANOVA were not significant, F(1, 261) = 0.17, p = .678,
suggesting that there were no differences in the knowledge differences scores by the
control and experimental groups. Since the ANOVA was not significant, the null
hypothesis cannot be rejected. Results of the ANOVA are presented in Table 6. Means
and standard deviations for knowledge differences scores by group are presented in Table
7.
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Table 6
ANOVA Results for Knowledge Difference Scores of Groups (Exp, Cont.)
Source

SS

Control and
Experimental
Groups
Error

0.33

494.81

df

MS

F

p

Partial η2

1

0.33

0.17

.678

.00

261

1.90

Table 7
Means and Standard Deviations in Knowledge Difference Scores by Group
Group
M
SD

Control

0.54

1.38

Experimental

0.61

1.37

Total

0.58

1.37

An additional ANOVA was conducted to assess if there were differences in
teaching styles used in the experimental group (lecture, video, role play, and group
discussion). Equality of variance was not met with the Levene’s test (p = .003), and thus
a more-stringent alpha level of .025 was used for the ANOVA. Results of the ANOVA
were not significant, F(3, 146) = 0.91, p = .441. This suggests that no teaching style was
significantly better than the others. Means and standard deviations for knowledge
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difference scores by teaching style are presented in Table 8. Results for the ANOVA are
presented in Table 9.

Table 8
ANOVA Results for Knowledge Difference Scores by Teaching Style
Source
SS
df
MS
F
p

Teaching Style
Error

5.13
276.19

3

1.71

146

1.89

0.91

Partial η2

.441

.02

Table 9
Means and Standard Deviations in Knowledge Difference Scores of experimental group
by Teaching Style
Group
M
SD

Lecture

0.83

2.00

Video

0.38

1.10

Role play

0.78

1.24

Group discussion

0.49

1.08

Total

0.58

1.37

Research Question 2
Do different educational methods have significant effects on increasing self-efficacy on
medication adherence in African Americans with chronic illness?
H02: There will be no significant difference in self-efficacy on medication adherence
between the intervention group and the control group.
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Ha2: There will be a significant difference in self-efficacy on medication adherence
between the intervention group and the control group.
To assess research question 2, an analysis of covariance (ANCOVA) was
conducted to assess if there were significant differences in the difference scores for selfefficacy by the control and experimental groups after controlling for age and gender.
Prior to analysis, the assumption of normality was assessed with a Kolmogorov Smirnov
(KS) test. The results of the test were significant (p < .001), suggesting that normality
was violated. However, with a large sample size, normality can be violated with little
effect on Type I error (Stevens, 2009). The assumption of equality of variance was
assessed with a Levene’s test. The results of the test were not significant (p = .671),
meeting the assumption.
Results of the ANCOVA were not significant, F(1, 259) = 0.96, p = .328,
suggesting that there were no differences in the self-efficacy differences scores by the
control and experimental groups. Since the ANCOVA was not significant, the null
hypothesis cannot be rejected. Results of the ANCOVA are presented in Table 10.
Means and standard deviations for self-efficacy differences scores by group are presented
in Table 11.
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Table 10
ANCOVA Results for Self-Efficacy Difference Scores by Group Controlling for Age and
Gender
Source
SS
df
MS
F
p
Partial η2

Control and
Experimental
Groups

0.19

1

0.19

0.96

.328

.00

By Age

2.53

1

2.53

12.63

.001

.05

By Gender

1.40

1

1.40

6.97

.009

.03

55.26

261

0.21

Error

Table 11
Means and Standard Deviations in Self-Efficacy Difference Scores by Group
Group
M
SD

Control

0.26

0.46

Experimental

0.25

0.46

Total

0.25

0.46

An additional ANCOVA was conducted to assess if there were differences in
teaching styles used in the experimental group (lecture, video, role play, and group
discussion) after controlling for age and gender. Equality of variance was met with the
Levene’s test (p = .091). The results of the ANCOVA were not significant, F(3, 144) =
0.73, p = .538. This suggests that no teaching style was significantly better than the
others. Means and standard deviations for self-efficacy difference scores by teaching
style are presented in Table 12. Results for the ANCOVA are presented in Table 10.
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Table 12
ANCOVA Results for Self-Efficacy Difference Scores by Teaching Style Controlling for
Age and Gender
Source
SS
df
MS
F
p
Partial η2

Teaching Style

0.44

3

0.15

0.73

.538

.02

Age

0.61

1

0.61

3.03

.084

.02

Gender

1.36

1

1.36

6.79

.010

.05

28.87

144

0.20

Error

Table 13
Means and Standard Deviations in Self-Efficacy Difference Scores of experimental group
by Teaching Style
Group
M
SD

Lecture

0.18

0.49

Video

0.34

0.50

Role play

0.26

0.50

Group discussion

0.23

0.35

Total

0.25

0.46
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Research Question 3
Do different educational methods have a significant effect in changing health beliefs in
African Americans with chronic illnesses?
H03: There will be no significant difference in health beliefs on medication adherence
between the intervention group and the control group.
Ha3: There will be a significant difference in health beliefs on medication adherence
between the intervention group and the control group.
To examine research question 3, a multivariate analysis of variance (MANOVA)
was conducted to assess if there were differences in the health beliefs difference scores
(necessity, concerns, overuse, and harm) by control and experimental groups. Prior to
analysis, the assumption of normality was assessed with KS tests. Results of the test
were all significant (p < .001), suggesting that normality was violated. However, Stevens
(2009) suggests that normality violations have little effect on Type I error. The
assumption of equality of covariance matrices was assessed with the Box’s M test.
Results of the Box’s M test were significant (p < .001), suggesting that equality of
covariance matrices was violated. As such, the Pillai’s Trace statistic will be interpreted
for the MANOVA, which is a more-conservative statistic for the MANOVA (Pallant,
2010).
Results of the MANOVA were not significant, F(4, 258) = 0.46, p = .765,
suggesting that there were no differences in the health beliefs difference scores by control
and experimental groups. Since the MANOVA was not significant, the individual
ANOVAs were not interpreted. In addition, the null hypothesis cannot be rejected.
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Results of the MANOVA are presented in Table 14. Means and standard deviations for
the health beliefs are presented in Table 15.

Table 14
MANOVA Results for Health Beliefs Difference Scores of Groups (Exp,Cont)
MANOVA
ANOVA F(1, 261)
F(4, 258)
Source
Necessity
Concern
Overuse

Control and
Experimental
Groups

0.46

1.37

0.29

0.05

Harm

0.41

Table 15
Means and Standard Deviations for Health Beliefs Difference Scores by Group
Control
Experimental
Health beliefs score

M

SD

M

SD

Necessity

-0.21

0.71

-0.08

1.01

Concern

-0.13

0.89

0.02

0.92

Overuse

0.08

0.78

0.05

0.84

Harm

0.03

0.64

0.02

0.69

An additional MANOVA was conducted to compare the health beliefs scores by
teaching style. The assumption of equality of covariance matrices was assessed with the
Box’s M test. Results of the Box’s M test were not significant at the .001 level (p =
.002), suggesting that equality of covariance matrices was met.
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Results of the MANOVA were not significant, F (4, 379) = 1.20, p = .285,
suggesting that there were no differences in the health beliefs difference scores by
teaching style. Since the MANOVA was not significant, the individual ANOVAs were
not interpreted. With the MANOVA not being significant, there was no leadership style
that was best among others for health belief scores. Results of the MANOVA are
presented in Table 16. Means and standard deviations for the health beliefs are presented
in Table 17.
Table 16
MANOVA Results for Health Beliefs Difference Scores by (Exp+Ctrl) Group
MANOVA
ANOVA F(1, 146)
F(12, 379)
Source
Necessity
Concern
Overuse

Control and
Experimental
Groups

1.20

1.02

2.26

1.73

Harm

0.73

Table 17
Means and Standard Deviations for Health Beliefs Difference Scores of Experimental
Group
Lecture
Video
Role Play
Group Discussion
Health beliefs score

M

SD

M

SD

M

SD

M

SD

Necessity

-0.03

0.83

-0.24

1.05

-0.19

1.00

0.11

1.11

Concern

0.28

0.73

-0.19

0.85

0.09

0.79

0.12

0.70

Overuse

0.20

0.86

0.08

0.73

-0.03

0.60

-0.14

0.55

Harm

0.41

0.73

0.22

0.82

0.18

0.49

0.23

0.74
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Summary of Chapter 4
A single-blind randomized controlled trial was conducted to assess the
effectiveness of using different educational methods such as lecture, video presentation,
role-playing, and group discussion to enhance medication adherence among patients with
chronic illnesses such as hypertension, diabetes, hyperlipidemia, asthma, and COPD.
The study took place in a church in a southwest community of Chicago, once a week for
a period of eight weeks. The study was conducted exactly as how it was planned and
explained in the methodology section of Chapter 3. The study participants were only
African Americans men and women, eighteen to sixty-five years of age, who were
diagnosed with and prescribed medications for hypertension, hyperlipidemia, diabetes,
asthma, and COPD, and also gave their willing consent to participate in the study.
The data was analyzed using SPSS Version 21.0 for Windows. Descriptive
statistics was performed to describe the sample demographics and research variables used
in analysis. Frequencies and percentages were calculated for nominal data such as gender
and age. Means and standard deviations were calculated for continuous data on
dependent variable scores. The hypotheses were analyzed using ANOVA statistical
method and shown in tables. Summary of the research findings, limitations of the study,
and recommendations for future actions are explained in chapter 5.
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Chapter 5: Introduction
In this chapter, I explain the purpose and nature of the study and the compelling
reason for the study to be carried out. Briefly summarized, the pertinent findings of the
study, the interpretation of the findings within the scope of empirical findings, and the
theoretical underpinnings that allowed this study to be designed and carried out are
explained through various scholars. The limitations of this study are explained,
recommendations were made for further studies on health promotion with medication
adherence and chronic illnesses, as was how education on medication adherence could
bring a positive social change in the management of chronic illnesses; thus, this would
have a greater impact in reducing morbidity, mortality, and healthcare costs.
Purpose: Review of the Purpose, Nature, and Reason for the Study
The purpose of this quantitative study was to assess the effectiveness of using
four different educational methods such as lecture, video presentation, role play, and
group discussion in enhancing medication adherence among African American men and
women between 18 to 65 years of age, who live in a southwest community of Chicago,
are diagnosed with hypertension, hyperlipidemia, diabetes, asthma, and COPD, and are
prescribed medications for these chronic illnesses. The study was designed to measure
statistically as how these educational methods the independent variables have impacted
the dependent variables, knowledge, self-efficacy, and change in health beliefs. The
study further examined the independent variables, the educational methods by comparing
one against another to assess which educational method was more effective in this study.

169

Nature of the Study
The study was conducted as a single blind, randomized controlled trial with a
pretest/posttest design. Both experimental and control groups received education on
medication adherence on hypertension, hyperlipidemia, diabetes, asthma, and COPD.
The experimental group received education through lectures, videos, role-playing, and
group discussions. The control group received education through pamphlets only. Both
groups completed the pretest prior to education and posttest after the education. Three
well-validated scales were used as pretest/posttest in this study.
Reason for this Study
The main reason for conducting this single blind randomized controlled trial was
to examine whether using different educational methods would be more effective in
enhancing medication adherence among African Americans with chronic illnesses by
increasing knowledge, self-efficacy, and changes in health beliefs. In this way, one could
bring about a positive social change through increasing medication adherence among
African Americans resulting in a reduction of morbidity, mortality, and healthcare costs,
and improving quality of life.
Summary of the Key Findings
Hypothesis 1
1. Do different educational methods have significant effects on knowledge gain in
medication adherence in African Americans with chronic illnesses?
H01: There will be no significant difference in knowledge gained on medication
adherence between the intervention group and the control group
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H11: There will be a significant difference in knowledge gained on medication adherence
between the intervention group and the control group
The results of the ANOVA were not significant F (1,261) = 0.17 and p = .678, suggesting
that there were no differences in the knowledge differences scores by group. Because the
ANOVA was not significant, the null hypothesis cannot be rejected (Table 3).
Hypothesis 2
Do different educational methods have significant effects in increasing self-efficacy on
medication adherence in African Americans with chronic illness?
H02: There will be no significant difference in self-efficacy on medication adherence
between the intervention group and the control group.
H12: There will be a significant difference in self-efficacy on medication adherence
between the intervention group and the control group. The results of the ANCOVA were
not significant, F (1,261) = 0.01, p = .914, suggesting that there were no differences in
the knowledge differences scores by group. Since the ANCOVA was not significant, the
null hypothesis cannot be rejected (Table 5).
Hypothesis 3
Do different educational methods have a significant effect in changing health beliefs in
African Americans with chronic illnesses?
H03: There will be no significant difference in health beliefs on medication adherence
between the intervention group and the control group
H13: There will be a significant difference in health beliefs on medication adherence
between the intervention group and the control group
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A multivariate analysis of variance (MANOVA) was conducted to assess if there were
differences in health beliefs difference scores including necessity, concerns, overuse, and
harm by group. The results of the MANOVA were not significant F (4,258) = 0.46 and p
= .765, suggesting that there were no differences in health beliefs difference scores by
group. Since the MANOVA was not significant, the null hypothesis cannot be rejected
(Table 7).
Results
Descriptive Statistics
A total of 263 observations were taken. Participation varied on a weekly basis
from week one to week five and weeks six to eight, which had the highest number of
participants, 27 in the experimental group and 17 in the control group.
The majority of the overall observations were from females (158, 60%)
Most of the observations came from participants who had high blood pressure (193, 73%)
and had high cholesterol (135, 51%)
The majority of the observations were not from participants with diabetes (145, 55%), or
from those with asthma (168, 64%), or from those with COPD (203, 77%)
The most common age group of the observation was 56-65 years old (122, 46%)
Educational Methods
Based on the statistical findings, all the four educational methods received equal
scores, which means that no one single educational method was better than the other
educational method
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Interpretation of the Findings
Hypothesis 1: Knowledge Gain
Do different educational methods have significant effects on knowledge gain in
medication adherence in African Americans with chronic illnesses?
H0: “There will be no significant difference in knowledge gained on medication
adherence between the intervention group and the control group”
Ha: “There will be a significant difference in knowledge gained on medication adherence
between the intervention group and the control group”
Analysis of Variance (ANOVA) was conducted to see whether there would be significant
differences in the difference scores for knowledge. Results of the ANOVA were not
significant, F (1,261) = 0.17, p = .678, suggesting that there were no differences in the
knowledge differences scores by group. Since the ANOVA was not significant, the null
hypothesis cannot be rejected.
Discussion
Failure to reject the null hypothesis on knowledge gain could have resulted
because of a few potential reasons as many scholars have suggested based on their
empirical findings. One of the most important suggestions that scholars have given was
prevailing poor health literacy among African Americans. The National Council on
Patient Information and Education (NCPIE), whose main task is to improve
communication and information between patient and healthcare providers to improve
medication adherence, suggested that poor health literacy is a significant problem among
African Americans resulting in poor understanding and comprehension of health
information leading to poor knowledge gain (as cited in Kourek, 2009). Kalichman et al.
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(2008) suggested in their studies on HIV/AIDS medication adherence that health literacy
plays a vital role in gaining knowledge on medication adherence and that health literacy
is particularly in demand for improving a patient’s knowledge, comprehension on health
messages, and adherence to prescribed medications. In addition, low health literacy skills
are closely associated with inadequate knowledge and poor comprehension (Kalichman et
al., 2008). Kripalani and colleagues (2006) have explained that low literacy skills may be
a potential risk factor for poor comprehension and inadequate knowledge gain (Kripalani
et al., 2006).
Marks (2009) and Wagner et al., (2009) have explained that low health literacy in
vulnerable populations could affect their listening skills, resulting in difficulties to
process the health information (Marks, 2009; Wagner et al., 2009). A few other scholars
have explained that low health literacy is also associated with low numeracy skills (Thai
& George, 2010). Low health literacy and low numeracy skills could have played a
subtle role in this study with pretest and posttest questionnaires that the null hypothesis
could not be rejected in knowledge gain.
Another potential reason for failing to reject the null hypothesis on knowledge
gain is possibly due to depression and fatigue associated with chronic illnesses as the
Institute of Medicine (IOM) reported in 2002 (Österberg & Blaschke, 2005; Ho et al.,
2009; Hill et al., 2010). This chronic depression and fatigue associated with chronic
illnesses could cause physical, sensory, and cognitive impairments (Österberg &
Blaschke, 2005; Hill et al., 2010), resulting in difficulties in processing health
information on medication adherence (Österberg & Blaschke, 2005). This subtle nature
of chronic depression and fatigue could have caused difficulties to study participants in
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understanding and comprehending Pretest and Posttest questionnaires in that the null
hypothesis on knowledge gain could not be rejected statistically.
In summary, the null hypothesis on knowledge gain could not be rejected by
statistical method. This might have happened because of possible factors associated with
the study participants: low literacy levels in that no one had completed high school,
inherent fatigue and depression associated with chronic illnesses, lack of adequate
numerical skills because of low literacy levels, and sensory defects because of depression
and fatigue. These factors could have played a significant role among the study
participants, causing difficulties with understanding and comprehension of
Pretest/Posttest questionnaires of MMAS in spite of assistance offered from the
volunteers with Pretest/Posttest questionnaires.
Hypothesis 2: Self-Efficacy
Do different educational methods have significant effects on increasing self-efficacy on
medication adherence in African Americans with chronic illnesses?
H0: There will be no significant difference in self-efficacy on medication adherence
between the intervention group and the control group
Ha: There will be a significant difference in self-efficacy on medication adherence
between the intervention group and the control group
To see if there would be significant differences in the difference scores for selfefficacy by group after controlling for age and gender, the team conducted an analysis of
covariance (ANCOVA). The results of the ANCOVA were not significant, F(1,259) =
0.96, p = .328, suggesting that there were no differences in the self-efficacy differences
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scores by group. Since the ANCOVA was not significant, the null hypothesis cannot be
rejected. In this way, the null hypothesis cannot be rejected in the second hypothesis.
Discussion
Failure to reject the null hypothesis by statistical analysis on increase in selfefficacy could be due to the fact that the role of self-efficacy depends greatly on human
functioning and this depends on an individual’s knowledge and skills (Bandura, 1977).
The authors Kralik and colleagues (2010) explained that future health status and health
behaviors in people with chronic illnesses are greatly dependent on their self-efficacy and
changes in it. In the context of living with chronic illnesses that require people to have
self-efficacy in self-management of their illness, they have to make considerable
adjustments and adaptations to daily life changes that require changes in self-efficacy
(Kralik et al., 2010). In order to make changes in life, one has to gain knowledge and
skills (Bandura, 1977).
In 2008, Friedman & Hoffman-Goetzl warned the healthcare providers that they
tend to overestimate a patient’s literacy skills and knowledge that the patients have full
comprehension of verbal and written instructions provided to them when in fact they do
not have such skills, and this lack of cognitive skills is often found among vulnerable
populations (Friedman & Hoffman-Goetzl, 2008). In this study, the participants were all
African Americans with one or more chronic illness and their educational level was that
of a high school level. Perhaps the volunteers and the researcher might have
overestimated their cognitive skills while doing the pretest and posttest; the study
participants also did not want to convey their inabilities with their reading and
comprehension of the pretest and posttest questionnaires. This low literacy level and
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poor comprehension possibly directly contributed to failure to reject the null hypothesis
on self-efficacy.
Gamble (1977) explained that African Americans are very fearful of any research
activities because of past experiences with racism and that they would be used as guinea
pigs (Gamble, 1977). Initially, the concept of medication adherence seen on the
invitation could have created some kind of fear about the study, because some of the
study participants had expressed this fear in that they would be asked to try some kind of
new medication for diabetes and hypertension. This kind of fear is real for the study
participants, especially among African Americans because of the past history of racism
associated with research activities, and this fear could have prevented them from
expressing their self-efficacy on the SEAMS Scale through pretest and posttest
questionnaires on self-efficacy that had possibly resulted in failure to reject the null
hypothesis.
IOM (2002), Österberg & Blaschke (2005), Ho et al. (2009), and Hill et al. (2010)
have explained that chronic illnesses can cause depression and fatigue because of their
chronicity in nature and that they have a negative impact on self-efficacy, knowledge
gain, and motivation (IOM, 2002; Österberg & Blaschke, 2005; Ho et al., 2009; Hill et
al., 2010). Schoenthaler and colleagues (2009) have explained in their study with African
Americans with hypertension that they suffer with depression and this depression has a
negative impact on self-efficacy (Schoenthaler et al., 2009). Manifestation of depression
in this study may not be directly seen, but could have had an impact on SEAMS
questionnaires through Pretest and Posttest that resulted in failure to reject the null
hypothesis.
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Self-efficacy plays a vital role in the self-management of chronic illnesses and it
is a major determinant in behavioral change (Bandura, 1977, 2004). Increase in selfefficacy greatly depends on knowledge gain on health literacy and it is necessary to
impart knowledge on medications. Kripalani and colleagues (2006) and Kalichman and
colleagues (2008) have explained that health literacy is vital to increase self-efficacy and
low health literacy skills are closely associated with inadequate knowledge, poor
comprehension, and low self-efficacy (Kripalani et al., 2006; Kalichman et al., 2008). In
this study, the study participants could have experienced low self-efficacy because of low
health literacy levels that could have reflected on the SEAMS Scale with pretest and
posttest, and this could have an impact on the null hypothesis in that the statistical
method did not reject it.
In summary, in this present study, the null hypothesis on self-efficacy score was
not rejected by ANCOVA statistical method. In other words, the scores on self-efficacy
have failed to demonstrate statistical significance; thereby, the statistical method could
not reject the null hypothesis. Possible explanation for this could be factors associated
with the study participants including fear of any research activities, depression and
fatigue associated with chronic illnesses, and low literacy levels among study
participants. Living with chronic illnesses is a major challenge for African Americans
and gaining self-efficacy on medication adherence is another challenge and they are
influenced due to individual factors such as fear, depression, fatigue, inadequate literacy
skills, and poor comprehension, which could have a direct impact on the null hypothesis.

178

Hypothesis 3: Health Beliefs
Do different educational methods have a significant effect in changing health beliefs in
African Americans with chronic illnesses?
H0: There will be no significant difference in health beliefs on medication adherence
between the intervention group and the control group
Ha: There will be a significant difference in health beliefs on medication adherence
between the intervention group and the control group
A multivariate analysis of variance (MANOVA) was conducted to assess if there
were differences in health beliefs difference scores including necessity, concerns,
overuse, and harm by group. The results of MANOVA were not significant, F (4,258) =
0.46, p = .765, suggesting that there were no differences in health beliefs difference
scores by group. Since the MANOVA was not significant, the individual ANOVA scores
were not interpreted. In addition, the null hypothesis cannot be rejected.
Failure to reject the null hypothesis on health beliefs may have various reasons.
The first reason is that African Americans are fearful and uncomfortable when they hear
about any research related to health that requires their participation. They are afraid that
they will be exploited and experimented with new medication and will be used as guinea
pigs. In 1997, scholar Gamble described that African Americans are fearful of any
medical research that requires their participation because of the past history with syphilis
study in Tuskegee, Alabama from 1932 to 1972, where the men who were diagnosed with
syphilis were deliberately denied treatment in order to study the natural history of
syphilis (Gamble, 1997). This past history on medical research with African Americans
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has a strong negative impact because the fear that percolates within them in that they do
not want to be involved with any research (Gamble, 1997).
The beliefs system of African Americans, related to medications with chronic
illnesses, has its base not only from the past history on medical research, but also their
experiences with social stigma, racial discrimination, and economic deprivation play a
vital role in that they do not trust the medical community (Piette et al., 2010). This
mistrust with medical research continues to prevail among African Americans in that they
consider medications to be more harmful than doing good and some even consider them
to be poison (Piette et al., 2010).
Low health literacy is another contributing factor for their beliefs about
medication adherence. Low health literacy in African Americans induces fear and doubts
about medications in that they are dissatisfied with the information related to medications
(Aikens & Piette, 2009). In this present study, the study participants’ educational level
was less than high school, and this low literacy could have had an impact on this research
question. The study participants were honest and raised concern about generic
medications prescribed for hypertension and other chronic illnesses. They believe that
generic medications are the root cause for medication allergies and intolerance, and this
fear will have a deleterious effect on medication adherence that will take time to
completely eradicate.
African Americans believe that stressful life situations can cause hypertension and
other illnesses (Lewis et al., 2010). Stressful life situations can cause emotional and
psychological distress that could prevent them from being adherent to their prescribed
medications. In addition, they believe that hypertension medications can cause serious
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adverse effects and sometimes could be physically debilitating. They believe that chronic
illnesses are caused by stressful situations and medications are not the only answer, and
that these stressful conditions have to be dealt with adequate social support in a realistic
way.
In summary, in regard to research question 3 on health beliefs, the null hypothesis
could not be rejected by the Multivariate Statistical method (MANOVA). The possible
reasons could be based on their beliefs including the fear of being used in medical
research, low health literacy that they did not understand and comprehend the validated
tools, persistent mistrust about medications, the fear of social stigma, racial disparities,
and economic deprivation, past history of slavery and discrimination, and stressful life
conditions that were not adequately dealt with. Out of all these reasons, fear, doubts, and
low health literacy levels could have contributed to this failing to reject the null
hypothesis.
Discussion
Failure to reject the null hypothesis on health beliefs may have various reasons.
The first reason is that African Americans are fearful and uncomfortable when they hear
about any research related to health that requires their participation. They are afraid that
they will be exploited and experimented on with new medications and will be used as
guinea pigs. In 1997, scholar Gamble described that African Americans are fearful of
any medical research that requires their participation because of the past history with
syphilitic study in Tuskegee, Alabama from 1932 to 1972 in which the men, who were
diagnosed with syphilis were deliberately denied treatment in order to study the natural
history of syphilis (Gamble, 1997). This past history on medical research with African
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Americans has a strong negative impact because the fear that percolates within them is
that they do not want to be involved with any research (Gamble, 1997).
The belief system of African Americans, related to medications with chronic
illnesses, has its base not only from past history on medical research, but also from their
experiences with social stigma, racial discrimination, and economic deprivation have
played a vital role in that they do not trust the medical community (Piette et al., 2010).
This mistrust with medical research continues to prevail among African Americans in
that they consider medications are more harmful than good, and some even consider them
to be poison (Piette et al., 2010).
Low health literacy is another contributing factor for their beliefs about
medication adherence. This low health literacy in African Americans induces fear and
doubts about medications in that they are dissatisfied with the information related to
medications (Aikens & Piette, 2009). In this present study, the study participants’
educational level was less than high school and this low literacy could have an impact on
this research question. The study participants were honest and raised concern about
generic medications prescribed for hypertension and other chronic illnesses. They don’t
trust generic medications and believe that they cause medication allergies and
intolerances; this fear could result in poor medication adherence and it is going to take
time to eradicate it completely.
African Americans believe that stressful life situations can cause hypertension and
other illnesses (Lewis et al., 2010). The stressful life situations can cause emotional and
psychological distress that prevents them from being adherent to their prescribed
medications. In addition, they believe that hypertension medications can cause serious
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adverse effects, and sometimes even physically debilitating ones. They believe that
medications are not the only answer for the chronic illnesses that stressful life conditions
cause and these conditions have to be dealt with adequate social support in a realistic
way.
In summary, in research question 3 on health beliefs the null hypothesis could not
be rejected through the Multivariate Statistical Method (MANOVA). The possible
reasons could be based on their beliefs, including the fear of being used in medical
research, low health literacy in that they did not understand and comprehend the validated
tools, persistent mistrust about medications, the fear of social stigma, racial disparities,
economic deprivation, past history of slavery and discrimination, and the stressful life
conditions that were not adequately dealt with. Out of all these reasons, fear, doubts, and
low health literacy levels could have contributed to this failing to reject the null
hypothesis.
Comparison of Educational Methods
In this study, four different educational methods were used to educate African
Americans with chronic illnesses on medication adherence. These educational methods
include lecture, video presentation, role-playing, and group discussion, and they were
used to increase knowledge, self-efficacy, and change in health beliefs on medication
adherence with chronic illnesses. Statistical analysis was done through comparing these
educational methods with each other to see which one was better among these four.
ANOVA with research question 1, ANCOVA with 2, and MANCOVA with 3 were used
for analysis. These statistical findings suggested that no educational method was better
than the other, or all four educational methods were equal in their performance.
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Discussion
This statistical finding on educational methods can be interpreted and explained in
two ways. Scholar de Young (2009) had explained that to improve medication adherence
with chronic illnesses, there is no single particular method that will bring behavioral
change (de Young, 2009). Chodosh and colleagues (2005) have explained that there is no
accepted single educational method that has shown improvement in medication
adherence and it is necessary to combine various educational methods to bring conviction
in people to change their behavior (Chodosh et al., 2005). The same authors have
explained that it is paramount to include cultural sensitivity and clarity of the subject
while educating people on medication adherence (Chodosh et al., 2005; de Young, 2009).
In the context of chronic illnesses, it is imperative to understand that people are
prescribed many medications for different illnesses at the same time because they come
in clusters. This paradigm requires an in-depth understanding and comprehension about
their medications and illnesses, especially people with low literacy and numerary skills.
From what these authors have found, this study analysis supports their view.
In addition, when no educational method is better than the other one by statistical
analysis, we can argue that all the four educational methods were equally good because
they were developed based on sound theories applied in this study and peer-reviewed
scholarly reports by various scholars. Furthermore, the educational materials were
obtained from national health organizations such as the National Institute of Health
(NIH), the Agency for Healthcare Research and Quality (AHRQ), and the materials were
pretested for cultural sensitivity and quality. In this way, all the four educational methods
were possibly effective, equally based on these arguments.
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Another interpretation of these statistical findings is that no educational method
was better than the other one could be that the study participants either did not understand
or comprehend the meaning of questions or they were afraid to express themselves on
paper. (Kalichman et al., 2008; Kripalani et al., 2006) have suggested in their studies
with low literacy skills and medication adherence that there is a reliable association
between health literacy and self-reported medication adherence (Kalichman et al., 2008;
Kripalani et al., 2006). Both literary skills and education level are of significant
importance in medication adherence with chronic illnesses. As suggested by the scholars
in their studies, the association between the literacy and medication adherence, it is
possible that this current study also could have impacted by the low literacy levels of the
study participants. In this way, the statistical findings on educational methods could have
an impact in this study resulting that no educational method was better than the other one
among these four educational methods.
Covariates of this Study
Gender
In this current study, the majority overall observations were reported from
females (158, 60%). There is no scholarly evidence to explain as to why women’s
participation was higher than that of men in this study. One possible explanation could
be that the pastor and the deacons of Step of Faith Ministries were all women and that
their contacts and influence with their people could have brought more women than men
for this study.
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Chronic Illnesses
From the statistical analysis, it was evident that most of the observations were
obtained from people who were diagnosed with and were taking medications for high
blood pressure and high cholesterol. Scholars Kripalani et al., (2007), Ogedegbe et al.,
(2007), and Schoenthaler et al., (2009), who have done extensive empirical studies on
African Americans and the medication adherent behavior, explained that African
Americans suffer more with hypertension than any other ethnic group and they have a
much higher prevalence of hypertension and high cholesterol than diabetes and asthma.
They pay frequent visits to emergency healthcare facilities and have frequent
hospitalization because of the consequences that they suffer with hypertension (Kripalani
et al., 2007; Ogedegbe et al., 2007; Schoenthaler et al., 2009). This scholarly report by
various authors provides adequate support for this study analysis in that African
Americans suffer with high blood pressure and high cholesterol more than any other
ethnic group and more than diabetes and asthma.
Age Group
The highest study participants in this current study were between 55 to 65 years
old. The possible explanation for this finding is that this age group might have been
affected by chronic illnesses more than the younger age group of African Americans as
they had indicated in the study and they wanted to hear more about their chronic illness
management. Another explanation may be possibly that they were free from the family
and other social responsibilities. In addition, they were regular members of Step of Faith
Ministries and regularly attend the meetings and activities pertaining to Step of Faith
Ministries. The explanations are quite contrary to the scholars’ evidence, who have
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explained in their studies that African Americans suffer with hypertension and high
cholesterol at a much younger age when compared with other ethnic groups (Ogedegbe et
al., 2007; Gerber et al., 2010; Lewis et al., 2010; IOM, 2002). In this study, the main
focus was to assess the effectiveness of four educational methods and not which age
group will do better in pretest and posttest than the other group. This statistical finding
might have affected the outcome of the research questions that the study had failed to
reject to the null hypothesis in three of the research questions and explain any differences
among the educational methods.
Weekly Participation
This study required a total number of 144 African Americans with chronic
illnesses and who are prescribed medications for the chronic illnesses. A total number of
210 people agreed to participate in the study and out of 210 study participants, 144 were
randomized who fit with study criteria to experimental and control groups. The
recruitment beginning and end dates and the study beginning and end dates were clearly
spelled out. Out of this randomized group, only a small number of people attended the
classes during the first three weeks, the number slightly increased during the fourth and
fifth week, and more numbers of study participants came on the sixth week; these
participants remained in their respective groups during the seventh and eighth weeks of
the classes.
It is important to explain as to why these variations happened in this study with
the study participants. This study population was only African Americans and the
outcome of this study might have been affected by some of the factors pertaining to
African Americans. Scholar Gamble (1997) had explained in detail that African
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Americans are fearful to participate in any health research because of their past
experiences with the medical community (Gamble, 1997). Some other scholars have
explained that African Americans are more likely to mistrust their healthcare providers;
medication-related beliefs are framed within their broader experiences with the social
institution and their undesirable past experiences with medical research, African
Americans may pose an ongoing barrier in gaining a desirable common understanding
with any health-related scientific activity (Piette et al., 2010). These possible factors
could have impacted this current study outcome resulting in failing to reject the null
hypotheses in all research questions and to explain any differences among the educational
methods.
In summary, the covariates of this study are explained including gender, chronic
illness, age group, and week participation and described as to how these variables could
have influenced this study outcome. The limitations of this study are discussed in the
next section.
Limitations of this Study
This single-blind randomized controlled study was designed to assess the
effectiveness of using four different educational methods to enhance medication
adherence with chronic illnesses by increasing knowledge, self-efficacy, and change in
health beliefs among African Americans between the ages of 18 to 65 years, who live in a
southwest neighborhood of Chicago. In this way, the study was limited to only a small
population of African Americans who live in this neighborhood and did not include other
African Americans who live very close to this neighborhood, are diagnosed with the
same health problems, and could have benefitted through this educational program. In
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this study, the African American population was chosen very specifically because of their
vulnerability of getting chronic illnesses at a much higher rate when compared with other
ethnic groups; in addition, they suffer with poor health (Ogedegbe et al., 2007; Coulter &
Ellins, 2007) and are less like to adhere to prescribed treatments and self-care plans
(Bandura, 2004; Schectman et al., 2002).
In this study, only a small group of African Americans were included. The study
was limited to other racial and ethnic groups who may be diagnosed with and are taking
medications for the same chronic illnesses and who also would have been benefitted from
this educational program. The inclusion criteria for this study were clearly spelled out in
that only African Americans, who live in the southwest neighborhood of Chicago, would
be selected for this study. For this reason, other racial and ethnic groups were limited to
this study.
Several other factors may have contributed to these limitations of this study. It
was hypothesized that though these four different educational methods, there would be an
increase in knowledge, self-efficacy, and change in health beliefs on medication
adherence and that it would be demonstrated through the statistical analysis method. On
the contrary, three research questions failed to reject the null hypothesis, which means
that the study participants did not understand the questionnaires. In spite of their ability
to provide their written consent, the study participants possibly did not understand or
comprehend the meanings of questionnaires and therefore the instruments might have
been filled out erroneously. This is a limitation in this study in that the researcher
assumed that the study participants have understood the questionnaires because they were
able to provide consent with clarity and spoke with comprehension and never had
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expressed their difficulties in comprehension with the questionnaires. All the study
participants’ educational level was less than high school, but in this study health literacy
was not intended for study.
Another potential factor could have been the life circumstances that these study
participants face daily in their neighborhoods such as intimidation and irrational gun
violence (reported in the Chicago Tribune, September 19, 2013), which could have an
effect on this study in that they were afraid to participate in the study in a leisurely
manner, and many, who promised to participate in the study, did not participate.
The other factors such as socioeconomic factors, lack of family and social support
systems, the use of tobacco, and recreational drugs and alcohol (Hill et al., 2010), social
isolation (Russell, 2006), and low health literacy (Kripalani et al., 2007; Ho, Bryson, &
Rumsfeld, 2009) could have an impact on this is three research questions. Also, these
variables were not the focus of this study, but could have indirectly affected the study
outcome.
Gamble (1997) expressed that African Americans are always afraid to participate
in any health-related study because of their past experiences with research work. This
scholar’s suggestion may have a credible truth in that these past experiences may
continue to act as a barrier for any future studies with African Americans (Gamble,
1997).
In summary, this study recognizes the limitations including that this study
specifically included only African Americans who live in a southwest neighborhood of
Chicago and who attend Step of Faith Ministry Activities. We were unable to recruit
other African Americans and other ethnic groups because of the study’s set limitations
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with the inclusion and exclusion criteria. This study focused on assessing the four
different educational methods to enhance medication adherence among African
Americans who live in a southwest neighborhood of Chicago and who are diagnosed with
and are taking medications for hypertension, hyperlipidemia, diabetes, asthma, and
COPD. Several other factors including low literacy, poor numerical skills, environmental
and neighborhood factors, lack of family and social support, economic factors, and
persistent fear resulted from past history could have had an indirect impact on this study,
even though these variables were not a part of this study. Based on these study
limitations, recommendations are suggested in the next section.
Recommendations
Increase Sample Size
Perhaps the major limitation of this study is that it relied on a small group of
English-speaking African Americans within a distinct geographical location in Chicago
when a larger population of African Americans from nearby neighborhoods could have
been included in this study. This limitation can have an effect on external validity in this
study. Therefore, it is recommended that this study be replicated by including a larger
population drawn from the neighborhoods of Chicago. It would be an added benefit to
assess by comparing African Americans living with chronic illnesses in other
geographical locations such as living in different counties in Illinois and other states such
as New York, Washington DC, California, Texas, Atlanta, and Pennsylvania because
sampling from a larger population could not only guarantee a large subject pool, but also
may yield further knowledge about medication adherence behavior with chronic illnesses
with different regions in the United States.
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Include Various Ethnic Groups
While this study included only a small group of African Americans to examine
the effectiveness of using four different educational methods to enhance medication
adherence with chronic illnesses, it may be an added benefit to research itself when other
non-English-speaking ethnic groups are included in the study employing the same
validated tools to determine their specific issues related to their adherence behavior. For
example, immigrants from Spanish-speaking regions and other languages spoken by
Asian countries are also at risk for not only suffering with diabetes and hypertension, but
the consequences that they face because of chronic illnesses. To replicate this study with
non-English-speaking groups, the tools have to be translated in their own languages, and
when they are employed in their languages, it is possible that they may yield a full range
of information about their medication adherence behavior in that it may lend richness to
the research itself. In Malaysia, the Morisky Medication Adherence Scale (MMAS-8)
was translated into the Malay native’s spoken language using forward and backward
translation procedures (Al-Qazaz et al., 2010). In this way, these validated tools can be
translated into people’s spoken languages in order to increase their understanding and
comprehension of this particular human behavior.
Replicate Using Mixed Research Methodology
Employing mixed research methodology while replicating the study using the
same tools may be an added benefit to research methods that allow the researcher to
understand this particular human behavior with a renewed perspective. Mixed Research
Methodology will allow the researcher to use both quantitative and qualitative research
methods. By employing both research methods, the researcher will be able to gather
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detailed information on medication adherent behavior through qualitative study,
collecting information in a systematic way through the quantitative study and blending
those responses from both research methods to yield a meaningful response, which will
ultimately provide an increased understanding of this medication adherent behavior.
Include These Tools As A Part Of Regular Health Records
These three tools could be added as part of the regular history and physical health
record. While people wait to see their healthcare providers, these tools could be
administered in the waiting area through the nurses and medical assistants, and could be
administered in the waiting area by the nurses and medical assistants, and keep them
ready for the healthcare provider that will allow the provider to give valuable counseling
and positive reinforcements accordingly on medication adherents behavior.
Summary
In summary, this present study could be replicated by using the same educational
methods and the validated tools. To gain a meaningful understanding of this particular
medication adherent behavior, increase the sample size of the population to be studied,
provide opportunities to non-English-speaking members by translating those tools in their
spoken languages, include people from different neighborhoods, employ mixed research
methodology, and make recommendations to public health and health sciences
organizations in that these validated tools become part of the health records, and it can be
administered to people while waiting to see their healthcare provider. This will allow the
healthcare providers to bring social change in medication adherent behavior through
positive reinforcement and counseling.
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Implications for Positive Social Change
This study aimed at bringing a positive social change in medication adherence
behavior with chronic illnesses: hypertension, hyperlipidemia, diabetes, asthma, and
COPD. The treatment of chronic illnesses often requires long-term use of
pharmacotheraphy. Haynes and colleagues (2002) have explained that increasing the
effectiveness of adherence interventions will have a far greater impact on the health of
the people than any improvement in specific medical treatment (Haynes et al., 2002). For
this reason, it is pertinent and imperative to use various educational methods to increase
knowledge and self-efficacy and change in health beliefs, thus aiming at inducing a
behavioral change with medication adherence. It is also the responsibility of the
agencies, who develop, promote and implement the policies pertaining to health
promotion with chronic illnesses, to take into consideration the lifestyle of the vulnerable
population and their educational and socioeconomic standards because poverty and low
health literacy have a direct impact on chronic illnesses.
For example, people with low health literacy could impose many challenges on
healthcare providers, especially when they are unable to read and understand the
medication labels and are thus unable to follow the medications that will result in nonadherence. These challenges include expressing disbelief, doubts about medications, and
fears of side effects of medications. The policies, related to health promotion with
chronic illnesses, consider these patients’ factors and address the short and long-term
goals, especially for people with low literacy aiming at controlling chronic illnesses,
thereby reducing morbidity and mortality, promoting quality of life, and reducing
healthcare costs.
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The short-term goals are to include clear explanations on medications in a
patient’s spoken languages with clear instructions to allay the fear about side effects of
medications. The long-term goals are to include techniques such as home monitoring of
blood sugar, using inhalers with proper techniques that will lead to gaining confidence in
self-management of their illnesses through gaining knowledge on health risks and
benefits, increasing confidence in self-management, and changing their health beliefs.
The short-term goals are to function as guiding principles for daily action, whereas the
long-term goals are to bring a social change in the self-management of chronic illnesses
that will result in improving quality of life through enhanced medication adherence and a
reduction in the national healthcare costs.
Furthermore, the health policies aimed at community health promotion need to
include the health needs of the aging population. In this present study among the study
participants, the highest age group was 55 to 65 years old. Quite often, the healthcare
providers have a tendency to believe that older people with multiple comorbidities will
show more adherence to their prescribed medications than the younger age group. Many
scholars have refuted this assumption explaining that non-adherence is a pervasive
problem and it is prevalent among all age groups (Bandura, 2004; Simpson, 2006; Gatti
et al., 2009). It is pertinent and imperative to develop non-discriminatory policies related
to health promotion so that all age and ethnic groups, in the community, could be
engaged in health promotion on medication adherence with chronic illnesses.
In addition, there should be validated tools to measure the outcome of health
promotion with chronic illnesses. Policies that are developed without tools to measure
the outcome may not be very effective in health promotion. Policymakers must realize
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that better community health becomes that national wealth; therefore, it is necessary to
allocate necessary funds and set the highest standards while measuring the outcome of
health promotion and the healthcare providers must strive to attain this highest standard
without ambiguity. Measuring the outcomes will allow patients to develop and practice
better educational methods to enhance medication adherence, to improve selfmanagement techniques and quality of life, and thus reduce the healthcare cost.
Traditionally, health promotion takes place at the bedside with an individual
patient or in a small group in clinical-based settings. Health promotion in small settings
may be of use only for a small group of people, but health promotion that takes place in
the communities may have a greater impact on the community’s health, especially when
community leaders, church leaders, community social workers, and other volunteers from
the community are included and involved in health promotional activities. In addition,
the effectiveness of health promotion will be far greater than the health promotion that
takes place in small clinical settings. In addition, the available community resources
could be pulled together and be utilized for health promotion. For example, using a
church basement to conduct a community awareness program on chronic illnesses such as
hypertension, stroke prevention, smoking cessation, control of diabetes, and awareness of
allergies could become very valuable to the members of the community when ageappropriate educational materials are used. In this study, the members of Step of Faith
Ministries became actively involved and served as volunteers and assisted in this entire
program and they live in the same community. In this way, the available resources
within the communities could be utilized to promote health promotion.
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Another scope of practice is that health promotion needs to focus on healthcare
providers, physicians, non-physician healthcare providers, nurses, social workers, and
nutritional support groups and they have to be included and engaged in health
promotional activities, especially on medications, dietary adherence, and selfmanagement of their illnesses. Controlling chronic illnesses requires a multi-disciplinary
approach and these healthcare providers have to be informed adequately in that
individuals have their own mindset and that behavioral change takes its own course.
Scholar Bandura (2004) explained that health habits are not changed by an act of will
(Bandura, 2004). For this reason, healthcare providers must strive to bring the best out an
individual through education and positive reinforcement that will lead to behavioral
change with self-efficacy.
In summary, social change with chronic illnesses depends greatly on the
individuals, healthcare providers, policymakers, and the community leaders. Social
change with medication adherence is no panacea for individuals who have multiple
comorbidities and are on multiple medications. Poor medication adherence or nonadherence is a pervasive behavior of age groups of all ethnicities. This study was done
only with African Americans with hypertension, hyperlipidemia, diabetes, asthma, and
COPD, and who live in a southwest community of Chicago. The purpose of this study
was to assess the effectiveness of using four different educational methods by increasing
knowledge, self-efficacy, and change in health beliefs. Even though this study was done
using only African Americans, the concept of social change with medication adherence is
applied to all peoples who take medications for chronic illnesses. It requires a multidisciplinary approach with short-term and long-term goals. Knowledge and self-efficacy
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are the foundations to cause change in health beliefs, resulting in behavioral change, and
ultimately leading to a reduction in morbidity and mortality, the improvement of quality
of life, and a reduction in healthcare costs.
Conclusion
Medication adherence is a complex human behavior. Many scholars have
explained through their empirical findings that medication non-adherence has become a
major public health problem resulting in increased healthcare costs, especially when
taking care of chronic illnesses. The same scholars have argued that there are many
determinants: individual, social, environmental, healthcare system, healthcare providers,
and healthcare laws and regulations. All of these are possible reasons for this nonadherent behavior. Furthermore, there are challenges that act as impediments: low health
literacy, low numerical skills, knowledge deficit on health matters, inadequate selfefficacy, beliefs about medications, and lack of trust in the current healthcare system.
For this reason, this present randomized controlled trial was focused on assessing
the effectiveness of using four different educational methods to enhance medication
adherence among African Americans who live in a southwest community of Chicago and
who were diagnosed with and prescribed medications for chronic illnesses. Education is
a powerful tool to bring transformation in any individual. In the same way, health
promotion with various educational methods is pivotal to bring a social change in the
entire healthcare of people, especially in the management of chronic illnesses, knowledge
and self-efficacy are to be infused when conducting health promotion with a hope of
bringing a change in health beliefs that will result in social change in individuals, groups,
and communities.
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In addition, the same type of educational program must be extended to other
different ethnic minorities whose spoken language would be other than English because
they too can be benefitted from similar educational programs when it is offered in their
spoken languages. Unfortunately, medication non-adherence is a pervasive societal
problem in which public health has much responsibility to bring this situation under
control through educational programs. According to the customs and beliefs, these
communities cluster together for any common good among themselves and health
promotion can be introduced into these communities and when it is conducted with
cultural sensitivity, the educational program itself becomes more vibrant and lively and
brings a social change in these communities. It is necessary that policies and health
educational programs, pertaining to various communities, understand and incorporate the
issues related to their culture and customs. In this way, the health educational programs
become successful among the communities with a great expectation of social change in
medication adherence.
Final Message
A nation’s health and wellness greatly depends on community health and it can be
achieved through education. Social change takes place when individuals and
communities act responsibly. Education is the powerful tool for transformation of
individuals, communities, and the nation.
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Appendix A
Randomized Controlled Pre-test/Post-test Design
Recruitment

N-144

Randomization

Experimental Group
n = 72

Control Group
n = 72

Health Promotion Schedule
Pre-test/Post-test
Pamphlets on Hypertension
Medication

Week 1
Hypertension
Medication

Pre-test/Post-test
Cholesterol Pamphlets

Week 2
High Cholesterol
Medication
Week 3
Diabetes Oral
Medications
Week 4
Diabetes Insulin
Medications
Week 5
Medication Review
Weeks 1 to 4
Week 6
Asthma Medications

Pre-test/Post-test
Lecture, and Video on
Hypertension Medications

Pre-test/Post-test
Lecture, Video & Group
Disc- Cholesterol Medican.
Pre-test/Post-test
Pre-test/Post-test
Diabetes Medications
Lecture, Video, Gr. Disc
Pamphlets
Diabetic Medications
Pre-test/Post-test
Pre-test/Post-test
Insulin Medication
Lecture, Gr. Discussion
Pamphlets
Insulin Medications
Pre-test/Post-test review
Pre-test/Post-test
Of Pamphlets of weeks 1
Lecture & Role Playing on
to 4
Weeks 1 to 4
Pre-test/Post-test
Pre-test/Post-test
Asthma Medications
Lecture & Video on
Pamphlets
Asthma Medications
Pre-test/Post-test
Week 7
Pre-test/Post-test
COPD Medications
COPD Medications
Lecture & Video on
Pamphlets
Diabetic Medications
Pre-test/Post-test
Week 8
Pre-test/Post-test
Asthma, and COPD
Review of COPD, and
Lecture & Role playing on
Pamphlets
Asthma Medications
Weeks 6, and 7
The control group that received only pamphlets in this 8-week study will now receive a
lecture, video presentation, group discussion, and a role play session on these subjects.
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Appendix B
I, Dieltroe Ford, give my permission, and will cooperate with Prema David for the
study of African Americans. Thank you.

From: prema david <pdavid1948a@yahoo.com>
To: "dieltroeford@yahoo.com" <dieltroeford@yahoo.com>
Sent: Friday, October 28, 2011 5:45 PM
Subject: letter

8/13/2011
From:
Prema David, MSN, NP-BC, AANP
Doctoral Student in Health Sciences, and Health Promotion
Walden University
To:
Mrs. Dieltroe Ford
Pastor/Evangelist of Step of Faith Ministries
Elim Christian Church
2735 W. 79th St.
Chicago, IL 60652
Dear Pastor,
I am a doctoral student at Walden University. My field of specialty is Health
Sciences, and Health Promotion. My topic of interest is to educate African
Americans on medication adherence with chronic illnesses that include
hypertension, high cholesterol, diabetes, asthma, and COPD through educational
methods of lectures, video presentations, role plays, and group discussions. The
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main purpose of this study is to assess the effectiveness of these educational
methods in promoting medication adherence.
Participation in the study is voluntary. The study participants, who remain in this
for eight-week educational program, will receive twenty-five dollars. I would truly
appreciate it if you would allow me to conduct my study at your church facility, and I
need your cooperation, and permission.
The study time will be planned, depending on permission from the school, as well as
giving consideration to extreme winter weather.
Thanking you
Prema David
Email: pdavid1948a@yahoo.com
(H) Phone: (847) 676-1534
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Thanks so much Prema for your kind words, and I wish you the very best of success
on your dissertation...I received your fax, and thanks...
dmorisky
On Today 5:21 PM, pdavid1948a@yahoo.com wrote:
Dear Dr. Morisky,
Thank you for sending all those articles. I owe you a debt of gratitude, and it will
be shown in my actions. I sent the agreement by fax yesterday 8/31/2011.
Thanking you
I'm so grateful
Prema
From: DONALD E MORISKY <dmorisky@ucla.edu>
To: "pdavid1948a@yahoo.com" <pdavid1948a@yahoo.com>
Sent: Wednesday, August 31, 2011 7:49 PM
Subject: Re: letter to Dr. Morisky

Here it is Ms. David, and sorry for not attaching it previously.
dmorisky
On Today 5:44 PM, pdavid1948a@yahoo.com wrote:
Dear Dr. Morisky,
I sincerely want to thank you for all the efforts that you have taken in sending the
articles. I could not find the waiver of license, and copyright agreement form along
with these articles. If you send me the form, I would definitely agree to adhere to
the copyright laws, cite your research wherever needed, and to provide your with a
brief summary of my findings upon completion of the study.
Thanking you very much,
Sincerely,
Prema David
From: Donald E. Morisky <dmorisky@uclaedu>
To: prema david <pdavid1948a@yahoo.com>
Sent: Tuesday, August 30, 2011 5:46 PM
Subject: Re: letter to Dr. Morisky
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Thank you very much Prema for your interest in our adherence scales, and
your request to use the copyrighted MMAS-8. I presume that you are
referring to the most recent adherence measure, the MMAS-8.
The scale is a generic assessment of medication-taking behavior, and has
been used in a number of health conditions, both chronic, and infectious
diseases. It is a reliable, and valid indicator to assess self
reported medication-taking behavior, including several levels of
criterion related validity (blood pressure control, HgA1c) discriminant
validity (social desirability), and persistence using pharmacy fills as a
criterion. The scale is not in the public domain, and should not be
on the internet without my permission, and can only be used through
issuance of a license agreement through the owner/developer. This
is the only way the integrity of the scale can be maintained, as you will
note so many "modified" versions being published.

Since you are a student at Walton
University, conducting
adherence research, I have put together a waiver of license, and copyright
agreement form for you to fill out, and sign, and return to me. My
only request is that you adhere to the copyright laws, cite our research
and provide me with a brief summary of your findings upon completion of
your study. I trust that you will abide with these simple
guidelines in using the scale, and thank you for your interest. I
have also attached recent articles that you can use in your background
citing additional levels of criterion-related validity of the
MMAS-8. I wish you the best of success on your psychometric course
and adherence research. I have attached several articles which
provide a historical overview of the development of the MMAS from its
original Morisky, Green, and Levine scale to the MMAS-4 to its current
MMAS-8. I also attached an article that uses the MMAS-8 for IBD
assessment. I hope you find these articles informative. I would
appreciate your thoughts.....

Sincerely,

Dmorisky

Donald E. Morisky,
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Sc.D., M.S.P.H., Sc.M.
Professor, and Program Director, Doctoral Training in the Social, and
Behavioral Determinants of HIV/AIDS Prevention
Department of Community Health Sciences
UCLA School of Public Health
650 Charles E. Young Drive South
Box 951772
46-071 CHS
Los Angeles, CA 90095-1772

email: dmorisky@ucla.edu
Phone: (310) 825-8508
Fax: (310) 794-1805At 09:54 AM 8/13/2011,
prema david wrote:

Dear Dr. Morisky,
Here is the letter that you asked for.

Sincerely

Prema David
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Dr. Risser conducted this work as one of my students. You have my permission to use
the instrument.
Thanks,
Sunil
From: prema david [mailto:pdavid1948a@yahoo.com]
Sent: Thursday, August 11, 2011 6:05 PM
To: Kripalani, Sunil
Subject: request for permission
Dear Dr Kripalani,
My name is Prema David, and I am a current Doctoral student at Walden University. I am specializing in
Health Sciences, and Health Promotion , and Public Health. My interest is to promote medication
adherence with chronic illnessess with inner-city African American Poulation in Chicago. I need your
permission to use SEAMS self efficacy scale for my study on medication adherence. I sent an e-mail to Dr
Jessica Risser, MD, MPH 2 days ago, and I did not get any reply from her. My mentor advised me to
contact you, and obtain permission so that I can prepare my teaching materials for my dissertation. My
dissertation topic is assessing the efectiveness of using different educational methods to promote
medication adherence with African Ametricans with chronic illnessess. I would appreciate your help
regarding this matter. Also, I should keep a copy of your permission with my final copy of my dissertation.
I can be reached at 847-676-1534. e-mail pdavid1948a@yahoo.com.
Thanking you,
Prema David MSN, NP-BC,AANP.

Yes, this is fine. Do you need something back from me in writing (besides this email)?
Thanks,
Sunil
From: prema david [mailto:pdavid1948a@yahoo.com]
Sent: Saturday, August 13, 2011 11:08 AM
To: Kripalani, Sunil
Subject: request
Dear Dr. Kripalani,
Here is the attachment for your permission.
Thank you
Prema David

August 15, 2011
RE: Use of SEAMS instrument
Dear Prema,
Thank you for your interest in using the instrument, Self-Efficacy for Appropriate Medication
Use
(SEAMS). You may use the instrument in your dissertation work, at no cost. Please cite the
article which
describes the scale’s development, and psychometric testing.
Sincerely,
Sunil Kripalani, MD, MSc
Associate Professor
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Chief, Section of Hospital Medicine
Vanderbilt University
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Dear Prema
Thank you for your email which Prof. Horne has forwarded to me, and apologies for the
delay in replying to you but we have had a few days holiday here this last week.
Thank for your interest in the BMQ in your research project. We ask all potential users to
sign up to our standard conditions for use of the questionnaire.
These conditions are found on the attached form. They are not designed to restrict your
research with the questionnaire or your rights to publish your findings. Rather, they are
designed to:
− Preserve the integrity of the questionnaire
− Promote uniformity of analysis, and presentation (to facilitate comparison of
findings across studies)
− Ensure that you are using a valid, and up-to date version of any disease
specific BMQ
If you agree to these conditions then please arrange for the Principal Investigator on
your study to sign the form, and return it by fax or email. Permission to use the
questionnaire is automatic on receipt on the signed form.
With regard to the psychometric paper I have attached the BMQ (1999) paper but this is
all Professor Horne has at the moment as he is currently compiling data from other
studies but this data is not ready yet.
I have also attached some guides to using the BMQ but please let me know if you
require further information.
Kind regards
Penny
Penny Reed
Research Administrator
Centre for Behavioural Medicine
School of Pharmacy
University of London
BMA/Tavistock House
Tavistock Square
London WC1H 9JP
Tel: +44 (0)20 7874 1281
Fax:+ 44 (0)20 7387 5693
Email: penny.reed@pharmacy.ac.uk
Find us at: http://www.pharmacy.ac.uk/fileadmin/documents/Practice_and_Policy/dppMap.pdf

226

From: prema david [mailto:pdavid1948a@yahoo.com]
Sent: 25 August 2011 03:01
To: Rob Horne
Subject: electronic request
From,
Prema David
8151 N Tripp, Skokie, Illinois. 60076-3249
USA
To,
Professor Rob Horne
Professor of Behavioural Medicine,
Director of Centre for Behavioural Medicine,
The School of Pharmacy, University of London
Sir,
My name is Prema David. I am a doctoral student at Walden University majoring Health Sciences, and
Health Promotion. I am currently writing my dissertation on medication adherence with chronic illnessess in
African American Population in Chicago, Il, USA. I would like to use the BMQ Scale-18 that you had
developed, and validated. I need your permission to use this scale. Also, I would like to have the
Psychometric property of this scale. I would be very grateful to you if you could kindly consider my request
very urgent, and send me your permission, and the Psychometric property of the scale.
I can be reached by e-mail at pdavid1948a@yahoo.com. My home phone no 001-847-676-1534
Thanking you,
sincerely,
Prema David
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Appendix C
Morisky Medication Adherence Scale (MMAS-8-Item). This is a generic adherence scale and
the name of the health concern can be substituted in each question item.
You indicated that you are taking medication(s) for your (identify health concern, such as “high
blood pressure”). Individuals have identified several issues regarding their medication-taking
behavior, and we are interested in your experiences. There is no right or wrong answer. Please
answer each question based on your personal experience with your [health concern] medication.
(Please circle the correct number)
Yes = 1 No = 0
1.) Do you sometimes forget to take your [health concern]
medication(s)?
2.) People sometimes miss taking their medications for reasons
other than forgetting. Thinking over the past two weeks,
were there any days when you did not take your [health
concern] medication(s)?
3.) Have you ever cut back or stopped taking your medication(s)
without telling your doctor, because you felt worse when you
took it?
4.) When you travel or leave home, do you sometimes forget to
bring along your [health concern] medication(s)?
5.) Did you take your [health concern] medication(s) yesterday?
6.) When you feel like your [health concern] is under control, do
you sometimes stop taking your medication(s)?
7.) Taking medication(s) every day is a real inconvenience for
some people. Do you ever feel hassled about sticking to your
[health concern] treatment plan?
8.) How often do you have difficulty remembering to take all
your medication(s)?

(Please circle the correct number)
Never/Rarely……………………………………....4
Once in a while……………………………………3
Sometimes…………………………………………2
Usually……………………………………………..1
All the time………………………………………...0
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Coding Instructions for the ©Morisky Medication Adherence
Scale (8-Item)
You will need to reverse the code response in a positive direction for
item number 5, and standardize the code for item 8 (0-4), resulting in a
scale from low adherence to high adherence. Item 8 is divided by 4
when calculating a summated score. This procedure standardizes the 5point Likert scale. The total scale has a range of 0 to 8.0. The eight-item
compliance scale had an alpha reliability of 0.83 (n= 1367) among
patients diagnosed with essential hypertension attending an outpatient
clinic of a large teaching hospital. We have used a 75 percent
completion criterion for establishing eligibility. The median value of all
missing items would be substituted for the missing item for individuals
meeting the eligibility criterion.
Re-codes:
If Item5 = 0 Item5r = 1 (high adherence)
If Item8=4 Item8r = 1 (highest adherence)
If Item8=3 Item8r = .75 (high adherence)
If Item8=2 Item8r = .50 (moderate adherence)
If Item8=1 Item8r = .25 (low adherence)
If Item8=0 Item8r = 0 (lowest adherence)

Adherence Level
Low Adherence (< 6)
Medium Adherence (6 to <8)
High Adherence (= 8)

percent
32.1
52.0
15.9

Chapter 1 Required citation, and footnote for the 8-item MMAS are as follows:
Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive Validity of a Medication
Adherence Measure for Hypertension Control. Journal of Clinical Hypertension 2008;
10(5):348-354.
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This footnote is required on all tables or figures which present the ©MMAS-8.
Use of the ©MMAS is protected by US copyright laws. Permission for use is
required. A license agreement is available from: Donald E. Morisky, ScD, ScM,
MSPH, Professor, Department of Community Health Sciences, UCLA School of
Public Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.
Additional citation you may use to document criterion-related validity with
pharmacy fills
Krousel-Wood MA, Islam T, Webber LS, Morisky DE, Muntner P. Concordance of SelfReported Medication Adherence by Pharmacy Fill in Patients with Hypertension.
Am J Managed Care 2009; 15(1):59-66.
Al-Qazaz HK, Hassali MA, Shafie AA, Sundram S, Morisky DE. The Eight-Item
Morisky Medication Adherence Scale (MMAS-08):Translation, and Validation
of the Malaysian version. Diabetes Research
and Clinical Practice 2010; 90:216-221.
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COPYRIGHT, and Licensure Fee Agreement for use of the Morisky Medication
Adherence Scale, MMAS-4, and MMAS-8
All translations, adaptations, computer programs, and scoring algorithms, and
any other related documents of the Morisky Medication Adherence Scale
(MMAS 4-, and MMAS-8 item versions), or Morisky Adherence Questionnaire
(MAQ 4-item version) are owned, and copyrighted by, and the intellectual
property of, Donald E. Morisky, ScD, ScM, MSPH. Professor of Community
Health Sciences, UCLA School of Public Health, Los Angeles, CA 90095-1772.
Copyright protection is also extended to electronic versions of all Morisky
Scale documents, and products. Permission will be granted to translate the
MMAS scale, however all translations must be conducted by the Mapi Institute.
Languages that have already been translated, and validated by the Mapi
Institute can be requested through the Mapi Trust. The Mapi Institute
employs the most rigorous standards in the translation process consisting of
two native linguistic experts who independently conduct forward, and
backwards translation. The developer of the instrument is integrally involved
in the construct validation of each item in the scale, before final approval of
the translated scale is provided.
Permission to use the scale is granted through a licensure agreement between
the owner, and licensee.
1) No changes to the wording or phrasing of any Morisky Scale document
can occur without written permission. If any changes are made to the
wording or phrasing of any MMAS item without permission, the
document cannot be considered the MMAS, and subsequent analyses,
and/or comparisons to other MMAS data will not be considered
appropriate. 2) The specific coding, and scoring criteria of the MMAS-8
cannot be divulged in any publication or external report without prior
permission from the owner; 3) Permission to use the name "MORISKY
SCALE" or MMAS will not be granted for any unauthorized use or
translations of the MORISKY SCALE or MORISKY SCALE items. Any
analyses or publications of unauthorized changes or translated
versions may not use the MORISKY SCALE name. Any unauthorized
translation will be considered a violation of copyright protection. If you
are interested in translating this scale, please notify me, and I will
advise you regarding the requirements for translation 4) The MORISKY
SCALE copyright information provided on these documents must be
included on every page of a MORISKY SCALE questionnaire in study
documents, and in any reproductions for manuscript or other
publication purposes. 5) If there are issues of scientific or copyright
misconduct in using the MORISKY SCALE system of questionnaires, Dr.
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Morisky reserves the right to withdraw permission for use, and seek
damages to the full extent provided by international copyright law.
I understand that the licensure fee for use of the copyrighted MMAS-8
will be waived, as I am a student conducting adherence research. The
license agreement is in effect for a two-year period or the duration of
the study, whichever is shorter. I agree with the specification outlined
above regarding the use of the Morisky Medication Adherence Scale, 8Items, MMAS-8, and will abide with its requirements. I agree to provide
results of my research to Professor Morisky upon completion of the
study. Please fax or scan, and email to: Donald E. Morisky, ScD, ScM,
MSPH, Professor, Department of Community Health Sciences, UCLA
School of Public Health, 650 Charles E. Young Drive South, Los Angeles,
CA 90095-1772, fax 310-794-1805.
Name, and contact information of Licensee: Prema David, Email:
pdavid1948a@yahoo.com, (H) Phone: (847) 676-1534
Title of Research:
8/30/2011
Signature of researcher

Date:
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Appendix D
SEAMS Questionnaire
Number

Questions

1

When you take several different
medicines each day?
When you take medicines more
than once a day?
When you are away from home?
When you have a busy day
planned?
When they cause some side effects?
When no one reminds you to take
the medicine?
When the schedule to take the
medicine is not convenient?
When your normal routine gets
messed up?
When you are not sure how to take
the medicine?
When you are not sure what time of
the day to take your medicine?
When you are feeling sick (like
have a cold or the flu)?
When you get a refill of your old
medicines, and some of the pills
look different than usual?
When a doctor changes your
medicines, how confident are you
that you can carry out the following
tasks?

2
3
4
5
6
7
8
9
10
11
12

13

Not
Somewhat
Confident Confident

Very
Confident

Grading Method:
Very Confident = 3 points
Somewhat Confident = 2 points
Not Confident = 1 point
Risser, J., Jacobson, T. A., & Kripalani, S. (2007). Development, and Psychometric
Evaluation of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) in LowLiteracy Patients with Chronic Disease. Journal of Nursing Measurement, 15(3), 203219
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Appendix E
Table: 1 Themes underpinning common beliefs about as presented in the Beliefs about
Medicines Questionnaire (BMQ)

Ref Horne, R (2000) Assessing perceptions of medication: psychological perspectives In
Handbook of Drug
Research Methodology Publ UK Drug Utilization Research Group ISBN 0 9537011 07

BMQ-SPECIFIC NECESSITY (Assesses patients’ beliefs about their prescribed
medicines)
Strongly
Agree
Uncertain
Disagree Strongly
Specific Necessity
Agree
Disagree
(Beliefs about necessity
and efficacy of medicines
prescribed for specific
condition.)
My health in the future
will depend on my
medicines
My health, at present,
depends on my medicines
My life would be
impossible without my
medicines
Without my medicines I
would be very ill
My medicines protect me
from becoming worse
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BMQ-SPECIFIC CONCERNS
Strongly
Specific-Concerns (Concerns
Agree
about the harmful effects of
medicines prescribed for specific
conditions)
Having to take my medicines
worries me
I sometimes worry about the longterm effects of my medicines
I sometimes worry about becoming
too dependent on my medications
My medicines are a mystery to me
My medicines disrupt my life

Agree Uncertain Disagree Strongly
Disagree

BMQ-GENERAL OVERUSE (Assessed general beliefs about medicines as a whole)
Strongly Agree Uncertain Disagree Strongly
General-Overuse (Beliefs
Disagree
that medicines in general are Agree
overused by doctors)
If doctors had more time with
patients they would prescribe
fewer medicines
Doctors use too many
medicines
Doctors place too much trust
on medicines
Natural remedies are safer than
medicines

BMQ-GENERAL HARM
Strongly
General-Harm (Beliefs that
medicines in general are harmful Agree
addictive poisons)
Most medicines are addictive
Medicine do more harm than good
People, who take medicines,
should stop their treatment for a
while, every now and then
All medicines are like poisons

Agree Uncertain Disagree Strongly
Disagree
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Informed Consent Form
Consent for Participation in Research
Field: To evaluate educational methods on medications with chronic illnesses
This is a research study. Prema David, a nurse practitioner at John Stroger, Jr.
Hospital of Cook County and a doctoral student at Walden University, developed this
study. This research study only includes African Americans between the ages of 18
to 65 years old and the ones who are already taking medications for any one of the
chronic illnesses such as high blood pressure, high cholesterol, diabetes, asthma,
and COPD. Your participation is entirely voluntary and you may leave the study at
any time without any penalty. Please take your time to make a decision.
Why only African Americans?
Many scholars have explained through their studies that chronic illnesses, such as
high blood pressure, high cholesterol, diabetes, asthma, and COPD, are prevalent at
an increased rate among African Americans when compared with other ethnic
groups. Also, there is a racial disparity that there is an increased morbidity and
mortality because of these chronic illnesses among African Americans, resulting in
poor quality of life.
Why is this study being done?
The purpose of this research is to evaluate educational methods used to teach on
medications with high blood pressure, high cholesterol, diabetes, asthma, and COPD
in order to increase knowledge and self-confidence to take medications, resulting in
an improved quality of life. Your evaluation on educational methods in this research
study will help improve our teaching strategies on medications with chronic
illnesses and also help research student Prema David to accomplish her dissertation
requirement.
What are the study inclusion criteria?
1.) African Americans, both men and women
2.) Age: 18 to 65
3.) Taking medications for any one of these conditions: high blood pressure, high
cholesterol, diabetes, asthma, and COPD
4.) Willing to provide a written consent
5.) Attend to Step of Faith Ministries
6.) Live in the Southwest Community
They need not to be a member of the church or Step of Faith Ministries
What is involved in the study?
The study involves testing the educational methods by using Pretest/Posttest with a
set of questionnaires. A total number of 142 to 144 people, who are willing to
participate in this research study, will be divided into two groups through a
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procedure called randomization. Randomization means that you are placed into a
group by chance. It is like flipping a coin. One group is called Green color group and
the other group is called Red color group. The group, which you are assigned to, will
be decided by a computer. Neither researcher nor the study participants will choose
what group you will be in. Every study participant will have an equal chance of
being placed in either group and all of you will evaluate educational methods.
In both groups, you will be asked to mark a set of questionnaires as Pretest and
Posttest. Pretest will be done before beginning of the class and you will return those
answers to volunteers. At the end of the class, you will complete the posttest and
return them to the volunteers. Both groups will do the same Pretest/Posttest
questionnaires for each class for eight weeks.
How long does the study last?
This research study will take place for 1 hour, weekly once on Friday evenings from
6PM to 7PM for eight weeks. You are allowed to leave the study at any time without
any penalty.
What are the risks of the study?
The risk is very low in that you may give 1 hour on Friday evenings for 8 weeks to
come to Elim Christian Church, the place where the study will take place.
Are there benefits to taking part in the study?
You may learn something new about medications, their usefulness, and they can
improve your health. In addition, the information that you gain through these
classes can be shared with your family members. Furthermore, you will be able to
increase your knowledge and confidence in taking medications, even in difficult
situations. You may gain new friends by attending this study program. You will
receive educational pamphlets to take home.
What Other Treatment Options are there?
This is a research study about measuring the usefulness of educational methods on
medications with high blood pressure, high cholesterol, diabetes, asthma, and COPD
and does not involve treatment or therapy. The alternative is not to participate.
What about confidentiality?
Every effort will be made to keep your information confidential. There will be
symbols and characters on the Pretest/Posttest questionnaire face sheet. The
symbols such as a blood pressure cuff indicates high blood pressure, a picture of a
narrowed artery indicates high cholesterol, a picture of a sugar cane indicates
diabetes, an inhaler picture indicates asthma, and a round disk indicates COPD; the
mark gender “x” character indicates male gender and “y” character indicates female
gender. The age group will be marked in range as 18-35, 36-45, 46-55, and 56-65.
The pretest/posttest will have code numbers. You will not write your name,
diagnosis, and your age. These symbols, characters, age ranges, and code numbers
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are necessary to protect your information and to keep it confidential. You will be
asked to mark these symbols, characters, and age range on the face sheet of the
questionnaire.
However, organizations, including Walden University Research Committee, the
Institutional Review Board of John H. Stroger, Jr. Hospital of Cook County, the
Bureau of Health Services, and the funding organization may inspect or gain a copy
of these research records for quality assurance.
What are the costs?
To help pay your costs in taking part in this study, you will receive a small token of
$25.00 in appreciation for your participation in this research study for eight weeks.
Healthy refreshments will be served after each class. Educational pamphlets will be
given to you to take home. A certificate will be given to you from Step of Faith
Ministry indicating your participation in this research study.
What are my rights as a research participant?
Taking part in this study is voluntary. You may choose not to take part. You may
leave the study at any time without any penalty.
What if I have questions or problems?
For questions about the study
Names
Prema David
Pastor Dieltroe Ford
Cathy Rowell
Yvonne Hunt Sanders

Contact Number
(847) 542-8147
(312) 322-9881
(773) 928-5762
(773) 776-1594
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Participant Consent
Please circle one
1.) I have read the information provided in this consent sheet
Yes/No
2.) I have the opportunity to clarify my questions
Yes/No
3.) I am willing to give my consent
Yes/No
4.) I understand that I can withdraw my participation from this study at any time
without penalty
Yes/No
Signature
I agree to take part in this research study
Participant: ________________________________________________________________(Print Name)
_______________________________________(Signature) ________________________________(Date)
Person Obtaining Consent: __________________________________________________(Print Name)
_______________________________________(Signature) ________________________________(Date)
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Instruction Sheet
1.) Please do not write your name, age, gender, and/or diagnosis on the
questionnaires
2.) Follow the pictures and mark accordingly
High Blood Pressure

High Cholesterol

Gender
X

= Male

Y

= Female

Age Group

18-35
Diabetes

36-45
Asthma

46-55
COPD

56-65
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Flyer

An Invitation to African Americans for an Educational Program

Purpose: This is a research study and its main purpose is to evaluate the
educational methods that will be used to educate on medications pertaining to High
Blood Pressure, High Cholesterol, Type 2 Diabetes, Asthma, and COPD
This educational program will last for a period of 8 weeks and it is only for African
Americans, 18 to 65, who are already taking medications for the above mentioned
conditions. The participation in this educational program is entirely voluntary and
you’re allowed to leave the program at any time with no cost.
Those, who remain in this program for 8 weeks, will receive 25 dollars as incentive
and every week refreshments will be served. Also, educational pamphlets will be
given for free. Participants are required to do a pretest and a posttest with simple
questionnaires. Your information will be kept confidential and will not be shared
with anyone else. This pretest and posttest will help us to evaluate as to how these
educational methods improve knowledge and confidence in taking medications.
The education will take place in a southwest community church with Step of Faith
Ministry once a week.
Address:
Elim Christian Church
2735 W. 79th St.
Chicago, IL 60652
Pastor Dieltroe Ford: (312)322-9881
Contact Numbers:
Pastor Dieltroe Ford: (312)322-9881
Qiana Allen: (773)580-1788
1594
Jada Fox: (773)633-1226
Ruby Tolliver: (773)928-8938

Cathy Rowell: (773)928-5762
Yvonne Hunt Sanders: (773)776James Keith Moore: (708)623-9610
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Curriculum Vitae
Prema David, MSN, APN, NP-BC, AANP-CV
Academics:
MS in Nursing, St. Xavier University, 1985, Chicago, IL
Adult Nurse Practitioner Certification, North Park University, 1998, Chicago, IL
Current Doctoral Student at Walden University, Minneapolis, MN
Professional Certification:
AANP Board Certification for Adult Nurse Practitioner since 1998
Professional Membership:
American Academy of Nurse Practitioners
American College of Nurse Practitioners
Licenses:
RN & APN by the State of Illinois
Clinical Experience in John H. Stroger, Jr. Hospital:
Pediatric Trauma, 1985-1986
Pediatric & Adult Burn Critical Care, 1986-1987
Nurse Practitioner:
Nurse Practitioner in Nephrology, 1987-Current
Primary Care in Nephrology/Consultation 1998-Current
Pulmonary Medicine, 2008-Current-AANP/Primary Care
General Medicine, 2009-Current-AANP/Primary Care
Clinical Responsibilities:
Complete Patient Care Management as a Primary Care Nurse Practitioner
Using Technology to complete Progress Sheets (Electronic Medical Records)
Prescribing Medications and Ordering Laboratory Work Using Electronic Devices
Ordering Necessary Diagnostic Tests according to Patient Needs
Educating the Patients on Medications, Diet, Exercise, and Self-Monitoring of Blood
Glucose
Referring when Consultations are needed
Health Promotion in Diabetes, Hypertension, and Hyperlipidemia
Telephone Consultation
Quality Assurance on Laboratory Reports and Take Appropriate Actions
Retrieve Sleep Report from the CPAP Machine and Interpret the Findings
Customize Education for Patients diagnosed with OSA
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Placing Orders to replace Defective CPAP Parts with consultation of Attending Physician
in compliance with Medicare & Medicaid for Illinois
Professional:
Maintain my continuous education requirements
Attend professional conferences
Meet the educational requirements of John H. Stroger, Jr. Hospital of Cook County (e. g.:
CPR, Fire)
Continue to maintain advanced education
Follow policies and procedures of Cook County Hospital
Research Activities:
Assisted in a study with Chief Nephrologist to study Membranous Renal Failure
Assisted in recruitment of African Americans for AASK studies
Currently assisting University of Illinois in recruiting African American patients with Sleep
Apnea
Teaching Experience:
Involved with preceptorship of North Park University Nurse Practitioner students from 2000 to
2009
Developed an educational program to educate patients at the clinical site along with other
supportive staff members and it is running well

